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Aims: A shift in attention away from a painful stimulus can cause pain relief. 
The mechanisms behind this process are thought to either be fully 
supraspinal or to involve spinal cord modulation by brainstem nuclei. The 
main object of investigation of the present thesis is to identify the neural 
pathways engaged during the attentional modulation of pain in healthy 
subjects and in patients with chronic pain (fibromyalgia) using functional 
magnetic resonance imaging. The role of endogenous opioids and of 
noradrenaline is investigated using selective pharmacology. 
Methods: In two different studies, healthy volunteers (n=57, Study1) and 
fibromyalgia patients (n=40, Study2) performed an attentional analgesia 
experiment during fMRI scanning of brain and brainstem. A third study 
(n=39, Study3) used an imaging sequence with manual shimming to acquire  
data simultaneously from brain, brainstem, and spinal cord. The opioid 
receptor antagonist naltrexone and the noradrenaline re-uptake inhibitor 
reboxetine are administered to the participants to examine the 
neurochemical components of attentional analgesia. 
Results: The attentional task was successful in inducing analgesia in healthy 
volunteers in all three studies presented. In Study1, a top-down mechanism 
where the cortex functionally connects to brainstem nuclei was 
demonstrated. In Study2, attentional analgesia was also observed in 
fibromyalgia patients, with involvement of similar brainstem mechanisms. 
In Study3, spinal cord activity mirrored the perceived pain intensity. A 
cortico-brainstem pathway was shown to modulate the dorsal horn of the 
spinal cord. Naltrexone blocked this path as well as the analgesic effect 
behaviourally. Conversely, reboxetine did not influence attentional 
analgesia.  
Conclusion: During high cognitive load and concomitant painful stimulation, 
the descending pain modulatory system, including locus coeruleus and 
rostroventromedial medulla is recruited for spinal cord modulation. This 
process is dependent on endogenous opioids. Fibromyalgia patients can 
achieve attentional analgesia by recruitment of brainstem nuclei, similarly 
to healthy volunteers. 
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Opioids have been a popular treatment for pain since the 1900 and to 
date they are one of the most effective ways of achieving analgesia (Morgan 
et al., 2011). However, it is increasingly evident that opioid-based 
medicaments are highly addictive and lead to drug misuse, which can result 
in death by overdose (Morone et al., 2013; Van Zee, 2009). In 2015 it has 
been reported that in the USA alone more than 40 people a day die f rom 
opioid misuse (Trang et al., 2015). An opioid crisis has been since declared in 
the US (Florence et al., 2016), and alternative methods for analgesia are 
being explored. In 2018 “The Opioid Crisis Response Act” has been issued to 
address this major problem.  
Cognitive modulation of pain is a strategy to achieve pain relief without 
the need for pharmacological intervention. It can be achieved by shifting 
focus away from the painful stimulus, it is not associated with side effects 
and does not cause addiction. A better understanding of the cellular and 
molecular mechanisms that lead to analgesia induced by distraction from 
pain is necessary for the development of new therapies for pain relief.  
The present thesis is structured as follows. A brief literature review is 
provided, highlighting the issues that remain unresolved. Methodological 
challenges and strategies to address them are explained. Following, research 
toward the understanding of how attention and pain interact in health and 
disease is presented in the form of three paper chapters. Finally, the overall 
message of the thesis is discussed in the general conclusions.  
 




1.2 Pain perception and its modulation 
 
1.2.1 Overview 
Nociception is defined as “The neural process of encoding noxious 
stimuli” by the International Association for the Study of Pain (IASP). Where 
a noxious stimulus is “a stimulus that is damaging or threatens damage to 
normal tissues”, typically the skin (Raja et al., 2020). This is a physiological 
process on which the survival of organisms depends, and is we ll 
phylogenetically preserved. Behavioural and cellular responses to noxious 
stimuli have been extensively studied in all vertebrates, including fish; and 
the molecular mechanisms behind it have been discovered in crustaceans, 
molluscs and even some insects (Smith et al., 2009; Walters et al., 2019) . 
Typically, nociception causes withdrawal from the stimulus and gives rise to 
‘repairing’ behaviour of the affected body part. Pain, on the other hand is 
defined as “an unpleasant sensory and emotional experience associated 
with, or resembling that associated with, actual or potential tissue damage” 
(Raja et al., 2020). Thus, the sensation of pain is only generated when 
transmission reaches the brain and enters an individual’s awareness. In the 
brain, the nociceptive stimulus is integrated with contextual and emotional 
information to generate a complex and highly subjective experience.  
1.2.2 The journey of a nociceptive stimulus 
Noxious stimuli received below the neck are conveyed to the spinal 
cord before reaching the brain (Brown, 1982). The spinal cord is a cylindrical 
structure part of the Central Nervous System (CNS), that runs along the 
vertebral column. This is the main interface of the CNS with the outside 
world, being responsible for transferring sensory stimuli from the periphery 
to the cerebrum. In addition, with extensive innervation of skeletal muscles, 
the spinal cord is an essential component of motor activity. The grey matter 
of the spinal cord has a typical “butterfly” shape, that divides it in four horns. 
The two dorsal horns receive sensory information from the ipsilateral side 
of the body, while the two ventral horns mediate ipsilateral motor activity.  




Inhibitory and excitatory interneurons within the spinal cord can modulate 
the activity of sensory or motor neurons, as well as connecting the two in 
spinal reflexes. A typical example of a spinal reflex is the withdrawal 
response to a painful stimulus, where the affected area is instinctively pulled 
away from danger (Derderian et al., 2019; Sandrini et al., 2005). This 
response is outside conscious control and relies on an internal network in 
the spinal cord composed of a sensory input, integrative interneurons, and 
a motor output. The latency between the stimulus delivery and the 
withdrawal reflex is often used in research as a measure of pain perception, 
for example for defining pain thresholds (Rhudy et al., 2007). 
The neurons that connect the skin to the spinal cord are part of the 
dorsal root ganglion. The cell body of these “pseudo-unipolar” neurons lies 
just outside the spinal cord and their axon has two branches, one innervating 
the periphery and one conveying the signal to the spinal cord. Such axons 
are also called “primary afferent fibres” and are bundled with motor fibres 
into fascicles that form the spinal nerves (Armett et al., 1961). Primary 
afferents are categorized by the myelination of their axons, giving rise to two 
main classes for nociception, A-δ and C fibres (Woolf et al., 2007). Both 
classes respond specifically to noxious stimuli, for example a very hot 
temperature (e.g. higher than 43 °C), and are silent during innocuous 
stimulation. The A-δ fibres are small, myelinated fibres, and are the first to 
respond to a noxious stimulus. They are specialized, with one fibre only 
carrying information on one type of stimulus (e.g. thermal). Engagement of 
A-δ fibres result in a short lasting, sharp painful sensation whose spatial 
localization is very precise. Conversely, C fibres are non-myelinated and give 
rise to secondary pain, a slower, dull sensation that is more diffusely 
localized (Brown, 1982). C fibres typically carry both thermal and mechanical 
information and are often classified as polymodal. Terminals of primary 
afferents in the skin expose transduction proteins (TRP) that are sensitive to 
specific noxious stimuli. These are typically transmembrane ion channels 
that once activated allow for influx of cation like calcium or sodium, thus 




causing membrane depolarization in the primary afferents (Tominaga, 
2006). 
A-δ and C fibres reach the dorsal horn of the spinal cord, where the 
nociceptive signal is transferred for the first time. The first synapse is 
typically between a primary afferent and a projection neuron directly. 
Projection neurons, or second order neurons, join ascending pathways to 
convey nociceptive information to supraspinal regions (Figure 1.1). The most 
widely studied is the spinothalamic tract, that connects the spinal cord to 
the thalamus and is considered the most evolutionarily recent (Kevetter et 
al., 1984). Second order neurons in this pathway cross the midline and travel 
through the lateral or medial part of the spinal cord, on the contralateral 
side in respect to the stimulation. This path is thought to relay information 
about the type of stimulus (e.g. thermal or mechanical) and the exact bodily 
location. Collaterals of the spinothalamic tract also project to other 
supraspinal areas, including brainstem nuclei, both contralaterally and 
ipsilaterally (Giesler, 2013). Other ascending pathways include for example 
the spinoreticular and spinomesencephalic tracts, where second order 
neurons connect the spinal cord to the reticular formation in the medulla 
and to the mesencephalon respectively (Fields et al., 1975; Hylden et al.,  
1986). Supraspinal areas like the thalamus and brainstem nuclei then feed 
into the cortex, where the sensation of pain is generated.  
1.2.3 Quantification of pain and cortical response to noxious stimuli 
Quantification of pain typically relies on a self-reporting score on a 
numerical scale. This is a measure used in diagnosis of painful conditions and 
to decide on the effectiveness of treatments. However, pain reporting is not 
an objective measure of the pain intensity perceived by an individual. 
Depending on a variety of factors, including past painful experiences and the 
unpleasantness of the sensation, pain intensity can be localized differently 
on a numerical scale. Some patients, for example children, patients with 
dementia or with disorders of consciousness, might also not be able to 
quantify their painful sensation on a numerical scale. Additionally, pain 




relieving drugs, especially opioids, can cause severe side effects like  
bradycardia, slowed breathing and nausea. Furthermore, opioidergic 
medications often lead to addiction, causing vulnerable patients to seek 
them even when not in pain. Clinical practice as well as pain research need 
a less subjective measurement of pain intensity to provide better care and 
further the understanding of how the pain sensation is generated. 
The idea that cerebral activity is necessary for the generation of a 
painful sensation started being accepted in the early 1900. Insights came 
mainly from patients with lesions in the thalamus and cortical areas, who 
cannot feel pain. However, localizing the exact source of the painful 
sensation was challenging. With the advent of advanced brain imaging 
technologies, researchers tried to resolve the exact brain regions 
responsible for this process. Different pain modalities have been used to 
elicit an acute pain sensation, including hot and cold thermal stimuli,  
mechanical insult, chemical substances, and electrical stimulation. Brain 
activity was recorded directly, for example through EEG, or via proxies of 
neural activation in fMRI and PET. Across studies, the cortical and subcortical 
regions more reliably responding to all types of nociceptive stimuli were the 
primary and secondary somatosensory cortex, the anterior cingulate cortex, 
the thalamus, and the dorsal posterior insula (Ingvar, 1999). Depending on 
the context and on the sensitivity of the brain measurement techniques 
used, additional regions would show activation, for example the amygdala, 
the hippocampus, prefrontal and temporal cortices (Tracey, 2005). These 
regions form an activation map that has been defined the “pain matrix”, a 
set of cortical and subcortical areas that together generate a painful 
sensation (Melzack, 1999). This was strikingly different to what has been 
observed in other sensory modalities, for example vision and smell, where a 
single cortical area is overall responsible for the sensation. Pain was already 
starting to be viewed as a much more complex phaenomenon, with distinct 
characteristics. 




It has been proposed that these different brain regions have specialized 
functions in their contribution to perception. The somatosensory cortices, 
S1 and S2, receive direct projections from the thalamus, organized in a 
somatotopic manner. In 1937, it was discovered by Penfield that different 
subregions of these large cortical areas respond to sensory stimuli delivered 
to specific parts of the body, thereby forming a map (Penfield et al., 1937) . 
These cortical areas are thought to specifically code sensory discrimination 
and the intensity of pain perception, forming the so-called “lateral pain 
system” (Bushnell et al., 1999; Kanda et al., 2000; Kenshalo et al., 1988). On 
the other hand, affective states associated with pain were thought to be 
represented in regions like the anterior cingulate cortex and the amygdala, 
part of the “medial pain system” (Kulkarni et al., 2005; Sewards et al., 2002; 
Vogt et al., 2000). The medial pain system would therefore mediate 
motivational responses to painful stimuli, for example aversion (Sewards et 
al., 2002). This definition however seems rather simplistic and does not 
consider the heterogeneous characteristics that many cortical areas present. 
For example, this classification fails to categorise the insular cortex, a region 
with a role in both affective pain processing (Craig, 2003) and sensory 
discrimination (Coghill et al., 1999; Craig et al., 2000), that would sit in 
between the two systems. The same is true for the anterior cingulate cortex, 
a region that was also found to directly correlate with the intensity of 
perceived pain (Brooks et al., 2017), in addition to mediate motivational 
aspects of behaviour. A more recent vision proposes that the personal 
experience of pain emerges from the net effect of transmission of 
information within this whole network (Mano et al., 2015; Tracey, 2005) . 
This would mean that the strength of the interaction between regions, more 
than the response of the individual regions themselves, is responsible for the 
subjective and context-dependent experience of pain. This is in striking 
contrast with the direct correlation between the pain intensity and activity 
in the dorsal posterior insula resolved with human imaging (Segerdahl et al.,  
2015). 




Not all researchers in the field accept the notion of a “pain matrix” as a 
unique and specific response to nociceptive stimuli. Discussions mainly stem 
from the absence of nociceptive-specific neural population in 
somatosensory cortices (Iannetti et al., 2010). While different sensory 
modalities, for example touch, are associated with specific cortical columns 
that are spatially segregated form each other, the same is not true for 
nociceptive stimulation. Cortical columns in the primary somatosensory 
cortex that responds to nociceptive stimuli also encode non-noxious 
stimulation (Kenshalo et al., 2000). In addition, neurons in frontal cortices 
that do seem to specifically respond to nociceptive stimuli and not to lower 
intensity touch or temperatures, were also found to encode threat (Dong et 
al., 1994; Hutchison et al., 1999). This finding lead to the hypothesis that 
these neurons do not necessarily encode a physical sensation of tissue 
damage, but more generically respond to aversive events (Iannetti et al., 
2010).  Furthermore, it is thought that studies that identified reliable brain 
activation to painful stimulation, are not able to discriminate whether the 
regions resolved are just encoding stimulus salience (Iannetti et al., 2010) . 
Saliency of a stimulus is defined as “its ability to stand out relative to the 
background” (Itti et al., 2001) that typically re-orients the individual 
attention (Nardo et al., 2011). Painful stimulation has all these 
characteristics, being intrinsically salient, subjective, and able to capture 
attention (Seminowicz et al., 2007; Van Damme et al., 2010). Additionally,  
regions thought to be pain matrix specific are found to respond to a variety 
of salient sensory events (Downar et al., 2000, 2003). Even the direct 
correlation between brain activity and the intensity of nociceptive 
stimulation or of pain perception could be explained in terms of saliency: 
events that more vigorously emerge from the background trigger a stronger 
alerting response in the brain (Iannetti et al., 2010).  
Following discussion on the specificity of the “Pain Matrix”, researchers 
worked to address the issues. For example, a recent fMRI study that 
controlled for stimulus saliency demonstrated that activity parietal 




operculum was specific for pain (Horing et al., 2019). In addition, the advent 
of high-performance computing and the increased use of computational 
modelling in neuroscience, allowed Wager and colleagues to resolve a 
“neurologic pain signature” (Wager et al., 2013). In this study, a machine 
learning algorithm identified a pattern of brain activity in more than 100 
volunteers that specifically responded to pain versus nonpainful stimulation. 
This pattern, or signature, reliably predicted whether the participants were 
in pain or not. Furthermore, its intensity of activation consistently lowered 
after administration of a potent analgesic. Once again, the brain regions 
resolved in this study were consistent with the pain matrix , including 
thalamus, the insula, the anterior cingulate cortex, and the secondary 
somatosensory cortex. Importantly, the net activity of all these areas was a 
much better predictor of the individual painful sensation than any individual 
region. 
1.2.4  Brainstem response to noxious stimulation  
Identification of brainstem nuclei in the perception of pain is even more 
challenging in humans. Its deep subcortical location prevents it being 
measured with electrophysiological techniques like EEG, as the signal 
coming from brainstem nuclei is confounded by activity in the cortex. Due 
to the small size of brainstem nuclei, the heterogeneity, movement with 
breathing, closeness to air filled spaces, and proximity to the Circle of Willis,  
measuring brainstem activity with functional imaging has not been much 
easier (see section 1.4.3 for details). For these reasons, human pain research 
mainly focused on large cortical structures, with only occasional studies able 
to examine subcortical areas.  
Many brainstem nuclei receive direct projections from second order 
neurons in the spinal cord and are of special interest because they can 
modulate cord interneurons with direct descending pathways. These nuclei 
include the periaqueductal grey (PAG) and the nucleus cuneiformis in the 
mesencephalon (Blomqvist et al., 1991; Keay et al., 1997), the pontine nuclei 
locus coeruleus (LC) and parabrachial nucleus, and the rostroventromedial 




medulla (RVM) (Cedarbaum et al., 1978, 1978; Doleys, 2014; Sugiyama et al.,  
2012; Voisin et al., 2005). The PAG is a crucial region in mediating the escape 
response to potential danger, as signalled by a noxious stimulus (Bandler et 
al., 1996). In animals, this region is found to be strongly involved with fight 
or flight behaviour (Henderson et al., 2018). It is typically divided in 
subregions that are involved in different behavioural strategies to threat 
(Lumb, 2002; Watson et al., 2016). Dorsolateral columns of the PAG are 
engaged during active coping, a “confrontational defensive reaction” to a 
threatening stimulus; ventrolateral columns are involved in passive coping, 
where the animal escapes from the stressor or freezes (Keay et al., 2001, 
1997; Koutsikou et al., 2014). Interestingly, the latter strategy is dependent 
on endogenous opioids, which might trigger bradycardia and analgesia (Keay 
et al., 1997; Waters et al., 1997).  
The advent of stronger MRI magnets and of advanced signal denoising 
techniques, allowed researcher to work toward resolving a brainstem 
signature of nociception. Early studies were able to identify in humans 
midbrain nuclei like the PAG and the nucleus cuneiformis, that with the 
ventral tegmental area showed activation in response to electrical pain 
stimulation (Dunckley et al., 2005). Researchers have also tried to 
investigate whether the functional organization of the PAG is similar in 
humans and in animals. This was challenging not only because of technical 
difficulties, but also because of the limitations caused by the experimental 
settings.  Acute pain, that in an ecological environment would be escapable, 
is typically made non-escapable for the participants of a human pain 
experiment, for example by fastening a pain device on the arm. This can lead 
to confusion for functional mapping of subregions of the PAG. However, 
findings from anatomical and functional connectivity studies in human 
volunteers tried to resolve a similar parcellation of the PAG. Functional 
connections to executive functions regions like the medial prefrontal cortex 
were predominantly identified in the dorsolateral PAG, whereas connections 
with areas of the descending pain modulatory system were, mainly localised 




in the ventrolateral PAG (Coulombe et al., 2016). Interestingly, anatomical 
connectivity indicated the opposite pattern, with the ventrolateral PAG 
connecting mainly with the prefrontal cortex and the dorsolateral area with 
the brainstem (Ezra et al., 2015).  Further studies, perhaps combining 
anatomical with functional connectivity analysis, are needed to conclusively 
identify the subdivisions of the PAG in humans. 
Recent brainstem-optimised fMRI acquisitions were able to resolve a 
pain signature also in the lower brainstem areas of the medulla, including 
the RVM, the LC, and pontine nuclei (Brooks et al., 2017; Napadow et al.,  
2019; Sclocco et al., 2016). The RVM was additionally found to correlate 
directly with the perception of pain, linking for the first time medullary 
activity not only to a role in relaying nociceptive information to the cortex, 
but to also encoding the subjective cognitive experience of pain perception 
(Brooks et al., 2017).  
1.2.5 Modulation of pain – descending modulatory pathways 
Pain is a subjective experience that can greatly vary between 
individuals and within an individual in different contexts (Beecher, 1946). For 
many years, it was thought that different pain experiences are only the 
result of cortical integration of context and emotional states, giving rise to 
an overall complex sensation. It is now known that interneurons in the dorsal 
horn of the spinal receive bidirectional modulation from descending control 
pathways originating in the brain. 
Top-down modulation is mainly achieved via direct spinal cord 
projections that originate in brainstem nuclei. The PAG is the most widely 
studied nucleus to endogenous pain modulation, being able to generate very 
powerful analgesia in rodents when stimulated (Koutsikou et al., 2007; Leith 
et al., 2010; Reynolds, 1969). Attempts of reproducing this result in human 
using deep brain stimulation were initially successful: PAG stimulation could 
indeed cause pain relief. However,  a number of side effects, like anxiety or 
even migraine were also triggered (Hosobuchi et al., 1977; Raskin et al.,  




1987; Richardson et al., 1977). The analgesia generated by stimulating the 
PAG was reversed by the opioid antagonist naloxone (Hosobuchi et al.,  
1977), suggesting a crucial role for endogenous opioids in this region. 
Consistent with these animals findings, a recent PET study in humans 
demonstrated the PAG to release endogenous opioids when electrically 
stimulated (Sims-Williams et al., 2017). 
While the PAG has some direct projections to the spinal cord (Bernard 
et al., 1998; Blomqvist et al., 1991; Mouton et al., 2000; Yezierski, 1991)   
these are relatively sparse, analgesia achieved by stimulating this region 
seems to be mediated by another nucleus. Injection of lidocaine, a local 
anaesthetic used in research to block a specific area, in the RVM can greatly 
diminish PAG-dependent analgesia (Sandkühler et al., 1984). This finding for 
the first time highlighted the importance of the interaction between these 
two regions in achieving endogenous analgesia, and opened for follow up 
work on the RVM. Typical studies on the functioning of this region used 
electrophysiological recording while observing rodent’s reflexes to noxious 
stimuli, for example tail-flick and paw withdrawal. In 1986, Fields and 
colleagues were able to identify two separate populations of cells within the 
RVM: the ‘on-’ and ‘off-’ cells (Cheng et al., 1986). Population of neurons 
that showed an increased firing rate immediately before the rodent initiated 
a tail-flick, were labelled ‘on-cells’. Population of neurons that decreased 
their firing rate at the same time, where labelled ‘off -cells’ (Fields et al.,  
1983; Heinricher et al., 1989; Potrebic et al., 1994). Interestingly, both 
populations project to the dorsal horn of the spinal cord, providing a strong 
indication for this region to bidirectionally modulate the cord response to 
noxious insult (Fields et al., 1995). Subsequent studies validated this theory, 
demonstrating that on-cells exhibited an enhanced firing rate in a 
hyperalgesic condition induced by, for example, opioid abstinence (Kaplan 
et al., 1991). Lidocaine injection in the RVM was able to abolish the increased 
nociceptive response, suggesting a causal role of this cell population for the 
exaggerated perception (Morgan et al., 1994). Conversely, systemic 




administration of a mu opioid receptor agonist increased the firing rate of 
off-cells, leading to the hypothesis that this population has a crucial role in 
opioid-induced analgesia (Fang et al., 1989). It was also found that 
opioidergic injections in the PAG could trigger off-cells activity in the RVM, 
providing insights on how the interaction between these regions leads to 
analgesia (Cheng et al., 1986). It is worth noting that PAG-dependent 
modulation of spinal cord is specific for noxious stimuli (Leith et al., 2010). 
The PAG-RVM system is not the only brainstem mechanism that can 
generate analgesia, the spinal cord is densely innervated by noradrenergic 
pathways. The locus coeruleus, the main source of noradrenaline in the 
brain, is one of the main nuclei with direct descending projections. 
Noradrenergic alpha2 adrenoceptors are strongly expressed in the spinal 
cord interneurons (Olave et al., 2003) as well as in primary afferent terminals  
(Stone et al., 1998). They are thought to be the main receptors to mediate 
noradrenergic analgesia via an inhibitory effect on second order neurons 
and primary afferents. These receptors are indeed especially engaged during 
persistent injury, as part of a compensatory response to hypersensitivity 
(Malmberg et al., 2001; Mansikka et al., 2004). Additionally, activating 
alpha2 receptors through agonists was found to be effective for analgesia, 
especially in injured animals (Mansikka et al., 1996; Stanfa et al., 1994; Xu et 
al., 1992; Yaksh et al., 1995). Alpha1 receptors are also expressed widely in 
spinal cord and could suppress nociceptive activity by acting on inhibitory 
interneurons (Nalepa et al., 2005), providing an additional mechanism to 
analgesia induced by noradrenaline. The pharmacological/therapeutic 
potential of noradrenaline has been thus explored in chronic pain states. For 
example, systemic delivery of reboxetine, a noradrenaline reuptake 
inhibitor, prevented the developing of exaggerated response to an 
innocuous mechanical stimulus in a chronic pain model in rats (Hughes et al.,  
2015). This effect was dependent on alpha2 receptors. Noradrenaline is 
therefore increasingly viewed as a powerful alternative to opioids in the 
treatment of chronic pain pathologies. Indeed, drugs that increase the 




availability of this neurotransmitter, like duloxetine and amitriptyline, are 
increasingly used in clinical practice with promising results (Kremer et al.,  
2016, 2018).   
Descending pathways are thought to be recruited by cortical areas 
(Figure 1.1, Quintero, 2013; Xie et al., 2009). The ACC, an area involved in 
pain perception, projects directly to the PAG and is thought to be one of the 
main cortical centres to trigger endogenous pain modulation. This region is 
typically associated with the emotional modulation of pain with its activity 
being consistently correlated to pain unpleasantness (Rainville et al., 1997; 
Vogt et al., 2000).  Direct evidence for the involvement of the ACC in the 
modulation of pain comes once again from analysing the behaviour of 
rodents. Researchers have demonstrated that electrical stimulation of the 
ACC shortens the latency of tail flick or paw withdrawal in response to a hot 
painful stimulus, thereby indicating enhanced nociception (Zhang et al.,  
2005). Interestingly, this pro-nociceptive process seems to be dependent on 
RVM activity (Calejesan et al., 2000). Just like the PAG-RVM system, the ACC 
modulates nociception bidirectionally, being also involved in analgesia. 
Endogenous opioids have an important effect on the ability of the ACC to 
modulate pain. For example, a PET study used a broad spectrum opioid 
ligand to demonstrate high availability of opiate receptors in this region 
(Baumgärtner et al., 2006). In addition, activation of mu opioid receptors in 
the ACC have been linked to pain relief (Zubieta et al., 2001). Intriguingly, 
endogenous opioids in the ACC have also found to be necessary to mediate 
pain relief triggered by non-opioid drugs (Navratilova et al., 2015). Thus, the 
ACC is thought to sit on top of pain modulatory nuclei in the brainstem, via 
connections to the PAG and the LC (Fig 1, De Felice et al., 2016). 
Somatosensory cortices are usually thought to passively encode the 
nociceptive stimulus, with a major role in sensory discrimination and 
identification of the site being stimulated (see section 1.2.3). However, 
evidence is suggestive of an active role for these structure s in pain 
modulation. A study found that stimulation of the secondary somatosensory 




cortex results in analgesia and in a decreased number of dorsal horn neurons 
active in response to noxious stimulation (Kuroda et al., 2001). This is 
suggestive of an active role of this region in recruiting subcortical/brainstem 
nuclei to modulate the spinal cord. Indeed, the antinociceptive activity in SII 
was found to be dependent on the RVM (Sagalajev et al., 2017), perhaps 
recruited indirectly by the ACC  (Xie et al., 2009).  Although the mechanism 
through which SII can achieve pain modulation is yet to be resolved, 
endogenous opioids are likely involved as receptors are highly expressed in 
this region (Baumgärtner et al., 2006).  
Human studies on pain modulation have also identified the dorsolateral 
prefrontal cortex as an important region for top-down control. This area is 
implicated in executive control through signalling from adjacent cortical 
areas, for example the medial prefrontal cortex, and in emotional regulation 
through connections with limbic structures, such as the amygdala (Ong et 
al., 2019). It is thus suggested that the dorsolateral prefrontal cortex has an 
important role in the cognitive aspects of pain perception and its modulation 
(Seminowicz et al., 2007). Human neuroimaging studies found activity in this 
area to negatively correlate with pain scores (Lorenz et al., 2003) and to be 
tonically active during pain inhibition (Freund et al., 2009). In addition, a 
study showed that ACC-midbrain and midbrain-thalamus correlations were 
stronger during low dorsolateral prefrontal cortex activity (Lorenz et al.,  
2003). This area has been consistently implicated in placebo analgesia 
(Eippert et al., 2009; Geuter et al., 2013; Petrovic et al., 2010; Wager et al.,  
2004), mainly through functional connections to the PAG, anatomically 
mediated by the ACC (Eippert et al., 2009; Sevel et al., 2015). Together, these 
findings suggest that this area is able to exert an inhibitory effect on 
descending facilitatory pathways. 





Figure 1.1 Ascending and descending modulatory pathways. Modified from 
Fields et al., 2004. The pink arrows represent a bottom-up pathway of pain 
perception, including projections from the dorsal horn to the periaqueductal grey 
(PAG), thalamus, insula, and anterior cingulate cortex (ACC). A top-down cortico-
brainstem pathway involved in the bidirectional modulation of pain is shown in red, 
where ACC, Insula, and thalamus recruit PAG, LC and RVM. The noradrenergic 
projection from the LC to the dorsal horn is shown in blue, the glutamatergic and 
GABAergic projection from the RVM to the dorsal horn is shown in green.  
 
1.2.6 Cognitive modulation of pain and attentional analgesia  
Pain perception is a complex experience that depends on context, 
expectations and on emotional and cognitive states. An identical noxious 
stimulus can elicit radically different perceptions in different people, but also 
in the same person in different moments. One of the most famous types of 
cognitive modulation of pain is probably the placebo effect. When a 




physician prescribes a medication for pain relief, the patient builds strong 
expectation on its effect. Even if the drug completely lacks active analgesic 
components, the patient will likely experience pain relief  (Colloca, 2019; 
Colloca et al., 2005). Interestingly, negative expectation can also have an 
enhancing effect on the perception of pain, in a phenomenon called nocebo 
(Colloca, 2017). When the placebo and nocebo effects started to attract 
more clinical interest, researchers also investigated other forms of cognitive  
modulation of pain, such as music analgesia, mindfulness-based pain 
reduction and attentional analgesia. The latter is the focus of this thesis and 
is especially fascinating as it can regularly be observed outside experimental 
settings. Just by shifting focus on something different from a painful 
stimulus, analgesia can be achieved. Like expectation-induced analgesia, the 
attentional modulation of pain is a bidirectional process, where focus on 
pain causes an increase in pain perception (Moore et al., 2017). The 
analgesic effect of attention can be induced by a variety of distractors, for 
example an attentional task (Bantick et al., 2002; Brooks et al., 2017, 2002; 
Petrovic et al., 2000; Sprenger et al., 2012; Valet et al., 2004), or even by 
mind wandering (Kucyi et al., 2013). In a typical experiment, healthy 
volunteers receive an identical painful stimulation under at least two 
conditions. In one condition, they are instructed to rest; in the other, to 
focus on something different, ignoring the sensation. Typically, the intensity 
of pain reported by the participants is lower when participants do not attend 
pain.  
Early studies on attentional analgesia found that diminished pain 
perception was observed in conjunction with a reduced response in 
somatosensory cortex and insula, consistent with these two regions coding 
sensation (Bushnell et al., 1999; Fairhurst et al., 2007; Markus et al., 2011) . 
Interestingly, the ACC also showed a diminished BOLD signal during 
distraction from pain (Bantick et al., 2002). This was surprising as this region, 
supposedly part of the medial pain system, was thought to only code pain 
affect and not the intensity of the sensation. However, the attentional 




modulation of pain does not only involve coding of pain intensity in the 
cortex but is likely to involve conflict resolution processes. As discussed 
above (section 1.2.3), pain inherently causes re-orienting of an individual’s 
attention, leading to selection of the appropriate behavioural response (e.g. 
fight or flight). A second stimulus competes for the subject’s attention, 
thereby inducing a conflict. In line with this idea, frontal cortices implicated 
in executive functions, such as the orbitofrontal cortex and the ACC, were 
found to be actively engaged in the attentional modulation of pain (Petrovic 
et al., 2000). In following studies, it soon became apparent that this process 
does not only involve cortical areas. Several experiments suggested that the 
pain modulatory system is involved in attentional analgesia. For example, an 
early study implicated PAG activity in endogenous pain modulation (Tracey 
et al., 2002). A significant correlation between the BOLD signal in this area 
and the analgesic effect, defined as the decrease in pain scores during 
distraction from pain, was revealed. This provided direct support for an 
active role of this region in the attentional modulation of  pain. A following 
study demonstrated that the PAG is recruited by the ACC during an 
attentional analgesia paradigm, showing for the first time a possible cortico-
brainstem pathway to analgesia induced by an attentional shift (Valet et al.,  
2004). These findings lead to the hypothesis of a top-down control system, 
where the cortex potentially resolves the attentional conflict and triggers 
analgesia by recruiting brainstem nuclei. Conclusive proof came with a spinal 
cord fMRI study, where the dorsal horn showed dampened activity during 
distraction from a painful stimulus (Sprenger et al., 2012). In line with these 
findings, a correlation between neural activity and analgesia was shown in 
the RVM (Brooks et al., 2017), which, as described above, can bidirectionally 
modulate the spinal cord via descending projections. Finally, the analgesic 
effect of attention was reversed by delivery of the opioid antagonist 
naloxone, an additional suggestion for the interaction between ACC-PAG-
RVM to be responsible for attentional analgesia (Sprenger et al., 2012).  




However, not the entire scientific literature is in agreement with the 
involvement of this descending pathway in attentional analgesia. It has been 
proposed that separate pathways are recruited in the emotional and 
attentional modulation of pain (Bushnell et al., 2013). According to Bushnell 
and colleagues, the ACC-PAG-RVM system is mainly implicated in the 
emotional modulation of pain perception, for example mood. The reason 
why this pathway is consistently resolved in attentional analgesia 
experiments would be the concurrent recruitment of affective and 
emotional processes. The superior parietal cortex, on the other hand, was 
implicated in distraction from pain in an experiment that controlled for 
emotional components (Villemure et al., 2009). This area, part of the 
attentional network, could thus modulate pain perception not by recruiting 
brainstem nuclei to modulate the spinal cord, but by cortico-cortical 
connections with the insula and somatosensory cortices.  Additional 
investigation is needed to reproduce previous findings and clarify whether 
the network involved in attentional analgesia is restricted to cortical 
interaction, or it extends to the brainstem. 
Cognitive modulation of pain has also been studied in rodents. While it 
is difficult to impose a shift in attention in animals, especially without 
introducing additional confounds like reward processing, environment 
enrichment has been used by researchers to distract rodents from pain. 
Enrichment is usually achieved by adding toys, running wheels, or peer 
animals in the same cage and was consistently found to improve 
neurogenesis (van Praag et al., 2000). In an experiment where rats received 
nerve injury, the resulting hypersensitivity significantly reduced when rats 
could run on a treadmill (Stagg et al., 2011). This process was reversed by an 
opioid antagonist, which was shown to act on PAG and RVM. While this may 
not be considered a strict equivalent of an attentional analgesia paradigm in 
humans, it indicates that cognitive mechanisms of pain modulation are 
phylogenetically preserved and the mechanisms behind it could be similar 
across species.  





1.3 When pain becomes a pathology 
1.3.1 Overview 
Pain is a physiological mechanism crucial for survival, but it can turn 
into a pathology. Chronic pain has been defined as “pain that persists past 
normal healing time” (Treede et al., 2015) and “that typically persists or 
recurs for more than three months” (Treede et al., 2019). This is a disabling 
pathology that affects between 13 and 50% of the entire UK population, 
predominantly females (Fayaz et al., 2016). Currently, a predominant 
therapeutic approach for chronic pain is prescription of opioidergic drugs, 
which can lead to dangerous side effects as well as to opioid addiction. Thus, 
in addition to different pharmacological targets, non-pharmacological 
approaches to pain relief are being increasingly tested such as Cognitive 
Behavioural Therapy, exercise interventions and pain management 
programs.  
1.3.2  Molecular and cellular mechanisms in the chronification of pain 
Chronic pain is conventionally thought to arise from long-lasting tissue 
damage and/or inflammatory states. It can initiate with a persistent injury, 
for example a surgery, where after tissue healing has occurred, pain is never 
fully resolved. Additionally, nerve injury caused by, for example, cancer or 
diabetes can lead to the neurochemical and neuroplasticity changes 
responsible for neuropathic pain. However, the molecular and functional 
mechanisms leading to the chronification of pain are not yet fully 
understood. Rodent models, where neuropathic pain is induced by spinal 
nerve ligation, are extensively used to investigate this issue (Honore et al., 
2000). Repeated engagement of nociceptors caused by tissue damage 
triggers the production of inflammatory molecules, such as prostaglandins, 
substance P, and cytokines by cells of the immune system or by primary 
afferents. These can act on G-protein coupled receptors that can sensitize 
and upregulate ion channels on nociceptors, leading to peripheral 




sensitisation (Voscopoulos et al., 2010). Inflammatory molecules and 
endogenous peptides can also activate a ‘silent’  class of nociceptors. These 
are mainly located on C-fibres and do not respond to thermal or mechanical 
stimuli but are sensitive to neuroinflammation, contributing to primary 
afferent excitation during sustained nociception (Gold et al., 2010) . 
Peripheral sensitization can lead to hyperalgesia, a physiological mechanism 
where mild noxious stimuli are perceived as extremely painful. These 
peripheral changes are normally localized to a site of injury and are resolved 
after healing. Transient modulations of nociception can however turn into 
longer lasting modifications in their genetic expression, in a mechanism that 
contributes to the transition from physiology to pathology (Doleys, 2014; 
Prato et al., 2017).  
Long-lasting modifications to nociception mechanisms in the central 
nervous system are directly involved in the chronification of pain. For 
example, it is thought that persistent noxious inputs to the spinal cord can 
cause neuronal death in dorsal horn interneurons (Moore et al., 2002) ,  
responsible for pain modulation. This leads to central sensitization of second 
order neurons that become more efficient in transmitting noxious stimuli to 
the brain (Voscopoulos et al., 2010). However, it should be noted that this 
effect is not seen in all chronic pain models (Polgár et al., 2004). Additionally,  
central neurons in the spinal cord can feedback to the periphery and 
contribute to inflammation through axonal reflex (Hagains et al., 2010) . 
Central neuroplasticity mechanisms are also thought to be dependent on 
NMDA receptors (Woolf et al., 1991), activated by glutamate released by C 
fibres. These receptors are known to mediate the main mechanism to neural 
plasticity, long term potentiation, in presence of persistent inputs. Normally,  
NMDA receptors’ channels are blocked by the positive ion magnesium and 
are not able to allow cations in the neuron after binding glutamate. If the 
neuron is depolarized by other mechanisms, for example excitation of the 
AMPA glutamate receptors, the magnesium is expelled, causing the NMDA 
channel to open. This allows calcium influx, leading to the activation of 




signalling transduction cascades that can cause genetic up- or down-
regulation and protein phosphorylation (Lüscher et al., 2012). These 
mechanisms were shown to be crucial for the transition from physiological 
to pathological nociceptive transmission (Price et al., 1994). 
1.3.3 Imbalance in descending pain inhibition in chronic pain 
Sustained alterations in the balance of descending modulatory 
pathways is also thought to be an important mechanism in the development 
of chronic pain pathologies (Tracey et al., 2007). In support of this view, it 
has been demonstrated that inflammation can enhance the activity of the 
pro-nociceptive on cells in the RVM (Burgess et al., 2002). Inhibition of the 
interaction of these cells with the spinal cord was able to reverse the 
exaggerated behavioural response to noxious stimuli following nerve injury. 
This finding indicated an active role of the RVM in the development of a 
chronic pain phenotype (Bee et al., 2008). Inhibition of the RVM had a similar 
effect in neuropathic pain models in rodents (King et al., 2009). The 
noradrenergic system is also thought to play an important role in pain 
chronification, as it was found to be augmented after nerve injury (Ma et al., 
2003). On the other hand, an intact noradrenergic system can delay the 
onset of enhanced pain perception in injured animals (Hughes et al., 2013) . 
Imbalances between inhibition and facilitation in the descending pain 
modulatory system are therefore also thought to play a crucial role in 
maintaining chronic pain states (Burgess et al., 2002; Lee et al., 2008).  
Human studies corroborated these hypotheses with numerous findings 
of dysfunctional endogenous pain inhibition in a variety of chronic pain 
pathologies (Ossipov et al., 2014) . The most widely used paradigm in the 
study of endogenous analgesia is conditional pain modulation. Here, a 
painful stimulus is presented alone or alongside a second noxious stimulus, 
typically of a different modality, in a second area of the body. In healthy 
subjects, pain perception to the first stimulus is higher when it is presented 
alone, in a process defined “pain inhibits pain”, that involves pain 
modulatory pathways (Knudsen et al., 2011). Studies in different chronic 




pain states, including irritable bowel syndrome, chronic back pain and 
fibromyalgia, revealed this mechanism to be malfunctioning in pathological 
pain states (Lewis et al., 2012). Interestingly, the efficiency of conditioned 
pain modulation is also able to predict whether a patient is at risk of 
developing post-operative pain, with an inverse relationship (Yarnitsky et al.,  
2008), as well as the efficiency of the noradrenergic drug duloxetine 
(Yarnitsky et al., 2012). 
The cerebral signature of this process is still under investigation. The 
dorsolateral prefrontal cortex has been implicated in chronic pain 
maintenance when a PET study resolved abnormal neurotransmission in this 
region (Grachev et al., 2000). The same area also shows diminished grey 
matter density in chronic back pain (Apkarian et al., 2004; Seminowicz et al.,  
2011), which was reversed after pharmacological treatment. Malfunctioning 
in this area might trigger a series of cascade events that result in imbalances 
in the pain descending modulatory system. However, it is equally possible 
that abnormal ascending signalling from the spinal cord and brainstem 
relays influences the activity of DLPFC and other cortical regions. On the 
other hand, a recent study used a machine learning approach to categorize 
healthy volunteers and chronic pain patients on the basis of their BOLD 
response to non-painful tactile stimulation (Lopez-Sola et al., 2017). In this 
study, increased activity was detected in regions of the “pain matrix”,  
including the insula, the prefrontal cortex and the cerebellum in fibromyalgia 
patients compared to healthy controls. Interestingly, activity in these regions 
directly correlated with the intensity of clinical pain presented by patients, 
implicating the extent of dysfunction in these areas in the worsening of the 
pathology. These findings suggest that chronic pain pathologies are 
characterised by an enhancement of pain facilitatory activity with 
concurrent malfunctioning of endogenous pain inhibition. 
 




1.3.4 Chronic pain and attention 
Attention and pain share a reciprocal, complex relationship. It has been 
consistently reported that patients suffering from different forms of chronic 
pain tend show cognitive, and especially attentional deficits. On one hand, 
patients show hypervigilance toward their painful sensation; on the other, 
they typically have trouble focusing on external events. Disruption of 
cognitive processes in chronic pain states has been investigated in 
experimental settings when it was found that patients in pain perform 
consistently worse than healthy controls in attentional tasks (Dick et al.,  
2002; Eccleston, 1994; Grace et al., 1999; Grisart et al., 1999; Oosterman et 
al., 2012; Veldhuijzen et al., 2012). This effect was not due to impairments 
in motor ability, but was specific to sustained attention, as revealed by 
worsening of performance in longer task duration (Oosterman et al., 2012) . 
Additionally, higher reported pain intensity seems to directly correlate with 
attentional deficits (Weiner et al., 2006). It is thought that these arise  
because the patients cannot disengage from the ongoing painful sensation, 
perceived as highly salient, to shift their attention on other events (Legrain 
et al., 2009). Attention management is therefore an important aspect in 
cognitive behavioural therapy for chronic pain, helping to divert the patients 
focus away from their painful sensation (Elomaa et al., 2009; Morley et al.,  
2004). The neural bases for these attentional impairments are however not 
currently resolved. A better understanding of the interaction between pain 
and attention in these pathologies can help to better characterize chronic 
pain and to improve the use of attentional shifting strategies to pain relief.  
1.4 Measuring cortical and subcortical brain activity without entering 
the skull: functional magnetic resonance imaging 
1.4.1 Overview 
Functional magnetic resonance imaging (fMRI) allows the non-invasive 
measurement of neural activity in cortical and subcortical structures. This 
technique is not directly sensitive to action potentials or electrical activity,  
but relies on changes in cerebral blood flow to make inferences on the 




engagement of brain/spinal cord areas. Increased energetic demand in a 
CNS region causes the need for blood rich in oxygenated haemoglobin, 
which has different magnetic properties compared to de-oxygenated 
haemoglobin. This effect gives rise to the blood oxygen level dependent 
(BOLD) signal measured by fMRI (Ogawa et al., 1990). A four-dimensional 
image of the brain/spinal cord is built by measuring BOLD from units, or 
voxels, without the need of using an exogenous contrasting agent or any 
type of surgery (Logothetis, 2003, 2008).  
Typical task fMRI studies infer spatially localized brain response by 
comparing the BOLD signal to the time-series of the experiment in a General 
Linear Model, effectively performing a statistical test for each voxel. In this 
analysis techniques, a haemodynamic response function is convolved with a 
model of the experiment, to create a realistic model of the measured signal 
(Figure 1.2). A statistical map of the entire functional image is built where at 
each voxel is attributed the result of a statistical test. Typically, only voxels 
whose statistical parameters are higher than a given threshold are 
categorized as ‘active’ (Woolrich et al., 2004).  
Figure 1.2 Classical analysis of fMRI data. A model of the experiment is 
convolved with a hemodynamic response function (HRF) to make it more similar to 
the measured data. The model is then used for statistical tests in each voxel of the 
functional image. Reproduced from FSL lectures (2017). 
 




1.4.2 The problem of multiple comparison and solutions 
The most convincing criticism of fMRI research is the famous study of 
the dead Atlantic salmon (Bennett et al., 2009). Here, a researcher put a 
dead Atlantic salmon in an fMRI scanner and imaged BOLD in its brain during 
a visual task. To everyone’s surprise, a statistical analysis of the data resulted 
in quite a few voxels of activation, suggesting residual brain activity in the 
deceased fish.  Unfortunately, since there was no brain activity the resulting 
“activation” was only a false positive, the result of chance, after a large 
number of statistical tests in each voxel of the functional image. The multiple  
comparison problem, caused by too many correlated statistical tests, was 
already a known problem in the field of statistics, but it was rarely addressed 
in the fMRI community thus far. In the following years, researchers and 
software developers began finding solution for the multiple comparison 
problem. In statistics this is typically solved using a Bonferroni correction, 
thus by dividing the statistical P value by the number of tests performed. 
This is however a very stringent method, especially given the very large 
number of voxels in a brain, and would preclude the detection of subtle 
signal changes. Two solutions emerged as more appropriate for the analysis 
of BOLD response in the CNS: cluster thresholding along the usual voxel 
thresholding and regions of interest (ROI) masking.  
Cluster thresholding imposes a specific number of adjacent voxels to 
respond to the experimental manipulation. This is under the spatial 
correlation assumption: a given voxel is highly correlated with its 
immediately neighbouring voxel, and especially so if it they are part of the 
same brain region. This is often the case when studying large cortical areas.  
Additionally, an important step of pre-processing of fMRI data is spatial 
smoothing, where a three-dimensional gaussian kernel is applied to each 
voxel, averaging its value with the adjacent voxels. This increases spatial 
correlation even more. A minimum number of voxels reaching a given height 
threshold is therefore set for a known spatial smoothness (Brett et al., 2003) . 




Regions of interest masking is normally used when researchers have a 
strong hypothesis on the CNS region expected to respond to a given 
stimulus. These hypotheses could derive from previous evidence in animal 
studies, human lesion studies or even from theoretical models. The use of 
ROIs greatly improves the multiple comparison problem, depending on the 
size of the mask used. This approach is however not considered enough to 
avoid the chance of reporting false positive and it is only typically accepted 
when used in conjunction with permutation testing. Permutation testing is 
a non-parametric statistical test that relies on the random shuffling of each 
data label, for example the group membership in a two-sample t test. This 
relies on the assumption that if the null hypothesis is true and there are no 
differences between a group A and a group B for the tested variable, the 
statistical result will be the same after scrambling the data labels. The 
resulting P value after permutation testing is therefore the proportion of 
tests where the difference between A and B is greater or equal to the 
difference originally observed. A significance level alpha is applied as usual. 
In the case of a one-sample t test, where only one group is tested, the 
permutation is only applied to the sign of the data, which is be flipped 
(Nichols et al., 2002; Winkler et al., 2014).  
1.4.3 Brainstem imaging 
FMRI in the brainstem is presented with additional challenges. 
Physiological noise, defined as signal of no interest that is derived from 
physiological processes, is predominant in this area and makes measuring of 
relevant BOLD signal nontrivial. The brainstem sits in the vicinity to the Circle  
of Willis, where multiple arteries are joined. Blood flow and CSF pulsatility 
during the cardiac cycle cause significant signal fluctuation in the BOLD 
measured in the brainstem. Respiration directly causes apparent movement 
of this structure and geometric distortions, leading to displacement of single 
voxels in different phases of the respiratory cycle (Terem et al., 2018) . 
Additionally, the vicinity of the brainstem to air and bone structures, adds 
distortions to the functional images by causing inhomogeneities in the 




magnetic field. The temporal signal to noise ratio is an objective measure of 
the amount of meaningful signal compared to the random fluctuation 
(Welvaert et al., 2013). This can be calculated by dividing the mean signal 
intensity across the time-series by the temporal standard deviation of the 
functional image (Parrish et al., 2000). The temporal signal to noise ratio is 
significantly decreased in the brainstem versus the cortex, in a typical 
functional image (Figure 1.3, Brooks et al., 2013). This means that it is much 
harder to detect a significant change in activity in brainstem nuclei, versus 
cortical regions. Signal must be recovered to study such areas.   
One of the most effective solutions to remove physiological noise 
influence on functional images is measuring heartbeat and respiration  
during the scan. This information can then be used in a general linear model 
in a similar manner to how the experimental model is used during normal 
fMRI analysis. The variance in the BOLD signal that strongly correlates with 
one of the two physiological noise sources, or a combination of the two, can 
be subsequently regressed out, or subtracted, from the rest of the data, 
leaving meaningful signal (Brooks et al., 2013). Fieldmap unwarping is an 
additional tool useful for correcting for image distortions caused by the 
interface between the brainstem and bone/air. In this procedure, an 
estimate of the field variation is measured before or after the functional 
images acquisition. The software (FUGUE) will then compute the 
displacement that would be seen in that area, as well as the necessary 
correction. Finally, permutation testing aids the identification of a-priori 
specified brainstem nuclei that would fail to reach the voxel and cluster 
threshold defined for large cortical areas  (Bosma et al., 2016; Brooks et al.,  
2008).  






Figure 1.3 Temporal signal to noise ratio in the brainstem is significantly lower 
than the cortex. Reproduced from Brooks et al., 2013. 
 
1.4.4 Spinal cord imaging 
When an object (such as a body) is placed within the magnetic field of 
an MRI scanner, it causes the main magnetic field (B0) to become non-
uniform. This inhomogeneity can give rise to distortion and signal dropout 
in MRI pulse sequences sensitive to such effects, such as those used to 
record changes in blood flow, i.e. echo planar imaging (EPI). Typically, the 
scanner attempts to correct for such inhomogeneity in a process called 
shimming: the inhomogeneity of the magnetic field is measured, and the 
necessary correction is computed. Shim coils will apply to the object of 
investigation the necessary gradient (shim offset) and attempt to improve 
magnetic field homogeneity. If the magnetic field varies linearly in any of the 
three axes, for example in a regular brain-only fMRI acquisition, then a 
combination of linear shim gradients is enough to cancel out this effect. In 
the spinal cord however, the field presents periodic variations along the cord 
in the z direction caused by the different magnetic properties of the tissue 
adjacent to the cord, such as intervertebral discs and vertebrae. The shape 




of the body also varies along the z direction with head, neck, and shoulders 
each introducing different distortions in the field (Figure 1.4B). To address 
this issue, (Finsterbusch et al., 2012) used a technique called z-shimming 
whereby a specific gradient offset is applied during the acquisition of data 
from each axial section of the cord. For calibration, a set of reference 
volumes where the shim offsets are systematically altered in equidistant 
steps is acquired and visually inspected. The shim offset that gives rise to the 
highest signal intensity and most appropriate cord shape is chosen for each 
slice for the subsequent acquisition (Figure 1.4B). Thanks to an image 
acquisition sequence built by Ron Hartley-Davies, Cric’s MRI physicist, we 
were able to use a similar approach on the spinal cord slices in our fMRI 
acquisition (Chapter 4). 
Another complication common to imaging brainstem and spinal cord is 
caused by cardiac and respiratory processes that cause physiological noise 
and voxels displacement and consequently a decrease in temporal signal to 
noise ratio. An effect that is amplified in these regions because of their 
proximity to blood vessels and air spaces (Brooks et al., 2013; Terem et al., 
2018). This problem was again addressed by recording heart and respiratory 
rate to remove their influence during pre-processing of the images.  





Figure 1.4 Axial slices in the cervical spinal cord acquired without (a) and with 
(b) z-shimming. The z-shimming approach recovers most of the signal in the spinal 
cord. Modified from Finsterbusch et al., 2012. 
  




1.5 Aims and relevance of the thesis 
The aim of the present thesis is furthering the understanding of  the 
mechanisms leading to attentional analgesia in health and pathology.  
Prior studies in humans on this topic provide limited evidence for the 
involvement of the brain and mid-brain in the descending pain modulatory 
system, whilst the animal literature suggests that the interaction of brain, 
brainstem and spinal cord is key to understanding this process. However, in 
humans the involvement of the entire CNS network in attentional analgesia 
has not been demonstrated in attentional analgesia. There is evidence in the 
literature for the involvement of endogenous opioids in this process, but the 
exact site for their action has not been resolved. In addition, noradrenaline 
has been hypothesized to play a dual role, by modulating attentional 
demand and spinal analgesia, but its implication remains theoretical.  
Understanding more about the brain interaction between pain and 
attention and their resolution can inform the development of new cognitive 
strategies to analgesia during acute pain. Examination of this interaction in 
chronic pain states can improve the understanding of such pathologies, 
leading to better care. These research questions are also relevant in a 
broader cognitive neuroscience context for its insights on the re -orienting of 
attentional resources. The current neuroscience reproducibility crisis 
problem caused by individual variability and by technical challenges is 
directly addressed by performing identical analyses on independent 
datasets. Furthermore, the technical challenges addressed in the pre sent 
thesis are common to other pain and non-pain imaging research. For 
example, functional imaging of the spinal cord is also studied in motor 
learning and in pathologies such as multiple sclerosis.  
In study 1, the problem of results reproducibility in fMRI is initially 
addressed. Data derived from three independent attentional analgesia 
experiments on healthy volunteers are pooled together to produce a larger 
dataset (N=57). This is analysed to reproduce and validate previous findings 




(Brooks et al., 2017). Subsequently, two effective connectivity analysis 
techniques, generalised psychophysiological interaction (McLaren et al.,  
2012), and dynamic causal modelling (Friston et al., 2003), are used to 
resolve a brain-brainstem network engaged during distraction from pain.  
In study 2, fibromyalgia patients were recruited to the imaging centre 
for an attentional analgesia experiment. This patient population is thought 
to have deficits in the pain descending modulatory system, but the exact 
neurobiological mechanism behind these impairments has never been 
resolved. Additionally, fibromyalgia patients suffer from attentional deficits. 
Analysis of pain scores combined with brainstem-optimized functional 
imaging addresses this gap in the literature.  
In study 3, an innovative technique for simultaneous functional imaging 
of the brain, brainstem, and spinal cord (i.e. entire CNS) is used in an 
attentional analgesia experiment. Effective connectivity analyses aimed at 
reproducing and expanding the previous results from study 1, by adding the 
final step of descending pain modulation. The opioid antagonist naltrexone 
is used to investigate the role of endogenous opioids in attentional 
analgesia, while the noradrenaline reuptake inhibitor reboxetine examines 
the role of noradrenaline. Concomitant functional imaging allows to 
pinpoint the exact location of the effect of these two drugs.  
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Attentional analgesia is a well-characterised phenomenon whereby 
increased cognitive load can decrease pain perception (Peyron et al. 2000; 
Bantick et al. 2002; Brooks et al. 2002; Valet et al. 2004; Brooks et al. 2017; 
Sprenger et al. 2012). This can be achieved by diverting attention from a 
painful stimulus to a visual task or simply by active mind-wandering 
(Bushnell et al., 2013; Kucyi et al., 2013). Central to attentional analgesia is 
the concept of divided attention, whereby less cognitive resource is available  
to be allocated to nociception and pain. Since noxious stimuli are inherently 
salient and therefore attention grabbing (Eccleston et al., 1999), then any 
concurrent cognitive task must compete for ‘attentional’ resource. 
Attention is thus cast both as a key component of pain behaviour (i.e. 
attending to pain Crombez et al., 2004; Legrain et al., 2009; Roelofs et al.,  
2002) as well as a putative mechanism for pain relief. The processes 
regulating attentional focus is of importance in the development, 
maintenance and potentially resolution of chronic pain states. 
The mechanisms that allow attention to regulate pain are currently not 
well understood and there has been ongoing debate about whether 
attentional analgesia requires engagement of descending control to 
attenuate nociception (Brooks et al., 2017; Bushnell et al., 2013; Lorenz, 
Minoshima, & Casey, 2003; Tracey et al., 2002; Valet et al., 2004). These 
studies have linked several cortical regions to the attentional analgesic 
effects, including the anterior cingulate cortex (ACC), dorsolateral prefrontal 
cortex (DLPFC) and also components of the descending pain control system 
including periaqueductal grey (PAG), rostroventromedial medulla (RVM) and 
locus coeruleus (LC). An interaction between cortical and mid-brain 
structures during distraction from pain has been identified (Lorenz et al.,  
2003; Valet et al., 2004), but these previous studies were unable to examine 
interactions between the pontomedullary regions that are known to be 
important for the descending control of nociception.  




The PAG, RVM and LC are all candidates for mediating attentional 
analgesia given their known anti-nociceptive roles (Millan, 2002). For 
example, multiple animal studies have demonstrated that interactions 
between the PAG and RVM produces endogenous analgesia, mediated by 
spinally projecting neurons in the RVM (Basbaum et al., 1979; Fields et al.,  
1978; Heinricher et al., 2009). Together with the ACC, these regions form 
one of the main pain modulatory pathways involved in the bidirectional 
modulation (i.e. facilitation and inhibition) of nociception in the spinal cord 
dorsal horn (De Felice et al., 2016; Ossipov et al., 2010; Quintero, 2013). 
Similarly, the LC is another potential candidate region that could 
mediate the interaction between attention and pain because of its 
projections to the spinal cord which release noradrenaline to produce 
analgesia (Hirschberg et al., 2017; Llorca-Torralba et al., 2016).  Additionally,  
it has a known role in salience signalling and attention mediated by 
ascending projections (Aston-Jones et al., 1999; Sales et al., 2019; Sara et al.,  
2012). Despite it being challenging to resolve with fMRI (Astafiev et al., 2010; 
Liu et al., 2017), the LC was recently identified as the only region whose 
activity reflected the interaction between task and temperature in an 
attentional analgesia paradigm (Brooks et al., 2017). The LC could therefore 
contribute to attentional analgesia as part of the PAG-RVM system, or as a 
parallel descending modulatory pathway perhaps receiving inputs directly 
from ACC (Aston-Jones et al., 1991; Bajic et al., 1999). 
Within this framework the ACC is ideally placed to mediate between 
competing cognitive demands (e.g. between a sustained visual attention 
task and pain) as it is active during conflict resolution (Braver et al., 2001; 
Kerns, 2006; Kim et al., 2011), its activity is modulated by attention (Davis et 
al., 2000) as well as being consistently activated by painful stimuli (Brooks et 
al., 2017; Garcia-Larrea et al., 2013; Peyron et al., 2000; Wager et al., 2013) . 
The ACC is known to code for pain intensity (Büchel et al., 2002; Coghill et 
al., 2003) and unpleasantness (Rainville et al., 1997), furthermore, sub-
divisions (e.g. dorsal anterior ACC) are involved in high level cognitive  




appraisal of pain, including attention (Büchel et al., 2002). Some have 
proposed a specific role for dorsal ACC (dACC) in pain perception (Lieberman 
et al., 2015), though this is disputed with other studies suggesting that 
activity within this structure reflects the multifaceted nature of pain (Wager 
et al., 2016). Connectivity between the ACC and structures involved in 
descending pain control e.g. the PAG, has been shown to vary with pain 
perception due to both attentional modulation of pain and placebo analgesic 
responses (Bantick et al., 2002; Eippert et al., 2009; Petrovic et al., 2000; 
Valet et al., 2004) suggesting a potential role in attentional analgesia. 
We hypothesised a top-down pathway mediating attentional analgesia 
where the PAG receives attentional-shift signals from the ACC and/or LC and 
directs the RVM and/or LC to attenuate nociceptive processing in the spinal 
cord. Given the multiplicity of possible pathways and interactions by which 
activity in the brainstem can generate analgesia, we anticipated that 
effective connectivity analyses could resolve the roles of these regions 
(identified in our previous investigation (Brooks et al., 2017) during 
attentional analgesia. To increase the statistical power to undertake this 
connectivity analysis, additional fMRI datasets were acquired using the same 
paradigm as per Brooks et al. (2017). Analysis of these additional datasets 
reproduced our previous regional activation results, and so the three 
datasets were pooled for the effective connectivity analyses and modelling. 
We tested for psycho-physiological interactions (PPI, Friston et al., 1997; 
McLaren et al., 2012; O’Reilly et al., 2012) to explore whether the 
connectivity between the PAG, RVM, LC and ACC altered during the 
experimental paradigm. Finally, we used dynamic causal modelling (DCM, 
Friston et al. 2003) to test the directionality and strength of the connections. 
  






Subjects were recruited using poster and email adverts at the 
University of Bristol for three different pain imaging studies at the Clinical 
Research and Imaging Centre (CRiCBristol) that used the same experimental 
paradigm: an initial study on attentional analgesia (Brooks et al., 2017), a 
study on sleep disruption and a study on fibromyalgia. The first two studies 
were approved by the University Bristol, Faculty of Science, Human Research 
Ethics Committee (reference 280612567 and 291112606 respectively) and 
the fibromyalgia study was approved by NHS South Central Oxford B 
Research Ethics Committee (reference 13/SC/0617). 
All subjects gave written informed consent after application of standard 
inclusion/exclusion criteria for participation in MRI studies. The presence of 
significant medical/psychiatric disorders (including depression) or 
pregnancy precluded participation. Subjects with a chronic pain condition, 
or those who were regularly taking analgesics or psychoactive medications, 
as determined by self-report, were also excluded. All subjects were right-
handed, verified with the Edinburgh handedness inventory (Oldfield, 1971). 
The discovery cohort were 20 right-handed healthy subjects (median 
age 25 years, range 18–51 years, 10 females). Subjects attended for two 
sessions. During the screening visit, written consent was obtained and both 
task difficulty and temperature of the thermal stimulation were individually 
calibrated. Subsequently the subjects returned for the test session where 
they completed the experiment in the MRI scanner (For full details on the 
discovery cohort see Brooks et al., 2017). 
The validation cohort composed of control subjects from two separate 
studies: Twenty healthy volunteers (median age 23, range 20-33, 10 
females) were recruited for a study investigating the effects of sleep 
disturbance on attentional analgesia. Subjects completed the same 
experiment protocol on two occasions; after a habitual and a disturbed 




night’s sleep (at the sleep laboratory at CRiCBristol). For the present study, 
only data obtained from the control condition was used, wherein subjects 
experienced their habitual sleep regime the night prior to their scan. A 
second group of 20 healthy participants (median age 31.5, range 20-59, 18 
females) was recruited from the control group of a study analysing 
attentional analgesia in fibromyalgia patients. 
 
2.2.2 Experiment 
Thermal stimuli were delivered to the left volar forearm (approximately 
C6 dermatome) using a circular contact thermode (CHEPS Pathway, MEDOC) 
and each lasted 30 seconds. The noxious thermal stimulus was individually 
titrated to obtain a 6 out of 10 pain rating (42-45˚C plateau). The innocuous 
stimulus plateau was set at 36˚C. In both cases brief heat spikes of 2, 3 and 
4˚C above the plateau temperature were added in a random sequence at a 
frequency of 1Hz. This heating profile was used to maintain painful 
perception, whilst avoiding skin sensitisation. The baseline thermode 
temperature was 32˚C.  
For the Rapid Serial Visual Presentation task (RSVP, Potter et al. 1969) ,  
subjects identified a visual target (the number “5”) among distractors (other 
letters and numbers), presented using back-projection to a screen visible to 
subjects lying in the scanner, responding with a button box (Lumina LP-400, 
Cedrus). Prior to entering the scanner, the speed of character presentation 
for the hard RSVP task was individually calibrated to obtain a 70% task 
performance. Task performance was assessed by calculating d’, a measure 
of task performance typically used in behavioural studies calculated by 
subtracting the z-transformation of the false alarm rate from the z-
transformation of the hit rate (Stanislaw et al., 1999). The d’ values were 
generated for a range of trial RSVP speeds for each subject and the data was 
fitted with a sigmoidal function (commonly used in psychophysics). This best 
fit model parameters were used to estimate each subject’s presentation 




speed corresponding to a 70% task performance, which ranged from 32 to 
96ms. The speed of presentation for the easy RSVP task was either 192 or 
256ms, depending on performance in the hard task (if the “hard” task 
interval for the subject was <80ms or >80ms, respectively). 
2.2.3 Data acquisition 
In the scanner, participants received noxious or innocuous thermal 
stimuli (high/low) while simultaneously performing the RSVP task with two 
levels of difficulty (easy/hard). Thus, there were four experimental 
conditions (in a 2x2 factorial experimental design): easy|low, easy|high, 
hard|low, hard|high. Each condition was repeated 4 times. Each 
experimental epoch started with instructions (5s), followed by the 30s 
experimental condition, followed by a 10s rest period before an 8s rating 
period where subjects rated the perceived pain intensity from 0 to 10 on a 
visual analogue scale (VAS) (Brooks et al., 2017). The post-stimulus interval,  
between the rating period and subsequent instructions, was 17s.  
The experiment for the validation cohort (n=38) was essentially 
identical to that of the discovery cohort. The titrated mean high temperature 
for the discovery cohort was 44.2˚C and for the validation cohort it was 43°C 
(range 42–45 °C). The whole imaging session lasted 26 minutes for the 
discovery cohort and sleep-disruption cohort and was 22 minutes for the 
fibromyalgia cohort.  The difference in experiment duration stemmed from 
the removal of a superfluous additional control condition, with no 
distraction during high temperature, in the fibromyalgia study as it was not 
required as part of the core 2x2 factorial design and had the additional 
benefit of reducing the number of noxious stimuli overall delivered to these 
subjects (and more importantly to the patients in the matched study group) . 
All data was acquired with a 3T Skyra MR system (Siemens Medical 
Solutions, Erlangen, Germany) and 32-channel receive only-head coil. In 
addition to blood oxygenation level dependent (BOLD) functional data, T1 
weighted structural scans were acquired with an MPRAGE sequence to allow 




image registration. Functional imaging data was acquired with 
TE/TR=30/3000ms, GRAPPA acceleration factor = 2, resolution = 1.5 x 1.5 x 
3.5 mm. The slices were angulated perpendicularly to the base of the 4th 
ventricle to better match the orientation (long axis) of brainstem nuclei. This 
slice orientation optimised the ability to discriminate between the small 
brainstem structures in the transverse plane and while allowing the capture 
of whole brain activity within 3 seconds. Fieldmap data was acquired with a 
gradient echo sequence (TE1/TE2/TR = 4.92 / 7.38 / 520ms, flip angle 60°, 
resolution 3 x 3 x 3 mm). During scanning, a pulse oximeter and a respiratory 
bellows (Expression MRI Monitoring System, InVivo, Gainesville, FL) were 
used to monitor cardiac pulse waveform and respiratory movement, 
recorded using an MP150 data logger (Biopac, Goleta, CA, USA)  for 
subsequent physiological noise correction (Brooks et al., 2013). 
2.2.4 Behavioural Data analysis 
Pain VAS ratings were converted to a 0-100 scale for a repeated 
measures ANOVA in SPSS software (after Brooks et al., 2017). Following 
estimation of main effects (task, temperature) and interactions, post-hoc 
paired t-tests were performed. The presence of attentional analgesia was 
pre-defined as a significant interaction between task difficulty and high 
temperature on pain rating assessed with post-hoc paired t-testing (p < 
0.05). To test for differences between the discovery and validation cohorts; 
group membership was added as a between subject factor to the two within 
subject factors (task and temperature). Subsequent analysis is reported on 
the pooled cohort. 
2.2.5 Imaging Data analysis 
2.2.5.1 Image Pre-processing 
Functional images were corrected for motion using MCFLIRT (Jenkinson 
et al., 2012) and co-registered to each subject’s structural scan using brain 
boundary-based registration (Greve et al., 2009) and then to the 2mm 
template (“MNI152”) brain using a combination of fieldmap based 
unwarping using FUGUE (Jenkinson, 2003), linear transformation using FLIRT 




(Jenkinson et al., 2001) and non-linear registration using FNIRT (Andersson 
et al., 2007) with 5mm warp spacing. Functional data was spatially smoothed 
with a kernel size of 3mm (FWHM) and high pass temporally filtered with a 
90s cut-off. Two subjects in the validation cohort and one from the discovery 
cohort were excluded from the analyses at this stage because of signal 
dropout (primarily in the brainstem) in the EPI data, leaving 57 subjects.  
Physiological data (cardiac and respiratory) were visually inspected and 
manually corrected as required. All first level models (block design and gPPI) 
included a basis set of regressors for physiological noise correction, which 
included 16 cardiac and respiratory terms (sine and cosine terms up to the 
4th harmonics), plus 16 terms that attempt to capture the interaction 
between cardiac and respiratory processes (Brooks et al., 2008; Harvey et 
al., 2008). It is important to note that the relative phases for each slice (e.g. 
position in the cardiac cycle at time of acquisition, used to calculate the 
physiological regressors), were calculated independently and modelled 
separately in the GLM. Only one out of 57 subjects lacked physiological 
recordings, due to equipment failure – this subject was not excluded as it 
was considered unlikely to increase false-positive rate in the final sample. 
Local autocorrelation correction was performed using FILM (Woolrich et al.,  
2001) as part of model estimation, which also attempted to correct for 
physiologically driven signals (originating from cardiac/respiratory 
processes) using slice-dependent regressors in PNM (FSL). Relative mean 
motion was extracted from each subject to look for excessive head 
movement. The average motion across subjects was 0.068mm, ranging from 
0.02 to 0.27. Since no subject moved more than half a voxel (i.e. 0.75 mm), 
no one was excluded on this basis.   
2.2.5.2 First level analyses 
The four conditions (easy|high, hard|high, easy|low, hard|low) and 
tasks of no interest (cues and rating periods) were modelled using a 
hemodynamic response function (gamma basis function, σ = 3s, mean lag = 
6s) alongside the physiological regressors within the general linear model in 




FEAT (Jenkinson et al., 2012). A separate analysis tested for an intra-subject 
parametric relationship between pain ratings (one per block) and BOLD 
signal (Büchel et al., 1998). In addition to tasks of no interest and 
physiological signal regressors, a constant regressor for all blocks (weighting 
= 1) and a regressor weighting the individual pain ratings for each block were 
included. None of the regressors were orthogonalized with respect to any 
other. 
2.2.5.3 Second level analyses 
Main effects were specified as positive and negative main effect of 
attention (hard versus easy task, and vice versa) and positive and negative 
main effect of temperature (high versus low thermal stimulus, and vice 
versa). A task x temperature interaction contrast was also specified. The 
parametric data was assessed using a simple group average – to examine 
whether the linear relationship between pain ratings and brain activity was 
consistent across the group. Lastly, a paired analysis compared activity 
during the easy|high and hard|high conditions - to examine whether the 
inter-subject difference in average pain ratings (i.e. easy|high  minus 
hard|high) was linearly related to the corresponding difference in BOLD 
signal (similar to Tracey et al. 2002 and Brooks et al. 2017). To test for 
differences between the discovery cohort and the validation cohort, we 
used an unpaired t test with FLAME (height threshold z > 3.09, corrected 
cluster extent threshold p < 0.05), in line with guidelines on corrections for 
familywise error (FWE) (Eklund et al., 2016). Subsequent analyses of the 
pooled cohort (i.e. all 57 subjects) used the same threshold.  
2.2.5.4 Brainstem-specific analyses 
Detecting activation in the brainstem is non-trivial due to its 
susceptibility to physiological noise and artefacts (Brooks et al., 2013), small 
size of structures of interest and relative distance from signal detectors in 
the head coil. Consequently, a brainstem focussed analysis was performed 
at the group level using a series of anatomical masks and statistical inference 
using permutation testing (Nichols et al., 2002) in RANDOMISE (part of FSL). 




Analyses utilised pre-defined regions of interest based on (i) a whole 
brainstem mask derived from the probabilistic Harvard-Oxford subcortical 
structural atlas (Desikan et al., 2006) and thresholded at 50% and (ii) 
previously defined probabilistic masks of the a priori specified brainstem 
nuclei (RVM, LC, PAG) from Brooks et al. (2017). The number of 
permutations were set to 10,000 in line with guidelines (Eklund et al. 2016)  
and results reported using threshold free cluster enhancement (TFCE) 
corrected p < 0.05 (Smith et al., 2009). 
2.2.5.5 Psycho-Physiological Interactions (PPI) 
Effective connectivity analyses were performed on the pooled cohort. 
We used generalised PPI (gPPI) to detect changes in interactions between 
regions during specific experimental conditions (O’Reilly et al. 2012; 
McLaren et al. 2012; Friston et al. 1997). In this technique a physiological 
signal (e.g. the time-course extracted from a seed region) is convolved with 
a modelled psychological variable (i.e. each one of the experimental 
conditions) to build interaction regressors. All interaction regressors were 
added to a general linear model (GLM) that also included the non-convolved 
experimental conditions and tasks of no interest (e.g. the rating period). 
Contrasts were built to test for connectivity differences that could be 
explained by the main effects of task and temperature and the task * 
temperature interaction. 
Four regions identified by the main effect analyses (temperature 
and/or attention) and inter-subject analgesic regression model in the pooled 
cohort, were selected as seed-regions for the gPPI analysis: PAG, right LC and 
ACC in the main effect of task and RVM in the main effect of temperature. 
For each subject, the physiological BOLD time course was extracted from the 
peak voxel of the pre-processed images (as described in the section ‘Image 
Pre-processing’) within each functional mask, and gPPI performed at the first 
level. Subsequently, group responses were estimated with permutation 
testing within the same functional masks e.g. effective connectivity between 
PAG seed region and the other three regions (RVM, right LC, ACC). To aid 




interpretation of significant results in the task * temperature interaction 
contrast, we focussed on the conditions of interest (i.e. easy|high and 
hard|high). Parameter estimates were extracted by first defining a sphere 
of radius 2mm at the voxel of greatest significance in the group gPPI result, 
then back-transforming this mask to subject space and extracting the signal 
from the voxel with highest Z-score. 
In summary, the procedure for gPPI analysis was: 
• Pre-processing of functional data 
• Time series extraction from functional masks 
• Convolution of time-series with experimental condition 
• Contrasts of interest tested using GLM via first level (single subject) 
analysis 
• Group analysis permutation testing with functional masks  
• Extraction of parameter estimates from the conditions of interest.  
 
2.2.5.6 Dynamic Causal Modelling (DCM) 
Given the inability of gPPI to resolve the directionality of connections, 
we sought to extend our findings by using DCM (Friston et al., 2003). This 
technique allows the specification of a hypothetical network model (based 
on equation 1) fitted to the fMRI data to resolve connection strengths.  
The change in activity of each region in a model with j inputs and n brain 
regions is formalized as follows: 
(1) 
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x - neuronal state of a region (i.e. BOLD signal convolved with 
haemodynamic response function)  
A - binary vector that defines the connectivity of x is to each of the other 
regions in the model,  
a - vector of parameters that define the strengths of such connections,  
u - external input to the model,  
B - binary vector that defines whether model connections are 
modulated by external input,  
b - vector of parameters that defines the strength of such modulation,  
C - binary vector that defines whether x directly receives the external 
input,  
c - contains parameters that regulate the strength of the received input,  
ω - random neuronal noise.  
Note since the model is estimated in a Bayesian framework, parameters 
are not single values but are posterior densities.  
Given the results of the PPI analysis, we specified bi-linear, one state, 
stochastic, input centred DCMs (Daunizeau et al., 2009, 2012) in SPM 12 
(Wellcome Trust Centre for Neuroimaging, London, UK). The models were 
estimated on a computer cluster (BlueCrystal) in the  Advanced Computing 




Research Centre, University of Bristol – http://www.bristol.ac.uk/acrc/. 
Random effects Bayesian Model Selection (BMS) was used to compare the 
models and Protected Exceedance Probability, the likelihood of a given 
model in respect to the others tested, was calculated. Bayesian Omnibus 
Risk, a measure of the risk of all models having the same frequency within 
the population, was also computed (Rigoux et al., 2014). Bayesian model 
averaging  (Penny et al., 2010) was used to extract the parameter estimates 
of interest. 
  





2.3.1 Comparison of the discovery cohort and validation cohort 
The behavioural and imaging datasets from the validation and 
discovery cohort were quantitatively compared as criteria to justify the 
decision to pooling the two together for subsequent analyses. A three-way 
repeated measures ANOVA was carried out on the pain scores using task and 
temperature as within subject factors and the group (discovery vs validation 
cohort) as between subject factor. This analysis showed no effect of group 
on the effects of temperature (P = 0.481), nor task (P = 0.833), nor on the 
task * temperature interaction (P = 0.481), indicating that the two groups 
are comparable in terms of the behavioural effect. 
An unpaired t-test on the functional image contrasts did not show any 
statistically significant differences between the discovery and validation 
cohorts for the main effect of temperature (positive and negative), main 
effect of task (positive and negative) and interaction contrast (positive and 
negative). Given the lack of demonstrable statistical differences between 
the two cohorts, we went ahead with our planned intention to combine the 
three datasets and all subsequent results relate to the pooled cohort 
comprising 57 subjects. We also note that the use of strict cluster thresholds 
for the brain, and of permutation testing for ROI-based analyses in ‘noisy’ 
brainstem regions, can produce robust and reproducible results even with a 
sample size of 20 Brooks et al., 2017). 
2.3.2 Behavioural analysis (Pooled cohort) 
The average high (noxious) temperature in the pooled cohort was 
43.4°C (range 42°C - 45°C).  Analysis of the pain ratings showed the expected 
main effect of temperature on pain scores (F (1, 56) = 252.799, P < 0.0001, 
repeated measures ANOVA) but no main effect of task (F (1,56) = 2.935, P = 
0.092).  There was a clear  task x temperature interaction (F (1, 56) = 31.969, 
P < 0.0001, Figure 2.1) and post-hoc paired t-test showed performance of 
the hard task produced a decrease in pain scores in the high temperature 




condition (mean hard|high = 38.1, SD 17.0 vs easy|high = 42.1, SD 16.5, P < 
0.0001, Bonferroni corrected), consistent with an attentional analgesic 
effect (Figure 2.1).   
Additional exploratory analysis did not detect any evidence of an order 
effect in the pain ratings (F (3,165) = 0.164, P=0.92 one-way repeated 
measures ANOVA), meaning that we did not observe a significant 
sensitisation or habituation in subjects’ pain ratings.  Similarly, there was no 
effect of gender on attentional analgesia (F(1,55)=0.091, P=0.764), nor on 
the main effects of temperature (F(1,55)=1.69, P=0.198) or task on pain 
ratings (F(1,55)=0.253, P=0.617, all mixed model ANOVAs). 
 
Figure 2.1 Pain ratings across experimental conditions for the pooled cohort 
(N=57). A 2-way repeated measures ANOVA on the pain ratings showed the 
expected main effect of temperature (P < 0.0001) and a task x temperature 
interaction (P < 0.0001). The attentional analgesic effect was observed as a 
decrease in pain scores in the high temperature condition during the hard task 
compared to the easy task (P < 0.0001, post-hoc paired t-test).  In contrast there 
was also a small increase in pain scores in the low temperature condition during the 
hard task compared to the easy task (P < 0.05). The main effect of task was not 
significant (P = 0.92). Error bars represent the standard error of the mean.  
 




2.3.3 Whole Brain & Brainstem-focussed analysis (Pooled cohort) 
Activations were found for the positive main effect of temperature in a 
range of regions including the anterior and posterior cingulate cortices, 
precuneus, cerebellum, post-central gyrus (S1), dorsal posterior insula and 
opercular cortex, in the latter three cases with more prominent clusters 
contralateral to the side of thermal stimulation (Figure 2.2A). In the negative 
main effect of temperature, significant clusters were found in the frontal 
medial cortex and in the subcallosal cortex (Figure 2.2A). We also found a 
cluster of activation in the RVM at this whole brain level. However, to 
improve our ability to resolve activity in hindbrain structures, we undertook 
permutation testing using a whole brainstem mask, which revealed clusters 
of activation in the positive main effect of temperature in the ventral PAG, 
LC bilaterally as well as the RVM (Figure 2.3A, p < 0.05, TFCE corrected). 
Analysis of the positive main effect of task, showed extensive areas of 
activation within the lateral occipital cortex, superior parietal lobule, 
anterior cingulate cortex and anterior insula, as well as the PAG (Figure 
2.3A). In the negative main effect of task, clusters were located in the 
posterior cingulate cortex, frontal medial cortex and in the lateral occipital 
cortex (Figure 2.2B). Permutation tests within the whole brainstem mask 
showed multiple clusters of activation, including in the LC bilaterally, RVM 
and PAG (Figure 2.3B, p < 0.05, TFCE corrected).  
In the interaction contrast between task and temperature no cluster 
reached significance either at the whole brain level nor when using the 
whole brainstem masked analysis. 
 
 




Figure 2.2 Whole brain main effect analyses in the pooled cohort (N=57). Positive (red/yellow) and negative (blue/light blue). Data was obtained from cluster-
based thresholding using an initial threshold of Z > 3.09 and FWE corrected p < 0.05, one-sample t-test. (A) Main effect of temperature. Positive activation in the high 
temperature conditions was found in anterior cingulate cortex (ACC), thalamus (THAL), dorsal posterior insula (dpIns), precuneus (Pcu), primary somatosensory cortex 
(S1) and rostroventromedial medulla (RVM). Activation in the negative main effect of temperature (low temperature vs high temperature) was observed in the frontal 
medial cortex (FMC). (B) Main effect of task. Activity in the positive main effect was found in the anterior insula (aIns), lateral occipital cortex (LOC), ACC, superior 
parietal lobule (SPL). Activity in the negative main effect was found in the frontal pole (FP), posterior cingulate cortex (PCC) and Pcu.




Figure 2.3 Main effect analyses in the brainstem. Results obtained after permutation testing with a probabilistic whole brainstem mask (p < 0.05, TFCE 
corrected). (A) Clusters of activation in the brainstem corresponding to the main effect of temperature was found in the ventral periaqueductal grey (PAG), 
rostroventromedial medulla (RVM) and bilateral locus coeruleus (LC). (B) Many areas in the superior brainstem show activity in the main effect of task, including the 
PAG, RVM and bilateral LC. (C) Shows the position and extent of the anatomical masks defined in (Brooks et al., 2017), identifying the PAG (red), LC (blue), RVM 
(green).




These findings from the pooled cohort showed close similarity to those 
of Brooks et al. (2017) with the same areas found in the main effects analysis  
(Supplementary Table 1). The additional findings at a whole brain level were 
that both the RVM and the precuneus now appear in the main effect of 
temperature and the dorsolateral PAG in the main effect of task (the RVM 
and PAG were only seen in a nucleus specific masked analysis in Brooks et 
al., 2017). Similarly, activity in the brainstem is now seen in more areas using 
a whole brainstem mask rather than only in the nucleus specific masks (e.g. 
main effect of temperature in RVM alone previously versus RVM, LC and PAG 
in this pooled analysis). 
Whilst the patterns of activity within the cerebrum were largely non-
overlapping, there were some areas which appeared to be common to both 
the main effect of task and temperature: ACC, FMC, and cerebellum. To 
formally test the degree of overlap, we performed a conjunction analysis 
(Friston et al., 1999) which revealed that of the hypothesised brain regions 
involved in the task, only the ACC was active in both conditions (cluster 
forming threshold Z > 3.09, FWE corrected p < 0.05). 
2.3.4 Linear encoding of pain intensity 
Brain regions whose activity was linearly related to perceived pain 
intensity were identified using an intra-subject parametric regression. This 
revealed a network of positively correlated regions (similar to those seen in 
the main effect of temperature) including primarily the right (contralateral)  
dorsal posterior insula and S1, the anterior cingulate cortex, frontal lobe and 
the precuneus (Figure 2.4A). Regions showing a linear decrease in activation 
with pain ratings were restricted to the occipital cortex bilaterally and 
ipsilateral primary somatosensory cortex (Figure 2.4A). Permutation testing 
in the brainstem (using RVM, PAG and LC masks) identified only the RVM as 
showing a positive correlation with pain intensity (Figure 2.4B). No 
brainstem region showed a negative correlation with pain. All these findings 
were consistent with Brooks et al (2017), with the addition of a cluster 
identified in the thalamus (Supplementary Table 2). 




2.3.5 Regions whose activity correlates with analgesic effect 
An inter-subject whole-brain mixed effects comparison between the 
hard|high and easy|high conditions did not identify any region whose 
activity linearly correlated with the differences in pain ratings (i.e. analgesia). 
A parametric regression showed a linear relationship between difference in 
activity and analgesic effect in only the contralateral (right) LC (i.e. decreased 
pain ratings were associated with increased BOLD difference), after 
permutation testing with LC, RVM and PAG masks (Figure 2.4C). A positive 
relationship was noted between the difference (“Delta”) in parameter 
estimates extracted from the rLC and the attentional analgesic effect on pain 
scores (Figure 2.4C).




Figure 2.4 (A) Pain encoding regions were identified by intra-subject parametric regression with pain ratings across all the experimental conditions, in the whole 
brain analysis. Regions whose activity linearly increased with perceived pain are shown red-yellow and regions whose activity decreases with pain in blue-light blue. 
(height threshold Z > 3.09, corrected cluster extent threshold p < 0.05) B) Brainstem intra-subject parametric regression with pain ratings, using RVM, LC and PAG 
masks. Only the RVM showed a linear increase in activity with the pain scores (p < 0.05, TFCE corrected). C) The right (contralateral) LC was the only region whose 
activity correlated with the analgesic effect (i.e. ratings of easy|high – hard|high, inter-subject parametric regression using a LC mask p < 0.05, TFCE corrected).




2.3.6 gPPI analysis between neural hubs linked to attentional analgesia 
To determine the changes in neuronal communication associated with 
attentional analgesia, this analysis aimed to identify changes in effective 
connectivity associated with task difficulty, temperature, and the task x 
temperature interaction. Results from main effects, conjunction and 
parametric analgesia analyses provided the motivation for selecting a subset 
of the activated brain regions, that were subsequently used for connectivity 
analysis. Time courses were extracted from functional masks for gPPI 
analyses: RVM for the main effect of temperature, and PAG, rLC and ACC for 
the main effect of task (see Methods). Permutation testing revealed 
increased connectivity with the following contrasts (see Figure 2.5A):  
• RVM seed - increased connectivity to PAG for the interaction contrast 
• ACC seed - increased connectivity with the right (contralateral) LC in 
the interaction contrast and with the PAG in the main effect of task  
• PAG seed - did not show any significant change in effective 
connectivity 
• rLC seed - did not show any significant change in effective 
connectivity. 
For all gPPI results, parameter estimates were extracted from the voxel 
with greatest significance in each individual to explore the nature of these 
interactions (Figure 2.5B). In all cases, the parameter estimates were greater 
in the hard|high compared to the easy|high condition, indicating an 
increase in coupling in the condition associated with attentional analgesia 
i.e. hard|high. 




Figure 2.5 Schematic representation of results of the gPPI analysis. Results were obtained with single-region functional masks and permutation testing (P < 
0.05, TFCE corrected).  (B) Parameter estimates extracted from the peak destination voxel from the PPI analysis (see text for details), in the easy|high and hard|high 
conditions. Note that all arrows are double-headed as it is not possible to determine the directionality of connections with gPPI analysis.





2.3.7 DCM to determine directionality of pathway interactions 
Dynamic causal modelling was used to resolve the directionality of the 
task effect on the connections identified in the gPPI. We systematically 
varied the location of the task inputs and modulation, while the temperature 
modulation was kept fixed in all models as a bottom-up effect. External 
inputs were both hard/easy task and high/low temperature, while 
modulations were only hard task and high temperature. Five models were 
specified (Figure 2.6A):  
• No modulation of connections,  
• Task bottom-up on the ACC-PAG-RVM and on the ACC-LC axis.  
• Task top-down for both pathways.  
• Task top-down in the ACC-PAG-RVM axis and bottom-up in the ACC-
LC connection.  
• Task bottom-up in ACC-PAG-RVM and top-down in ACC-LC.  
Models 3 and 4 were found to best fit the data in BMS, with protected 
exceedance probability = 0.45 and 0.55 respectively (Figure 2.6B), and 
Bayesian omnibus risk of zero. In both, the task had a top-down influence on 
ACC-PAG-RVM, while the ACC-LC connection was top-down modulated in 
one model and bottom-up modulated in the other. Bayesian model 
averaging was used to extract parameter estimates (Supplementary Table 
3).  
All connections were also tested with an analgesic covariate, to find 
whether one or more consistently differed in participants that showed an 
analgesic effect. No connection reached significance in this test.  




Figure 2.6 (A) Specified network interactions assessed with Dynamic Causal Modelling and result of Bayesian Model Selection. The effect of temperature is 
always bottom-up, while the task could have a bottom-up or top-down effect. The inputs are both easy/hard task and low/high temperature, while the modulations 
of connections are only high temperature and hard task. Model 3 and 4 (outlined with dashed box) have the strongest evidence of reproducing the data, with slightly 
stronger evidence for model 4. (B) Schematic representation of interactions during attentional analgesia, after PPI and DCM.




2.4 Discussion  
The brainstem involvement in attentional analgesia has been 
investigated in previous studies, demonstrating a mediating role of the PAG 
and of its interaction with cortical regions (Brooks et al., 2017; Tracey et al.,  
2002; Valet et al., 2004). However, possibly because of a lack of statistical 
power or technical limitations, the neuronal interactions between cortex, 
PAG and the lower brainstem nuclei in this context have never been fully 
resolved. Reassuringly, in the context of the reproducibility crisis that is 
afflicting neuroscience, especially in fMRI experiments (Button et al., 2013; 
Eklund et al., 2016), we have recapitulated the core findings regarding the 
brainstem hubs involved in attentional analgesia (Brooks et al., 2017) and 
have extended our analysis to determine how they interact to produce 
attentional analgesia by functional network analysis.  This identifies a top-
down pathway from the PAG to the RVM, engaged by cortical input from the 
ACC during high cognitive demand. In addition, there is a paralle l 
bidirectional communication between ACC and LC during attentional 
analgesia.  
2.4.1 Identification of brainstem nuclei involved in attentional analgesia  
The higher statistical power provided by 57 subjects, some 3-fold 
greater than in Brooks et al. (2017), yielded stronger findings especially in 
the brainstem nuclei. In the main effect of temperature, the specificity of 
the pattern of nociceptive information flow is striking with activations 
confined to discrete territories including ventral PAG, LC and RVM as well as 
activations in the region of parabrachial nucleus, nucleus solitarius, sub 
nucleus reticularis dorsalis and nucleus cuneiformis. This expands our 
previous result showing only RVM response to high temperature stimulation 
(Brooks et al., 2017). While it has long been known from animal studies that 
these brainstem regions receive nociceptive input from the spinal cord 
(Blomqvist & Craig, 1991; Cedarbaum & Aghajanian, 1978; Keay et al., 1997)  
this has seldom been clearly demonstrated in human imaging studies. In 
addition, an intra-subject linear regression analysis with pain scores revealed 




that the BOLD signal in the RVM linearly scales with perceived pain, in  
agreement with recent studies (Brooks et al., 2017; Horing et al., 2019). This 
clearly demonstrates that this brainstem territory is likely to be playing an 
important role in coding nociceptive intensity. It is possible that the voxels 
resolved in this analysis are related to the activity of the pro-nociceptive ON-
cells in the RVM. To our knowledge, no other single study has been able to 
produce such a complete activation map in the human brainstem in 
response to noxious stimulation (see review by Henderson & Keay, 2018). 
In the main effect of task, we again detected activity in PAG, RVM and 
LC bilaterally, in addition to a more diffuse activation in the brainstem. It is 
interesting to note that the attentional task recruited the dorsal and ventral 
PAG whereas the noxious input produced activation in the ventral region of 
the nucleus, perhaps in line with the known behavioural specialisation of 
columns within this crucial integrating nucleus (Linnman et al., 2012; Roy et 
al., 2014). 
The magnitude of the analgesic effect showed a correlation with 
activity in the right LC (a finding that we previously noted in Brooks et al.  
(2017) but was just below formal statistical significance). This was the only 
location in the neuroaxis that showed this relationship, and is the reason 
why connectivity analysis focused on the right LC. One intriguing aspect of 
this interaction is the lateralised nature of the relationship between the right 
LC (i.e. contralateral to the stimulus) and the analgesic effect  - a finding that 
has previously been noted in rodent studies where noxious stimuli increase 
the activity in the contralateral LC to a greater effect (Cedarbaum et al.,  
1978). The LC is well positioned both anatomically and functionally to 
mediate a component of attentional analgesia, not only because it is 
responsive to attentional states and cognitive task performance (Aston-
Jones & Cohen, 2005; Sales et al., 2019; Sara, 2009; Yu & Dayan, 2005) and 
to nociceptive inputs (Cedarbaum & Aghajanian, 1978; Howorth et al.,  
2009), but also particularly in being able to cause analgesia via its direct 
spinal cord projections (Hirschberg et al., 2017; Jones et al., 1986) . 




Intriguingly, the spinal cord-projecting neurons are located in the caudal part  
of the LC in rodents (Hirschberg et al., 2017), as is the LC region that we 
found to correlate with the analgesic effect. Previous studies have 
demonstrated linear relationships between the analgesic effect and activity 
located in the PAG (Tracey et al., 2002, in 9 subjects) and RVM (Brooks et al., 
2017, in 20 subjects). We note that neither of these findings were replicated 
in our current study of 57 subjects. While all three of these regions have 
biological plausibility for mediating analgesia, a larger sample size seems 
necessary to produce robust results with inter-subject regression (especially 
in small, noisy brainstem nuclei) and this is likely to be complicated by the 
known interactions between these regions in nociceptive processing 
(discussed below). 
2.4.2 Parallel cortical-brainstem pathways 
Given the involvement of PAG, RVM and LC in both aspects of the 
experiment, and their known involvement in endogenous analgesia (Ossipov 
et al., 2010), we tested all three nuclei for connectivity changes during the 
attentional analgesia paradigm.  
Cortical regions involved in the endogenous modulation of pain in 
humans include the anterior cingulate cortex, the dorsolateral prefrontal 
cortex and the ventrolateral prefrontal cortex (Bushnell et al., 2013). Among 
these, the ACC was the only frontal cortical area showing activity in the 
conjunction analysis between main effects of task and temperature, and 
prior evidence showed its interaction with the PAG to be involved in 
attentional analgesia (Valet et al., 2004). In light of the recent discussions 
around compartmentalisation of the cingulate (Van Heukelum et al., 2020) ,  
it should be acknowledged within this framework that our results pertain to 
both MCC (involved in conflict resolution between competing attentional 
demands) and ACC (nociceptive, affective processing). The location of the 
ACC region resolved here is indeed on the ACC-MCC border, where activity 
likely reflects a combination of task demand and pain processing. 
Intriguingly, inputting the coordinates of the peak attentional activation of 




the ACC to Neurosynth (Yarkoni et al., 2011) identified four studies where 
the same region was involved in response to conflict (Barch et al., 2001; 
Scholl et al., 2017; van Veen et al., 2005; Wittfoth et al., 2008). In addition, 
voluntary control over the activation of this area was shown to result in 
modulation of pain perception in a neurofeedback study (deCharms et al.,  
2005). 
To examine the interplay between the cortical and brainstem 
structures we hypothesised to be involved in attentional analgesia, we  
initially performed a generalised PPI, which determines how connectivity 
changes as a result of experimental manipulation (i.e. effective 
connectivity). We observed altered connectivity between the ACC and 
contralateral (right) LC during the interaction between task and 
temperature. Furthermore, coupling increased between ACC and PAG with 
task demand, and between PAG and RVM during the task x temperature 
interaction. Extraction of parameter estimates revealed that all interactions 
were enhanced in the hard task/high temperature condition. 
The identified network interactions lacked directionality and could 
equally be evidence for an ascending pathway, where the attentional 
demand modulates how the nociceptive information reaches the brain, or a 
descending pathway, where the cortex recruits brainstem nuclei to 
modulate the spinal cord. Therefore, dynamic causal modelling was 
employed to explore these hypotheses by fitting different models to the 
data. Bayesian Model Selection validated the results of the gPPI by 
excluding, for lack of evidence, a model where no connection was 
modulated by task. In addition, BMS resolved a top-down influence of task 
on the ACC-PAG and PAG-RVM connections, consistent with a descending 
pain modulatory system involved in attentional analgesia (Sprenger et al.,  
2012). The ACC-LC pathway was however not resolved as clearly, with similar 
evidence in BMS for task modulation of the top-down and bottom-up 
connection. On examination of the parameter estimates, it was noted that 
the task modulation had a negative effect on all connections that were also 




modulated by temperature. Conversely, the ACC-PAG connection, only 
modulated by task, has a positive parameter estimate. This effect suggests a 
disinhibitory effect, or a negative feedback loop in the PAG-RVM and ACC-
LC connections. Neurobiological mechanisms that could account for these 
effects are discussed below.     
Effective connectivity changes in these pathways may mediate the 
process of attentional analgesia. This could be achieved through LC 
projections to the ACC increasing the signal-to-noise (or salience) of one 
input over another (Manella et al., 2017; Muller et al., 2019; Sales et al.,  
2019; Sara, 1985; Vazey et al., 2018) and/or ACC to spinally projecting LC 
neurons modulating the activity of dorsal horn neurons (i.e. decreasing 
nociceptive transmission), both actions potentially giving 'precedence' to 
the task. It is possible that the ACC and the LC work in a reciprocal negative 
feedback loop during attentional analgesia (Breton-Provencher et al., 2019; 
Ramos et al., 2007). The reduction in perceived pain could equally be 
achieved via ACC recruiting the PAG and RVM to produce antinociception at 
a spinal level during the attention demanding task (Millan, 2002), for 
example by disinhibition of the RVM “off-cells” (Lau et al., 2014). This 
conceptually extends previous studies that have identified the ACC-PAG 
connection as being involved in a distraction from pain (attentional 
analgesia) paradigm (Valet et al., 2004), as well as in a placebo analgesia 
paradigm (Petrovic, 2002). The PAG-RVM descending control system has 
also already been implicated in placebo analgesia (Eippert et al., 2009; Grahl 
et al., 2018) via an opioid-dependent mechanism. The behavioural 
component of attentional analgesia has been reported to be impaired by 
opioid blockade, possibly by disrupting connections between the ACC-PAG-
RVM descending control system (Sprenger et al., 2012). It is also quite 
conceivable that the parallel ACC-LC and ACC-PAG-RVM systems described 
here work in concert to cause analgesia. Previous animal studies show that 
electrical stimulation of the PAG triggers noradrenaline release in the 
cerebrospinal fluid and the analgesic effect of stimulation can be partially 




blocked with intrathecal alpha2-antagonists (Cui et al., 1999; Hammond et 
al., 1985). In addition, it was demonstrated that mice not able to synthesize 
noradrenaline were less sensitive to the analgesic action of morphine (Jasmin 
et al., 2002). Thus, it still remains to be demonstrated whether these two 
pathways are working in a parallel independent fashion, or are dependent 
upon each other in producing attentional analgesia.  
We propose that the ACC acts to resolve the conflict caused by an 
attention-demanding painful stimulus and the cognitive load of a sustained 
visual attention task, by sending downstream signals to brainstem structures 
to facilitate optimal behaviour. This interpretation is in accordance with 
previous hypotheses on the function of the ACC-LC interaction, implicated 
in re-orienting attentional processes (Corbetta et al., 2008). In addition, 
recent evidence from a human fMRI study identified the same connection 
during conflict resolution in an incongruent Stroop task (Köhler et al., 2016) .  
We propose that this network could be relevant for mindfulness-based 
analgesic techniques, especially the “focused attention” type, where focus 
on an internal signal (e.g. breathing), can distract subjects from pain (Zeidan 
et al., 2011). While this might be only one of the mechanisms to meditation 
analgesia, it is worth mentioning that this process is not mediated by 
endogenous opioids (Zeidan et al., 2016) but relies on the rACC (Zeidan et 
al., 2012; Zeidan & Vago, 2016), perhaps by exclusively engaging the ACC-LC 
pathway. 
We further postulate that this network may be of importance in chronic 
pain conditions (e.g. fibromyalgia), where disruption of attention and 
cognition are co-morbid alongside pain. Pharmacological therapies that 
target the noradrenergic system have some benefit in chronic pain 
conditions (Hughes et al., 2015; Kremer et al., 2016, 2018), possibly by acting 
on the LC system (Hiroki et al., 2017). On the other hand, evidence for 
malfunction of endogenous pain modulation in such pathologies (Julien et 
al., 2005; Lannersten et al., 2010; Staud et al., 2005; Vierck et al., 2001) ,  




together with the evidence of low effectiveness of opioid drugs (Goldenberg 
et al., 2016; Kia et al., 2017), might point toward impairments of the PAG-
RVM interaction. 
2.4.3 Methodological considerations 
Because of the increased sample size, we were able to detect activation 
in the RVM and PAG in the main effect of temperature and task respectively, 
without the aid of masking. This experimentally validates the results in 
Brooks et al., (2017) as well as the use of permutation testing with 
anatomical masks of a-priori specified ROIs. Notwithstanding the difficulty 
of accurately assigning measured functional activity to specific brainstem 
nuclei (Betts et al., 2019; Keren et al., 2009; Tona et al., 2017) and the 
problems faced when trying to image these structures (Brooks et al., 2013) ,  
the ability to corroborate our earlier findings should provide confidence for 
future studies of the brainstem. However, there is still a clear and pressing 
need for an objectively defined probabilistic brainstem atlas, as exists for 
other brain structures (Kurth et al., 2010). 
We used gPPI analysis, a well-established technique in the 
neuroimaging field, for network discovery. The strength of gPPI is the ability 
to detect functional changes in the interaction between two regions, caused 
by experimental manipulation. This is different from a seed-based analysis 
that detects functional interactions between regions that remain constant 
during the whole acquisition period.  We then used DCM with the singular 
purpose of resolving the directionality of the connections (after (Yoshino et 
al., 2010)), . DCM can be used on its own for network discovery, with a larger 
model space that tests all possible connections and modulations. However, 
a large model space is likely to cause a dilution of model evidence, leading 
to less clear results. In addition, the complexity (e.g. the number of 
connections) was kept constant across models, to avoid the risk of 
overfitting. 




We employed stochastic DCM, which allows for modelling of random 
neuronal noise in the system, to improve network resolution in brainstem 
areas significantly affected by physiological noise (Brooks et al., 2013). This 
routine was shown to improve the characterization of network structure and 
parameter inference over deterministic DCM (Daunizeau et al., 2012; Osório 
et al., 2015) and has been widely used in resting state and task-based fMRI 
studies since its release (Kahan et al., 2014; Ma et al., 2015, 2014; Ray et al.,  
2016; Zhang et al., 2015). 
2.4.4 Conclusion 
In this study we have been able to resolve parallel cortical – brainstem 
pathways that form a network that is functionally engaged when pain 
perception is attenuated during attentional analgesia. We note that the 
spinal cord BOLD response to nociception has previously been shown to be 
modulated by attention (Sprenger et al., 2012). Whether this spinal 
modulation of nociception is the product of activation of the ACC-PAG-RVM 
and/or the ACC-LC system still needs to be demonstrated in humans. It is 
known that both pathways could involve opioids (Fields, 2004) and so 
previous studies using naloxone do not discriminate between these 
possibilities. It would be interesting to explore whether conflict resolution 
resulting in attentional analgesia is dependent on the ACC-LC interaction or 
it could be achieved independently via the ACC-PAG-RVM path. A 
connectivity analysis examining the network activity between cortical 
territories, brainstem nuclei and dorsal horn in toto may help to define the 
key pathway in attentional analgesia.  
  




2.5 Supplementary material 
Supplementary Table 1 Activation clusters from main effects of temperature 
and distraction in the pooled cohort obtained with cluster-forming threshold Z>3.09 
and cluster-corrected p<0.05. The tables were created with Autoaq (part of FSL), 
with atlas labels based on the degree of overlap with probabilistic atlases (Harvard 
Oxford Cortical Structural Atlas, Harvard Oxford Subcortical Structural Atlas, 
Cerebellar Atlas in MNI152 space after normalization with FNIRT). 






Atlas labels  
Main effect of temperature in the pooled cohort 
2680 8.53 40 -18 18 46% Central Opercular Cortex, 27% 
Parietal Operculum Cortex, 5% Insular 
Cortex 
2072 5.08 6 -86 -24 3% Occipital Fusiform Gyrus 
839 7.03 -36 4 12 61% Central Opercular Cortex, 10% Insular 
Cortex 
386 4.87 0 -70 48 76% Precuneus Cortex 
352 4.84 0 20 28 87% Cingulate Gyrus, anterior division 
345 6.58 -38 -18 18 50% Central Opercular Cortex, 20% Insular 
Cortex, 5% Parietal Operculum Cortex 
268 5.26 22 -46 72 54% Superior Parietal Lobule, 12% 
Postcentral Gyrus 
265 5.23 32 -26 62 35% Precentral Gyrus, 28% Postcentral 
Gyrus 
238 4.75 4 -26 8 28.2% Right Thalamus  
223 4.87 -28 54 18 85% Frontal Pole 
133 4.31 4 -26 30 81% Cingulate Gyrus, posterior division 
97 4.09 12 -10 18 55.0% Right Thalamus 
95 4.7 -34 -56 42 29% Superior Parietal Lobule, 18% Angular 
Gyrus, 13% Supramarginal Gyrus, posterior 
division, 12% Lateral Occipital Cortex, 
superior division 
43 4.25 20 16 18 5.8% Right Caudate 
42 4.47 36 46 8 47% Frontal Pole 
41 4.34 2 -90 -6 34% Lingual Gyrus, 23% Occipital Pole, 13% 
Intracalcarine Cortex 
39 4.73 -26 -50 -50 57.0% Left VIIIa, 35.0% Left VIIIb  
36 3.97 -34 32 40 66% Middle Frontal Gyrus, 7% Frontal Pole 
34 4.54 -16 8 22 25.6% Left Caudate  
34 4.11 -48 -54 46 44% Angular Gyrus, 25% Supramarginal 
Gyrus, posterior division, 9% Lateral 
Occipital Cortex, superior division 
32 4.8 36 -82 -22 7% Lateral Occipital Cortex, inferior 
division 
32 4.33 48 -44 50 46% Supramarginal Gyrus, posterior 
division, 17% Angular Gyrus 
29 4.31 -4 -40 -44 100.0% Brain-Stem 
26 4.3 -48 -64 -30 99.0% Left Crus I 




Negative main effect of temperature in the pooled cohort 
67 4.25 6 30 -6 21% Subcallosal Cortex, 13% Cingulate 
Gyrus, anterior division 
28 4.06 -4 46 -12 63% Frontal Medial Cortex, 28% 
Paracingulate Gyrus 
Main effect of task in the pooled cohort 
4948 7.22 22 -90 -8 29.00% Occipital Fusiform Gyrus, 22.00% 
Occipital Pole, 10.00% Lateral Occipital 
Cortex, inferior division 
4790 7.33 -28 -76 20 41.00% Lateral Occipital Cortex, superior 
division 
3773 7.13 46 16 0 48.00% Frontal Operculum Cortex, 6.00% 
Insular Cortex 
635 6.81 -34 26 0 38.00% Frontal Orbital Cortex, 20.00% 
Frontal Operculum Cortex, 13.00% Insular 
Cortex 
540 5.26 36 38 36 56.00% Frontal Pole, 23.00% Middle 
Frontal Gyrus 
433 5.87 -42 6 26 27.00% Precentral Gyrus, 26.00% Inferior 
Frontal Gyrus, pars opercularis 
241 6.33 -8 -74 -38 43.0% Left VIIb, 38.0% Left Crus II 
205 5.43 4 -26 -2 12.8% Brain-Stem 
58 4.68 -46 -38 38 25.00% Supramarginal Gyrus, anterior 
division, 10.00% Supramarginal Gyrus, 
posterior division 
46 4.65 44 -8 -10 66.00% Planum Polare 
45 4.14 -28 -2 58 28.00% Middle Frontal Gyrus, 16.00% 
Superior Frontal Gyrus, 6.00% Precentral 
Gyrus 
41 5 -38 -52 -44 63.0% Left Crus II, 13.0% Left VIIb, 6.0% 
Left Crus I 
38 5.71 10 -74 -38 57.0% Right Crus II, 18.0% Right VIIb 
27 4.52 -14 -22 36 19.00% Cingulate Gyrus, posterior division 
Negative main effect of task in the pooled cohort 
1731 6.31 8 -56 30 38% Precuneus Cortex, 20% Cingulate 
Gyrus, posterior division 
1126 6.6 -38 -72 48 68% Lateral Occipital Cortex, superior 
division 
876 5.43 -34 18 56 63% Middle Frontal Gyrus, 2% Superior 
Frontal Gyrus 
511 5.77 32 -70 -36 44.0% Right Crus I, 24.0% Right Crus II  
461 5.95 50 -66 40 83% Lateral Occipital Cortex, superior 
division 
346 4.66 6 28 -4 14% Subcallosal Cortex anterior division 
257 5.06 -36 -24 70 32% Postcentral Gyrus, 24% Precentral 
Gyrus 
125 4.97 -38 -72 -36 97.0% Left Crus I  
94 5.33 -66 -42 -6 54% Middle Temporal Gyrus, posterior 
division, 29% Middle Temporal Gyrus, 
temporooccipital part 




92 4.99 -16 64 18 82% Frontal Pole 
78 4.47 -42 52 2 88% Frontal Pole 
41 4.07 -38 -18 18 50% Central Opercular Cortex, 20% Insular 
Cortex, 5% Parietal Operculum Cortex 
38 4.38 -24 -50 18 1% Precuneus Cortex 
34 4.16 -64 -8 -14 44% Middle Temporal Gyrus, anterior 
division, 24% Middle Temporal Gyrus, 
posterior division, 8% Superior Temporal 
Gyrus, posterior division 
 
 
Supplementary Table 2  Results from intrasubject parametric regression with 
pain ratings in the pooled cohort obtained with cluster-forming threshold Z>3.09 
and cluster-corrected p<0.05. The tables were created with Autoaq (part of FSL), 
with atlas labels based on the degree of overlap with probabilistic atlases (Harvard 
Oxford Cortical Structural Atlas, Harvard Oxford Subcortical Structural Atlas, 
Cerebellar Atlas in MNI152 space after normalization with FNIRT).  






Atlas labels  
9467 6.36 32 -28 64 40% Postcentral Gyrus, 26% Precentral 
Gyrus 
3621 8.37 40 -18 18 46% Central Opercular Cortex, 27% Parietal 
Operculum Cortex, 5% Insular Cortex 
3481 7.78 -56 -2 8 45% Central Opercular Cortex, 28% 
Precentral Gyrus, 5% Planum Polare 
1693 5.93 -26 46 26 79% Frontal Pole 
287 4.98 -62 -56 -10 54% Middle Temporal Gyrus, 
temporooccipital part, 21% Inferior 
Temporal Gyrus, temporooccipital part, 7% 
Lateral Occipital Cortex, inferior division 
285 5.2 4 -26 8 28.2% Right Thalamus 
120 4.42 20 -8 28 3.1% Right Caudate 
 
95 4.18 42 48 8 80% Frontal Pole 
86 4.71 16 -20 10 099.8% Right Thalamus 
 
71 5.79 -26 -50 -50 57% Left VIIIa, 35% Left VIIIb 
 
59 4.41 46 26 36 65% Middle Frontal Gyrus 
46 3.82 -20 -28 68 39% Precentral Gyrus, 23% Postcentral 
Gyrus 
38 4.17 -42 -72 24 72% Lateral Occipital Cortex, superior 
division 
37 4.11 -18 -38 66 51% Postcentral Gyrus 
36 3.84 2 -66 -38 69% Vermis VIIIa, 13% Vermis VIIIb 
34 3.83 24 54 26 76% Frontal Pole 




33 4.48 52 30 22 32% Middle Frontal Gyrus, 30% Inferior 
Frontal Gyrus, pars triangularis 
31 3.78 28 58 0 76% Frontal Pole 
1637 6.16 46 -64 2 56% Lateral Occipital Cortex, inferior 
division, 10% Middle Temporal Gyrus, 
temporooccipital part 
1184 5.36 -42 -74 0 63% Lateral Occipital Cortex, inferior 
division 
176 5.38 -26 -76 30 67% Lateral Occipital Cortex, superior 
division 
126 4.73 26 -52 50 34% Superior Parietal Lobule, 3% Lateral 
Occipital Cortex, superior division 
51 4.32 -54 -16 52 57% Postcentral Gyrus, 8% Precentral Gyrus 
 
Supplementary Table 3 Summary of mean parameter estimates for 









Group Mean    
ACC-PAG 
connection 
0.084 (0.0012) 0.029 (0.0052) - 
ACC-LC connection 0.058 (0.0011) -0.019 (0.0054) - 
PAG-ACC 
connection 
0.083 (0.0012) -0.0058 (0.0026) - 
PAG-RVM 
connection 
0.039 (0.0011) -0.038 (0.0061) - 
LC-ACC connection 0.054 (0.0012) -0.012 (0.0052) -0.0404 (0.0065) 
RVM-PAG 
connection 
0.034 (0.0012) -0.0004 (0.0026) -0.0419 (0.0061) 
 
  




Chapter 3 Attentional analgesia and 
its central pain modulatory 








Work presented in the present chapter refers to the following paper: 
Oliva, V., Gregory, R., Brooks, J. C. W. & Pickering, A. E. (2020). Attentional 
analgesia and its central pain modulatory mechanisms are preserved in 
Fibromyalgia. 
The paper is in submission to pain.  
Valeria Oliva was involved in the acquisition of the data with RG, 
conceptualized the paper, performed all the analyses, wrote the paper, 
revised it, and made the images. RG lead the data acquisition. AEP 
conceptualized the paper, was involved in the analyses, revised the paper, 
and supervised the work. JCB conceptualized the paper, was involved in the 
analyses, revised the paper, and supervised the work. 
  





Fibromyalgia is a common, chronic condition characterised by 
widespread pain with hyperalgesia in muscles and joints, without any 
identifiable causative pathology or injury (Borchers et al., 2015; Schmidt-
Wilcke et al., 2014; Wolfe et al., 1990). In addition to widespread pain, 
fibromyalgia is syndromically-linked to fatigue, sleep deficits and difficulties 
in concentration, an array of symptoms which has been referred to as 
“fibrofog” (Katz et al., 2004; Vincent et al., 2013). A single underlying 
pathophysiological cause for fibromyalgia is yet to be fully elucidated 
(Schmidt-Wilcke et al., 2017) and the diagnostic criteria rely on self-reported 
measures (Stewart et al., 2019; Wolfe et al., 2010, 2016). 
There are a plethora of studies reporting alterations in nociception and 
pain processing in patients with fibromyalgia. One intriguing line of 
investigations has described a small fibre deficit and altered function of 
nociceptive primary afferents (Grayston et al., 2019; Levine et al., 2015; 
Oaklander et al., 2013; Serra et al., 2014; Üçeyler et al., 2013) which may 
give rise to hyperalgesia. Fibromyalgia has also been considered as a 
“centralised” pain condition (Clauw, 2014) characterised by augmented 
brain responses to noxious stimuli that result in hyperalgesia (Desmeules et 
al., 2003; Gracely et al., 2002; Price et al., 2002) . The putative central 
aetiology of fibromyalgia has been reported to include impairments in 
endogenous pain modulatory mechanisms (Brietzke et al., 2019; Julien et al.,  
2005; Lautenbacher et al., 1997; Vierck et al., 2001). This has, in part, been 
the justification for the use of treatments to boost monoaminergic signalling 
in central pain modulatory circuits through the use of re-uptake inhibitors 
(increasing noradrenaline and serotonin) which are amongst the few 
medications with evidence of efficacy in fibromyalgia (Clauw, 2014). 
Endogenous pain modulation can be engaged by cognitive  
manipulations, such as expectation of analgesia (i.e. placebo (Benedetti et 
al., 2019; Eippert et al., 2009) or a shift in attention (Bantick et al., 2002; 
Valet et al., 2004). In healthy subjects, attentional analgesia has been shown 




to involve brainstem structures such as the rostral ventromedial medulla 
(RVM), locus coeruleus (LC) and periaqueductal grey (PAG) (Brooks et al., 
2017; Oliva et al., 2020; Tracey et al., 2002; Valet et al., 2004) that mediate 
a component of their pain modulatory effects via endogenous monoamines 
(Ossipov et al., 2010). These brainstem regions are intrinsically challenging 
to image and have been only sparsely investigated in fibromyalgia despite 
being implicated as part of the causative central pathology.   
We hypothesised that there would be a demonstrable deficiency in 
attentional analgesia in patients with fibromyalgia, and further that whole 
brain/brainstem fMRI could help to determine where any deficit originated 
within the descending pain modulatory system or the attentional network.  
We find that, in keeping with previous studies, the fibromyalgia group show 
thermal hypersensitivity and impaired performance on the attention 
demanding task. Importantly, however, fibromyalgia patients can exhibit 
attentional analgesia of equivalent magnitude to healthy controls if the task 
difficulty and intensity of noxious stimulus are individually titrated according 
to performance and percept. For both groups this analgesic effect correlates 
with brainstem activity in RVM and PAG suggesting that fibromyalgia 
patients can engage the descending pain modulatory system. 
  





The study had ethical approval from the NHS South Central Oxford B 
Research Ethics Committee (reference 13/SC/0617).  All subjects gave 
written informed consent for study participation.  The study was undertaken 
in the Clinical Research and Imaging Centre at the University of Bristol 
(CRiCBristol). 
3.2.1 Recruitment 
Fibromyalgia patients were recruited from local pain management 
clinics by clinician referral and poster advertisements.  Sex-matched healthy 
control subjects were recruited using poster and email advertisements at 
the University of Bristol.  All subjects were screened for participation by 
telephone prior to attending for their single session. To meet inclusion 
criteria, they required a confirmed clinical diagnosis of fibromyalgia for at 
least six months prior to entry into the study.  They were excluded if they 
had other diagnosis of chronic painful conditions, were pregnant, or had a 
history of neurological or major psychiatric illness. Additionally, for control 
subjects, the presence of significant medical or psychiatric disorder 
(including depression), or of any chronically painful condition precluded 
participation.  Normal safety inclusion/exclusion criteria for participation in 
MRI studies were also applied. 
A total of 54 subjects (32 patients, 22 controls) were screened for the 
study, of which 14 failed the screening (3 were left-handed, 9 were unable 
to attend, 1 was unable to lie flat in the scanner, 1 did not pass the MRI 
screening).  Twenty right-handed fibromyalgia patients (mean age 43, range 
25-60, 18 females) were enrolled in the study. Patients were not required to 
alter their regular medications. Twenty right-handed, healthy subjects 
(mean age, 35 years, range 20-59 years; 18 females) participated in the 
study.  





Written informed consent was taken and MRI safety questionnaires 
were completed on the day of study.  The American College of 
Rheumatology (ACR) Widespread Pain and Symptom Severity index (Wolfe 
et al., 2010) was completed with the assistance of clinician experimenters. 
An Edinburgh Handedness Inventory (Oldfield, 1971), PainDETECT 
(Freynhagen et al., 2006), the "pain now” and “Pain average” scales from the 
Brief Pain Inventory (Cleeland et al., 1994), Hospital anxiety and depression 
scale (HADS, Zigmond et al., 1983) and Pain Anxiety Symptom Scales (PASS, 
(McCracken et al., 1992)) were also completed. Any medications taken in the 
72 hours prior to the session were recorded for all participants. Both groups 
then underwent thermal Quantitative Sensory Testing (QST)  with a circular 
contact thermode (CHEPS Pathway, MEDOC) applied to the left volar 
forearm using a standardised protocol and script that included warm 
detection threshold, heat pain threshold, cold detection threshold and cold 
pain threshold. Furthermore, study participants were tested for pressure 
pain thresholds on the thenar eminence using an algometer (Somedic). After 
a short comfort/snack break, participants returned to CRiCBristol for the 
fMRI experiment.  
The fMRI experiment was identical in structure to the one described in 
Brooks et al., (2017). Briefly, participants received thermal stimuli to their 
left forearm for 30s at either 36°C (low temperature) or 42-45°C (high 
temperature), and a pseudo-random series of 1 second long “spikes” of 2, 3 
or 4°C above these temperatures were superimposed to minimise  
habituation to stimulation. The high temperature was individually adjusted 
to a level that elicited a verbal pain rating of 6/10 in the absence of task.  
Participants also performed a rapid serial visual presentation (RSVP) 
attentional task (Potter et al., 1969), where they were presented with rapidly 
changing letters and numbers on a display screen and they were instructed 
to press a button when spotting the number 5. The task had two possible 
levels of difficulty (easy or hard). The task was individually titrated such that 




its speed of presentation (i.e. inter-stimulus interval, ISI) was performance 
matched to ability.  Each participant’s task performance was assayed over a 
range of ISIs (from 32 to 256ms) and assessed by fitting a sigmoidal function 
to the data (using d-prime). The speed at which they performed at 70% 
accuracy was used for the hard task during the experiment. The ISI for the 
easy task was set to: 192ms if the subject’s hard task ISI was < 96ms; 256ms 
if the hard ISI was ≥ 96 & ≤ 256ms; 384ms if the hard ISI was > 256ms. The 
experiment therefore had a 2x2 factorial design with four conditions 
(easy|high, hard|high, easy|low, and hard|low). Conditions were presented 
in pseudo-random blocks within sessions and across participants.  Pain 
ratings and task performance (hits, misses and false alarms) were recorded 
during the experiment. 
3.2.3 MRI data acquisition 
Brain images were acquired with a 3T Siemens Skyra whole-body MR 
system using the same acquisition sequences (as per Brooks et al., 2017; 
Oliva et al., 2020). Briefly, subjects’ heads were positioned within the 32-
channel receive only head coil, and memory foam pads placed around the 
skull to help minimise movement. Following acquisition of localiser images, 
a sagittal T1-weighted MPRAGE volumetric scan was acquired with TE/TR = 
2.28/2200ms, flip angle = 9° and resolution of 0.86 x 0.86 x 0.86mm, phase 
encoding direction = A-P, GRAPPA acceleration factor = 2. Functional imaging 
data was acquired with an echo planar imaging (EPI) sequence and GRAPPA 
acceleration factor = 2, TE/TR = 30/3000ms, flip angle = 90° and a resolution 
of 1.77 x 1.77 x 3.5mm. Finally, to correct image distortion in EPI data, a 
gradient echo field map was acquired with TE1/TE2/TR = 4.92 / 7.38 / 520ms, 
flip angle 60°, resolution 3 x 3 x 3.5mm. During the fMRI experiment, cardiac 
and respiratory waveforms were recorded using pulse oximeter and 
respiratory bellows for subsequent physiological noise modelling (Brooks et 
al., 2013).  




3.2.4 Questionnaire, QST and behavioural data analysis  
All statistical analyses (questionnaires, QST, pain ratings, task 
performance) were carried out in SPSS (version 26). Unpaired t-tests were 
used on questionnaire results to detect differences between patient and 
control groups.  
Hit rate (the proportion of correct responses to targets) and false alarm 
rate (the proportion of responses to non-targets) were calculated and z 
transformed. Subsequently, d’ was calculated as the difference between z 
transformed hit rate and z transformed false alarm rate.  The interstimulus 
intervals were compared with a Mann-Whitney U-test. 
Pain ratings and task performance recorded during the fMRI 
experiment were analysed with a mixed ANOVA (with two within-subject 
factors, task, and temperature, and one between-subjects factor, group). 
Prior to statistical analysis, data was examined for the presence of outliers, 
normality of distribution and equality of variance.  
Results are reported as mean ± standard deviation or median and 
[range] where appropriate. The indicative significance level was set to 
P<0.05 throughout.  
3.2.5 fMRI analysis 
Functional images were pre-processed and analysed in FEAT (FSL 
version 6, Jenkinson et al., 2012). The pre-processing pipeline was consistent 
with our previous paper (Brooks et al., 2017) and included motion correction 
with MCFLIRT (Jenkinson et al., 2002), fieldmap unwarping with FUGUE 
(Jenkinson, 2003), registration to standard MNI template with FNIRT 
(Andersson et al., 2007) and FLIRT (Jenkinson et al., 2001), 4mm spatial 
smoothing and high-pass temporal filtering using a 90s cut-off. The general 
linear model (GLM) in FEAT, part of FSL, was used to assess brain activation 
to the four experimental conditions (easy|high, hard|high, easy|low, 
hard|low) and nuisance regressors (task instruction, rating periods), which 




were convolved with a hemodynamic response function. The design also 
included temporal derivatives, local autocorrelation correction (FILM, 
Woolrich et al., 2001) and a set of regressors modelling physiological noise 
(Brooks et al., 2008; Harvey et al., 2008). Main effect contrasts (positive and 
negative main effect of task and of temperature, task * temperature 
interaction) were estimated at the first level, i.e. single subject analysis.  
Whole brain group differences were assessed with an unpaired t-test in 
FEAT using a mixed-effects model (FLAME) and cluster-based correction for 
multiple comparison (Z > 3.1 for height and p < 0.05 for cluster extent, in 
accordance with the latest recommendations  (Eklund et al., 2016). 
Nonparametric permutation testing (RANDOMISE, Nichols et al., 2002)  
with 10000 permutations was used to identify signal change in brainstem 
nuclei. An appropriate two-sample unpaired t-test design was built with 
GLM (part of FSL) in accordance with the FEAT guidelines. Masks for the PAG, 
RVM plus left and right LC (defined in Brooks et al., 2017) were used for 
permutation testing. In all analyses using RANDOMISE, significant 
activations are reported using a threshold free cluster enhancement (TFCE) 
corrected p < 0.05.  
Where interactions were found in the imaging data, further 
investigation using FEATQUERY was performed to elucidate the nature of 
these changes. Parameter estimates were extracted from each experimental 
condition (i.e. easy|low vs rest, hard|low vs rest, easy|high vs rest, 
hard|high vs rest) and their relationship to the individual behavioural 
responses examined. 
In a separate FEAT analysis, the whole group mean for healthy controls  
and fibromyalgia patients was examined in a one-sample t test. RANDOMISE 
was used for brainstem nuclei. 




The magnitude of attention-mediated analgesia was compared to BOLD 
signal change in the brainstem nuclei (PAG, RVM and LC) specified a priori 
(as per our earlier study, Brooks et al., 2017).  Average pain ratings obtained 
during high temperature stimulation at the two different task difficulties 
were subtracted (i.e. easy|high – hard|high) and demeaned to obtain a 
group-level covariate. The difference in the BOLD signal recorded for 
hard|high minus easy|high was correlated with the difference in pain 
ratings in an inter-subject parametric regression model. RANDOMISE was 
used to assess correlations in PAG, RVM, left and right LC masks. The latter 
analysis was done on the whole cohort (fibromyalgia patients and healthy 
controls).   
All whole brain results (group means and group comparisons) are 
reported for Z > 3.09, cluster corrected P < 0.05. All brainstem results are 
reported for P < 0.05, TFCE corrected.  
  





3.3.1 Demographics  
All patients met the ACR 2010 Diagnostic Criteria for fibromyalgia 
(Wolfe et al., 2010), scoring 13.5±2.6 on the Widespread Pain Index (WPI) 
and 10.0±1.5 [7-12] on the Symptom Severity (SS) scale score (WPI ≥7 and 
SS ≥5, Table 1).  None of the healthy controls met the ACR 2010 Diagnostic 
Criteria, scoring 1.0±1.0 [0-3] on the WPI and 2.0±1.1 [1-4] on the SS (Table 
1).  As expected, the fibromyalgia patients had higher scores on the 
PainDETECT questionnaire compared to controls (15.7± 8.2 vs 2.4±3.3 
respectively, P < 0.0001), as well as for ‘pain now’ (5.3±1.6 vs 0.1±0.2 
respectively, P < 0.0001) and ‘average pain’ (6.4±1.7 vs 0.7±1.0 respectively, 
P < 0.0001) domains of the BPI (Table 1).  Fibromyalgia patients had elevated 
anxiety and depression scores (12.2±3.6 and 10.5±4.7, on HADS 
respectively) in comparison to healthy controls (4.6±4.0 and 1.3±1.3) on the 
HADS (P < 0.0001 in both cases, Table 1).  Fibromyalgia patients also had 
higher scores in the cognitive, avoidance, fear, and anxiety sections of PASS 
(all P < 0.0001, Table 1).   







Widespread Pain Index 13.5±2.6 1.0±1.0 N/A 
Symptom Severity 10±1.5 2±1.1 N/A 
Hospital Anxiety  12.2±3.6  4.6±4.0 N/A 
Hospital Depression 10.5±4.7  1.3±1.3  P < 0.0001 
Pain anxiety symptom 
(cognitive) 
18.4±4.3 5.3±6.6 P < 0.0001 
Pain anxiety symptom 
(avoidance) 
14.6±5.6 5.8±5 P < 0.0001 
Pain anxiety symptom (fear) 11.2±6.8 1.6±1.9 P < 0.0001 
Pain anxiety symptom 
(anxiety) 
11.6±5.5 1.5±2.4 P < 0.0001 
PainDETECT 15.7± 8.2 2.4±3.3 P < 0.0001 
Pain now 5.3±1.6 0.1±0.2 P < 0.0001 
Pain average 6.4±1.7 0.7±1.0 P < 0.0001 
 




3.3.2 Quantitative sensory testing 
Patients with fibromyalgia exhibited hyperalgesia to thermal and deep 
pressure stimuli when compare to controls, and higher sensitivity to non-
noxious thermal stimuli. The heat pain threshold was lower in the 
fibromyalgia patients (41.6±4.6 fibromyalgia vs 45.3±3.9°C controls, P=0.01, 
unpaired T-test, Figure 3.1A) and the cold pain threshold was at a higher 
temperature (median 25.65°C, range [1.7 – 32] fibromyalgia vs median 
4.450°C, range [0 – 30.6] healthy controls, P = 0.001, Mann-Whitney U test, 
Figure 3.1B). There was an increase in the warm detection threshold in 
fibromyalgia patients (median 34.70°C, range [33.4 – 46.8] vs 33.90°C, range 
[33.3 – 36.2] P = 0.016, Mann-Whitney U test, Figure 3.1C) but no difference 
in the cold detection (median 30.60 °C, range [23.7 – 13.2] vs median 30.6°C, 
range [26.8 – 31.4], P = 0.73, Mann-Whitney U test). Finally, the pressure 
pain threshold was lower in fibromyalgia patients (fibromyalgia median 
181.5kPa, range [37 – 303] vs control median 251kPa, range [29 – 513],  
P=0.0019, Figure 3.1D). 




3.3.3 Titration of thermal stimulation and task difficulty  
In keeping with thermal hyperalgesia identified by QST, the percept 
calibrated high (painful) thermal stimulus to be used during fMRI was set at 
a lower temperature for the fibromyalgia patients. The temperature eliciting 
a pain intensity rating of 6 out of 10 was 42±2°C for fibromyalgia patients 
and 43.1±1.7 °C for healthy controls (P=0.047, Figure 3.1E). The difficulty of 
the ‘hard’ RSVP task to be used during the experiment, was individually 
calibrated for each participant. Fibromyalgia patients required a longer 
interstimulus interval in the RSVP task to perform at 70% of optimal 
(fibromyalgia median 96ms, range [48ms – 256ms] vs control median 64ms, 
range [32ms – 96ms], P=0.009, Mann-Whitney U,  Figure 3.1F). 
Figure 3.1 Quantitative Sensory Testing (hot pain threshold (A), cold pain 
threshold (B), warm detection threshold (C), Pressure pain threshold (D)); high 
temperature used for the experiment (E), characters presentation speed in the RSVP 
task (F). 
 




3.3.4 Pain ratings during the fMRI experiment 
The purpose of the experiment was to examine whether pain score 
evoked by the thermal stimuli (low or high temperature) were affected by 
the concurrent performance of the RSVP task (easy or hard task). 
Behavioural data (pain scores) was initially pooled for both groups ( Figure 
3.2A). A mixed ANOVA showed an expected main effect of temperature (F 
(1,38) = 174.8, P < 0.001) and a temp*task interaction (F (1,38) = 13.1, P = 
0.001). There was no main effect of task (F (1,38) = 2.6, P = 0.12). There were 
no differences between the control and fibromyalgia groups: temp*group (F  
(1,38) = 0.2, P = 0.65), task*group (F (1,38) = 4.7, P = 0.66), or 
temp*task*group (F (1,38) = 0.01, P=0.97)). A planned post-hoc paired t-test 
revealed decreased pain ratings in the hard|high (43.8±2.8) versus the 
easy|high (47.9±2.4) condition consistent with an attentional analgesic 
effect (P = 0.001).  
To demonstrate the similarity between the controls and the 
fibromyalgia patients the results are plotted separated by group (Figure 
3.2B-C).  In healthy controls a main effect of temperature and a task * temp 
interaction was evident (F (1,19) = 104.2, P < 0.0001 and F (1,19) = 11.9, P = 
0.003 respectively). Likewise, in fibromyalgia patients there was a main 
effect of temperature and a task * temperature interaction (F (1,19) = 73.9, 
P < 0.0001, F (1,19) = 4.6, P = 0.046, respectively). In both groups, post-hoc 
paired t-tests revealed that the interaction was due to an attentional 
analgesic effect with a decrease in pain scores in the  hard|high versus the 
easy|high condition. 
  




Figure 3.2 Mean pain ratings after each experimental condition for both fibromyalgia patients and healthy controls (A), fibromyalgia pat ients only (B), and 
healthy controls only (C). Error bars represent the standard error mean (SEM).





3.3.5 Task performance during the fMRI experiment 
To see whether the performance of patients and controls on the 
RSVP task was as expected during the fMRI experiment, button responses 
were recorded and used to calculate d-prime (d’). Importantly and as 
intended, the hard task was more challenging than the easy as assessed 
with a mixed ANOVA revealed a main effect of task (F (1,38) = 46.0, P < 
0.0001, Figure 3.3). Patients and controls showed a similar drop in 
performance when comparing the easy with hard tasks as there was no 
interaction between task performance and group, (F (1,38) = 2.7, P = 0.11). 
We noted that controls performed the task better overall in the scanner 
as reflected in the between subjects (i.e. group) effect (F (1,38) = 10.2, 
P=0.003) indicating that our initial calibration (outside the scanner) had 
not managed to fully compensate the differences in performance levels 
between the groups when they were challenged within the scanner.  
Further analysis indicated that stimulus temperature had no effect 
on task performance (main effect of temperature F (1,38) = 0.2, P = 0.63), 
and there was no interaction between task and temperature (F (1,38) = 
0.9, P = 0.34), nor between temperature and group (F (1,38) = 2.6, P = 
0.12). However a task * temperature * group interaction was observed (F 
(1,38) = 8.3, P = 0.007) and subsequent exploratory post-hoc paired t-tests 
revealed that the high temperature had a disruptive effect on task 
performance in fibromyalgia patients when the task was easy (paired t-
test, fibromyalgia group only, P = 0.03). 
  




Figure 3.3 Mean task performance (d') during each experimental condition for fibromyalgia patients (A) and healthy controls (B). Error bars represent the 
standard error mean (SEM).





3.3.6 Neuroimaging analysis 
The behavioural results indicated that the fibromyalgia patients had 
thermal hyperalgesia and overall worse performance on the RSVP task, 
but when these factors were mitigated by adjusting stimulus temperature 
to percept and task speed to performance (albeit outside the scanner 
session), they could still produce attentional analgesia.  However, it was 
not clear if they would recruit the same brain networks as healthy controls 
to produce this analgesic effect. Therefore, the same analysis strategy 
used for the pain ratings was also applied to the fMRI data. To determine 
main effects in the patterns of activation in brain and the brainstem both 
groups were pooled and subsequently differences between groups were 
assessed.  
Whole brain analysis of the main effect of temperature in pooled 
group data revealed the expected patterns of activity in the cortex 
including prominent clusters in the contralateral (i.e. right) dorsal 
posterior insula, primary somatosensory cortex and anterior cingulate 
cortices among others (Figure 3.4A, Supplementary Table 4). Brainstem 
region-masked analyses showed a main effect of temperature in the RVM 
(Figure 3.4A). Analysis of group level differences in the whole brain 
response to temperature, showed no differences with the singular 
exception of an enhanced response in healthy controls in the anterior 
medial frontal pole (Brodmann Area 10, Figure 3.4B, Supplementary 
Table 4). Similar analyses in the brainstem only showed a group level 
difference in the left LC, again with an enhanced response in healthy 
controls (Figure 3.4B). 
To explore the possible origins of these differences, we conducted an 
exploratory analysis based on the observed need to use a hotter high 
temperature stimulus for the healthy controls than for fibromyalgia 
patients (Figure 3.1E). Therefore, the correlation of BOLD signal change 
for each area (BA10 and LC) and difference between the high and low 




applied temperatures was calculated. The left LC BOLD signal showed a 
positive correlation with the delta between high and low temperatures 
(Pearson’s R=0.48, P=0.02, Figure 3.4B), suggesting that the difference in 
applied temperature might account for the group level difference. A 
similar analysis did not reveal any correlation between temperature delta 
and activity in BA10 (R=0.19, P=0.47). 
  





Figure 3.4 Main effect of temperature in fibromyalgia patients and healthy controls in the whole brain, showing activity in dorsal posterior insula, anterior 
cingulate cortex and primary somatosensory cortex among the others (Z>3.1 cluster corrected P < 0.05), and in the left LC, showing a stronger response in healthy 
controls (B, TFCE corrected P < 0.05). Correlation between main effect of temperature in LC and difference in temperatures (R = 0.49, P = 0.002).




Whole brain analysis of the main effect of task in the pooled data 
showed a familiar pattern of increased activity in lateral occipital cortex, 
anterior insula and anterior cingulate cortex amongst others, and a 
decrease in activity in the precuneus and lateral occipital cortex (Figure 
3.5, Supplementary Table 4). Brainstem region masked analyses showed 
a main effect of task in the PAG, RVM, and left LC (Figure 3.5). No 
difference between the fibromyalgia and control groups was detected in 
the main effect of task at whole brain or brainstem level.




Figure 3.5 Main effect of task in fibromyalgia patients and healthy controls in the whole brain, showing increase in activity in anterior insula, anterior cingulate 
cortex and lateral occipital cortex among the others (red-yellow), and a decrease in activity in the precuneus and lateral occipital cortex (Z>3.1 cluster corrected P < 
0.05). Main effect of task in the brainstem, in the PAG and RVM (TFCE corrected P < 0.05).




No task * temperature or task * temperature * group interaction 
(that could be the neural substrate of the observed behavioral interaction 
between task and temperature i.e. attentional analgesia) was seen at the 
whole brain or brainstem level in line with the findings of our previous 
studies (Brooks et al., 2017; Oliva et al., 2020). 
A planned analysis sought correlations between the fMRI data 
(individual BOLD differences between hard|high and easy|high 
conditions) and the change in pain scores (i.e. analgesic effect, easy|high 
minus hard|high) to improve the power to identify possible 
neurobiological substrates involved in the analgesic effect (Brooks et al., 
2017; Oliva et al., 2020). The whole brain regression analysis (i.e. inter-
subject) did not identify any significant regions of activity. However, 
masked brainstem analyses with the same model showed a positive 
correlation between analgesic effect and the change in activity in the PAG 
and the RVM (Figure 3.6).  




Figure 3.6 Inter-subject parametric regression with the analgesic effect (i.e. pain ratings of easy|high – hard|high), in PAG and RVM (p < 0.05, TFCE corrected).





We demonstrated that fibromyalgia patients can achieve attentional 
analgesia with similar central mechanisms to healthy volunteers.  
Analysis of pain ratings during the fMRI experiment revealed that high 
cognitive load was successful in distracting both patients and controls from 
the painful stimulus. Thus, we revealed that contrary to what was expected, 
attentional analgesia is preserved in fibromyalgia patients in the context of 
hot thermal stimulation. This result is in contrast with previous evidence of 
endogenous pain modulation malfunctioning in this patient population 
(Julien et al., 2005; Kosek et al., 1996; Lannersten et al., 2010; Staud et al., 
2005; Vierck et al., 2001). For example, conditional pain modulation was 
consistently found to be impaired in fibromyalgia patients (Brietzke et al., 
2019; Harper et al., 2018; Paul-Savoie, 2012; Potvin et al., 2016; Schoen et 
al., 2016), up to the point of becoming a test used for the evaluation of novel 
pharmaceutical therapies (de Zanette et al., 2014). However, the present is 
not the only study that suggests that attentional analgesia is preserved in 
fibromyalgia patients. A Stroop task was successful in causing a decrease of 
ratings to pressure (Martinsen et al., 2014) and thermal (Ellingson et al., 
2018) pain. In addition, expectation of analgesia and music seem to be able 
to produce some pain relief in this patient population (Goffaux et al., 2009; 
Häuser et al., 2012; Pando-Naude et al., 2019), although with lower efficacy 
in patients with a longer disease duration (Kosek et al., 2017). It therefore 
seems that different modalities of endogenous pain modulation have 
different efficacy and that if modulation of pain is triggered by cognitive  
state it has better results. It has been proposed that the lack of analgesia 
induced by exercise or by a conditioned stimulus in fibromyalgia is caused 
by the engagement of pain disinhibitory networks, that facilitate instead of 
attenuating pain (Jensen et al., 2009; Lannersten et al., 2010; Martinsen et 
al., 2014). Another possibility is that the cortex-brainstem-spinal cord 
modulatory system is disrupted in this patient population and that they are 
only able to achieve analgesia by cognitive processes. The latter hypothesis 




was motivated by the presence of unchanged spinal withdrawal reflex 
during placebo analgesia, despite the reduction in pain scores, suggesting 
that the spinal cord activity was not modulated (Goffaux et al., 2009). 
To resolve brain regions crucially involved in attentional analgesia, we 
used the same strategy as in Brooks et al., (2017) and Oliva et al., (2020): the 
analgesic effect, defined as the difference in pain ratings between easy|high 
and hard|high conditions, was correlated with the BOLD change in the same 
conditions. This analysis revealed that in both groups PAG and RVM showed 
a positive linear relationship with the analgesic effect, suggesting that these 
regions are directly implicated in attentional analgesia. This result, in 
contrast with previous fMRI evidence showing an impaired relationship 
between PAG and RVM during conditional pain modulation (Harper et al., 
2018), suggests that during attentional analgesia, an endogenous pain 
modulatory system is recruited in fibromyalgia patients. Interestingly, a 
resting state fMRI study revealed stronger connectivity between PAG and 
ACC or Insula in fibromyalgia patients but, notably, not with the RVM (Truini 
et al., 2016). Conclusive, direct evidence that PAG and RVM modulate the 
spinal cord during attentional analgesia was not found yet, but it has been 
extensively suggested (Brooks et al., 2017; Oliva et al., 2020; Sprenger et al., 
2012; Tracey et al., 2002). Our result seems therefore in contrast with the 
suggestion of a supraspinal mechanism to endogenous analgesia in 
fibromyalgia patients (Goffaux et al., 2009). Functional imaging of brainstem 
and spinal cord during an endogenous analgesia paradigm would help 
clarifying this issue by determining whether the downstream 
communication between brainstem and spinal cord is indeed impaired in 
fibromyalgia. 
Quantitative sensory testing revealed thermal hyperalgesia in 
fibromyalgia patients in response to both hot and cold stimuli, in line with 
what previously reported by other research groups (Blumenstiel et al., 2011; 
Brietzke et al., 2019; Hurtig et al., 2001; Potvin et al., 2016). It has been 
proposed that this disfunction is due to altered functioning in primary 




afferents leading to a latent small fibre neuropathy. A hypothesis supported 
by the evidence of reduction in small diameter fibres in patients with 
fibromyalgia (Doppler et al., 2015) and hyperexcitable C-nociceptors (Serra 
et al., 2014). Indeed, skin biopsies revealed a reduction in unmyelinated 
fibres in fibromyalgia patients (Üçeyler et al., 2013). On the other hand, 
recent evidence coming from a retrospective LEP study, failed to reveal the 
expected abnormal response to the laser stimulation in patients (Van Assche 
et al., 2020). This adds to the evidence of highly variable phenotype in 
fibromyalgia. 
With the purpose of achieving comparable cognitive load within and 
between groups, we calibrated the hard version of the attentional task for 
each participant (Brooks et al., 2017). We found that the inter-character 
presentation speed was significantly lower in the fibromyalgia group 
compared to healthy controls. This is in line with previous findings reporting 
higher reaction time in the patient group in, for example, a Stroop task 
(Martinsen et al., 2014; Veldhuijzen et al., 2012) and supports the evidence 
of impaired attentional/cognitive processes in fibromyalgia patients. It has 
been proposed that such behavioural impairments are reflected by 
abnormal functioning of the caudate nucleus and hippocampus (Martinsen 
et al., 2014), a finding that is not reproduced in the present study, possibly 
because of the different nature of the RSVP task. Because of the calibration, 
task performance at the target speed was comparable between patients and 
controls before the attentional analgesia experiment. Interestingly however, 
during the experimental phase the fibromyalgia patients performed worse 
than controls. In particular, success rate in patients dropped when they 
received high temperature stimulation, a phenomenon that was especially 
observed when the task was easy. This result suggests that painful 
stimulation has a disruptive impact on the cognitive ability of patients, 
possibly because of hypervigilance and catastrophizing (Crombez et al., 
2004; Ellingson et al., 2018; González et al., 2010; Van Assche et al., 2020) . 
Nevertheless, it is important to note that even during the experiment, a 




contrast in performance between easy and hard task was present in 
fibromyalgia patients, as revealed by a significant main effect of task in the 
single group ANOVA. Indeed, the perceived difference in difficulty between 
the hard and easy task was homogeneous between groups, as evidenced by 
the absence of group difference in the main effect of task: both cohorts 
engaged the ACC, LOC, and SPL in this contrast. 
As mentioned above, there was no group difference in BOLD change in 
response to task difficulty. In both groups a main effect of task revealed the 
expected response in brain regions such as lateral occipital cortex, anterior 
cingulate cortex, anterior insula and PAG, LC and RVM in the brainstem. On 
the other hand, a group difference was found in the anterior prefrontal 
cortex (BA10) and in the left LC in the main effect of temperature. 
Interestingly, on further investigation of this result we revealed that BOLD 
change in the LC correlated with the temperature used for the attentional 
analgesia experiment, similarly to what has been seen in a pupillometry 
study (Eisenach et al., 2017). Therefore, it is possible that the difference in 
LC activity in this contrast is due to the patients receiving a significantly lower 
temperature in respect to controls, and therefore weaker spinal inputs. On 
the other hand, BOLD signal in BA10 does not directly depend on the 
temperature applied but is possibly related to more cognitive aspects of pain 
perception (Peng et al., 2018). This region was found to consistently respond 
to painful stimulus in healthy volunteers in a variety of imaging modalities 
(e.g. fMRI, NIRS and PET, Peng et al., 2018) and it was reported that patients 
suffering chronic pain conditions show reduced grey matter density in this 
and in adjacent cortical regions (Kuchinad et al., 2007). In addition, grey 
matter density in this area was reported to correlate negatively with the 
intensity of chronic pain (Fritz et al., 2016; Krause et al., 2014; Moayedi et 
al., 2011; Obermann et al., 2013). Thus, this region is hypothesized to be 
important in the chronification of pain, although its role in this context is yet 
to be fully elucidated (Peng et al., 2018). 




In conclusion, the present study demonstrated that fibromyalgia 
patients are able to produce analgesia when distracted from a painful 
stimulus. To this end, they engage brainstem nuclei similarly to healthy 
controls. This new evidence suggests that, contrary to what was believed, at 
least some of the elements of the pain descending modulatory system are 
functional in fibromyalgia patients and can be appropriately recruited. 
 




3.5 Supplementary material 
Supplementary Table 4 Results from main effect analyses in the whole brain 
obtained with cluster-forming threshold Z>3.09 and cluster-corrected p<0.05. The 
tables were created with Autoaq (part of FSL), with atlas labels based on the degree 
of overlap with probabilistic atlases (Harvard Oxford Cortical Structural Atlas, 
Harvard Oxford Subcortical Structural Atlas, Cerebellar Atlas in MNI152 space after 
normalization with FNIRT). Only those structures to which the cluster had a ≥5% 
chance of belonging to are presented. 







Group differences in main effect of temperature 
124 3.98 -22 60 18 71% Frontal Pole 
58 3.87 20 54 16 45% Frontal Pole 
Main effect of temperature 
2676 7 42 -12 8 83% Central Opercular Cortex 
1605 4.86 0 -74 -14 100% Vermis VI 
1292 6.09 -36 4 8 66% Central Opercular Cortex 
238 4.58 2 -62 54 69% Precuneus Cortex 
166 4.87 24 -40 70 39% Superior Parietal Lobule, 33% 
Postcentral Gyrus 
156 4.19 -20 -84 -38 100% Left Crus II 
121 4.48 0 30 28 70% Cingulate Gyrus, anterior division, 
13% Paracingulate Gyrus 
90 4.23 -54 -30 18 70% Parietal Operculum Cortex, 6% 
Central Opercular Cortex, 6% 
Supramarginal Gyrus, anterior division, 
5% Planum Temporale 
85 4.81 -48 -66 -30 81% Left Crus I 
84 4.53 -4 22 44 78% Paracingulate Gyrus, 7% Superior 
Frontal Gyrus 
79 4.73 2 -10 44 73% Cingulate Gyrus, anterior division, 
17% Cingulate Gyrus, posterior division 
77 4.16 -50 44 -10 83% Frontal Pole 
73 3.85 -20 -88 -24 13% Occipital Fusiform Gyrus, 66% Left 
Crus I 
72 4.11 16 -14 6 97% Right Thalamus 
65 4.34 30 -26 62 39% Postcentral Gyrus, 27% Precentral 
Gyrus 
62 3.93 4 -6 12 34% Left Thalamus 
62 4.71 -28 -50 -48 70% Left VIIIa, 14% Left VIIb 
58 3.98 -38 62 8 54% Frontal Pole 
56 3.77 -54 -52 48 46% Angular Gyrus, 33% Supramarginal 
Gyrus, posterior division, 5% Lateral 
Occipital Cortex 
      
Main effect of task 
4234 6.22 -30 -94 8 5% Lateral Occipital Cortex 
3671 6.68 34 -86 4 21% Lateral Occipital Cortex, inferior 
division 
1147 6.27 8 28 30 48% Paracingulate Gyrus, 22% Cingulate 
Gyrus, anterior division 
887 5.47 32 24 2 54% Frontal Operculum Cortex, 11% 
Inferior Frontal Gyrus, pars opercularis, 
5% Inferior Frontal Gyrus, pars 
triangularis 




382 5.53 -30 28 -2 54% Insular Cortex 
273 5 -48 0 32 43% Precentral Gyrus, 12% Middle Frontal 
Gyrus, 11% Inferior Frontal Gyrus, pars 
opercularis 
182 4.03 -4 -42 -20 43% Left I-IV 
156 4.26 28 -52 54 43% Superior Parietal Lobule, 12% 
Angular Gyrus 
155 4.96 -8 -70 -16 98% Left VI 
140 5.27 4 -30 -4 70.9% Brain-Stem 
130 4.59 -54 -20 2 51% Planum Temporale, 10% Heschl's 
Gyrus (includes H1 and H2) 
104 4.25 -8 -74 -38 64% Left Crus II, 31% Left VIIb 
54 3.75 -24 -68 -54 92% Left VIIb 
 
  




Chapter 4 Mechanistic dissection of 









Work presented in the present chapter refers to the following paper:  
Oliva, V., Hartley-Davies, R., Pickering, A. E. & Brooks, J. C. W. (2020). 
Mechanistic dissection of the attentional modulation of pain.  
The paper is in submission to Neuron. 
 Valeria Oliva conceptualized the project, requested ethics approval, 
screened participants, acquired all the experimental data, conceptualized 
the paper, performed all the analyses, wrote the paper, revised it, and 
made the images. AEP conceptualized the paper, was involved in the 
analyses, revised the paper, and supervised the work. JCB conceptualized 
the paper, was involved in the analyses, revised the paper, and supervised 
the work. 





Pain is an essential signal that is typically prioritised to enable survival 
and maintain homeostasis. However, pain is not universal and unmodifiable. 
A commonly used approach for minimising the amount of perceived pain is 
the use of active coping mechanisms, such as reappraisal and task 
engagement (Büssing et al., 2010). Regarding the latter of these, a simple 
shift in attention away from a noxious stimulus can cause a decrease in pain 
perception – a phenomenon known as attentional (or distraction) analgesia. 
Such top-down processes are thought to engage brainstem structures 
capable of producing anti-nociception (Fields, 2004; Heinricher et al., 2009; 
Ossipov et al., 2010), through monoaminergic systems targeting the spinal 
cord (Bushnell et al., 1984; Catherine Bushnell et al., 1985; Duncan et al.,  
1987; Miron et al., 1989). Understanding how forebrain structures interact 
with the brainstem, to prioritise or supress incoming information from spinal 
cord is key to understanding how, in some people, pain may become 
persistent.  
Limited evidence from human fMRI studies demonstrate attentional 
analgesia to involve direct spinal cord modulation (Sprenger et al., 2012) . 
The authors found that spinal cord response to noxious stimulation was 
significantly reduced when healthy volunteers performed an attention 
demanding n-back task during thermal stimulation. In keeping with findings 
from the animal literature, it has been postulated that modulation of the 
human spinal cord is achieved by recruitment of brainstem nuclei with direct 
spinal projections, though this remains to be demonstrated. Recent 
evidence supports the involvement of  periaqueductal grey (PAG), 
rostroventromedial medulla (RVM) and locus coeruleus (LC) in attentional 
analgesia (Brooks et al., 2017; Oliva et al., 2020; Tracey et al., 2002). These 
studies utilised a factorial design, whereby subjects would experience high 
pain or low pain thermal stimuli, whilst simultaneously performing a hard or 
easy sustained attention task.  




Considering the brainstem circuits likely to be involved in attentional 
analgesia, the PAG-RVM system achieves analgesia by recruiting ON- and 
OFF-cells in the RVM, that can bidirectionally modulate spinal cord neurons, 
enhancing or diminishing their response to noxious stimuli (Fields, 1995) . 
The connection between these two regions, recruited by the anterior 
cingulate cortex (ACC), has been identified in fMRI studies on pain 
modulation induced by expectation (i.e. placebo) or by a shift in attentional 
focus (Eippert et al., 2009; Oliva et al., 2020; Valet et al., 2004), however it 
remains to be demonstrated whether this is the system responsible for 
spinal cord modulation in attentional analgesia. This ACC-PAG-RVM pain 
modulatory network is rich in opioid receptors (Fields, 2004), and their 
interaction has been shown to be abolished by an opioid antagonist during 
placebo analgesia (Eippert et al., 2009). It has been suggested that 
endogenous opioids are involved  in attentional analgesia, however the 
exact location of their action is yet to be resolved (Sprenger et al., 2012). 
Similarly, there is evidence for a role of noradrenaline in attentional 
pain modulation. The locus coeruleus (LC) is the main source of 
noradrenaline in the brain and has been implicated in cognitive processes 
like salience signalling or orienting attention, through cortical projections 
(Aston-Jones et al., 1999; Sara et al., 2012). Additionally, the LC is capable of 
producing analgesia through spinal projections by an action on alpha2 
adrenoceptors (Hirschberg et al., 2017). Thus, this brainstem nucleus sits in 
a central position in a network mediating attention reorienting and pain 
modulation. A bidirectional interaction between LC and ACC has been 
recently implicated in attentional analgesia, possibly operating in concert 
with the ACC-PAG-RVM system in modulating spinal cord response to painful 
inputs (Oliva et al., 2020). On the other hand, it is equally possible that the 
ACC-LC network is responsible for selecting the destination of attentional 
resources, prioritising a visual task over a noxious stimulus, or vice versa 
(Corbetta et al., 2008). 




To define which of these descending control systems is involved in 
producing attentional analgesia requires imaging of the spinal cord and 
brainstem and supratentorial structures. Measuring BOLD changes in the 
spinal cord has historically been challenging due to its small size, magnetic 
field distortions and the impact from physiological noise (Brooks et al., 2008; 
Finsterbusch et al., 2012). This adds to the difficulty of acquiring functional 
data in a very large field of view required to image the whole neuroaxis.  
However, significant advances have been made in spinal imaging using a 
technique called z-shimming, first introduced in 2012 by Finsterbusch et al.   
The improvement in field homogeneity produced by z-shimming permits 
measurement of BOLD signal over a larger field of view, including cortex and 
spinal cord. In practice, functional images are acquired over a range of shim 
values for calibration, and on a slice-by-slice basis the shim resulting in 
lowest signal loss is selected for use in the subsequent fMRI experiment. 
Since its inception, z-shimming has been used for studies on pain perception 
and motor learning (Islam et al., 2019; Sprenger et al., 2015; Tinnermann et 
al., 2017; Vahdat et al., 2015), however to our knowledge it has not yet been 
used in the context of cognitive pain modulation.  
We designed a double-blind, three arm, placebo controlled, cross-over 
experiment in healthy volunteers to investigate the opioidergic and 
noradrenergic mechanisms of attentional analgesia using whole Central 
Nervous System (CNS) imaging and an extensively validated experimental 
paradigm.  We took advantage of the improvements in spinal cord fMRI to 
resolve the involvement of cortex, brainstem, and spinal cord in the 
attentional modulation of pain, in a single contiguous acquisition. Psycho-
physiological interactions analysis (Friston et al., 1997; McLaren et al., 2012)  
was used to investigate connectivity changes between a-priori specified 
regions (ACC, PAG, RVM, LC) and the spinal cord, during different contexts 
of an attentional analgesia paradigm. To test for the involvement of 
endogenous opioids in attentional analgesia, and to examine the impact on 
the network caused by their attenuation, the opioid antagonist naltrexone 




was delivered to healthy volunteers. Furthermore, the noradrenaline 
reuptake inhibitor reboxetine was used to define the role of noradrenaline.  
4.2 Methods 
4.2.1 Experiment overview 
The study was approved by the University of Bristol Faculty of Science 
Human Research Ethics Committee (reference 23111759828) and all 
participants taking part gave written informed consent. It was conducted 
within the Clinical Research and Imaging Centre at the University of Bristol 
(CRiCBristol) and followed the standard operating procedures for imaging 
studies involving drugs. Healthy volunteers were invited to participate in the 
study consisting of three imaging sessions, where they were given either 
naltrexone, reboxetine or an inert placebo. During the experiment, 
participants received a thermal stimulus (high or low pain intensity) whilst 
simultaneously performing a sustained attention task (easy or hard). After 
each block, pain ratings were obtained to track changes due to higher 
cognitive load (i.e. measure its analgesic effects) and how this was altered 
by the drugs. At the same time, fMRI data was simultaneously acquired from 
brain, brainstem, and spinal cord.  
4.2.2 Participants 
Healthy volunteers were recruited through email and poster 
advertisement in the University of Bristol and were screened via self-report 
for their eligibility to participate. Exclusion criteria included any psychiatric 
disorder (including anxiety/depression), diagnosed chronic pain condition 
(e.g. fibromyalgia), left handedness, recent use of psychoactive compounds 
(e.g. recreational drugs or antidepressants) and standard MRI-safety 
exclusion criteria.  
Of fifty-seven subjects screened, two were excluded for claustrophobia, 
three were excluded for regular or recent drug use (including recreational), 
and five were excluded due to intolerance of the thermal stimulus. This was 
defined as high pain score (≥ 8/10) for a temperature that should be non-




nociceptive (<43 °C). In addition, six participants withdrew from the study as 
they were unable to attend for the full three visits. One participant had an 
adverse reaction (nausea) to a study drug (naltrexone) and dropped out of 
the study. One subject was excluded for not performing the task correctly 
(i.e. pressing the button randomly). Thirty-nine participants completed all 
three study visits (mean age 23.7 [18 - 45] years, 18 females).   
4.2.3 Calibration of temperature and task velocity 
In the first screening/calibration visit, the participants were briefed on 
the experiment and gave written informed consent. The participants were 
familiarised with thermal stimulation by undergoing a modified version of 
Quantitative Sensory Testing (QST) based on the DFNS protocol (Rolke et al., 
2006).  QST was performed using a Pathway device (MEDOC, Haifa, Israel) 
with a contact ATS thermode of surface area 9cm2 placed on the subject’s 
left forearm (corresponding to the C6 dermatome). Subsequently, the 
CHEPS thermode (surface area 5.73cm2) was used at the same site to deliver 
a 30 second hot stimulus, to determine the temperature to be used in the 
experimental visits. Each stimulus consisted of a plateau temperature of 36 
to 45°C, with pseudorandomised "heat spikes" of 2, 3, or 4 degrees above 
the plateau, and each lasting 1s. Participant were asked to rate the sensation 
they felt during the whole stimulation period, in a scale from 0 (no pain) to 
10 (the worst pain imaginable). The temperature corresponding to a 6/10 
pain scores was used for the noxious stimulation in the experiment. If the 
participant only gave pain scores lower than 6, then the maximum 
programmable plateau temperature of 45°C was used, but with higher 
temperature spikes of 3, 4 and 5 degrees above, reaching the highest 
temperature allowed for safety (50˚C maximum).  
The session also included a calibration of the Rapid Serial Visual 
Presentation (RSVP) task (Potter & Levy, 1969), where participants were 
asked to spot the number 5 among distractor characters. The task was 
presented 16 times at different velocities (i.e. different inter-character 
intervals) in pseudorandom order, ranging from 32 to 256ms. To identify the 




optimal speed for the hard version of the RSVP task (defined as 70% of each 
subject’s maximum d-prime score), the d’ scores for the different velocities 
were plotted and the curve fit to a sigmoidal function, using a non-linear 
least squares fitting routine in Excel (Solver). Once parameterised, the target 
speed for 70% performance was recorded for subsequent use during the 
imaging session. 
4.2.4 Imaging sessions 
Following the screening/calibration session, participants returned for 
three imaging sessions, spaced at least a week apart. Participants underwent 
drug screening (questionnaire) and pregnancy testing. After eating a light 
snack, they were given either an inert placebo capsule, naltrexone (50mg)  
or reboxetine (4mg) according to a randomised schedule. The tablets were 
encased in identical gelatine capsules and dispensed in numbered bottles 
prepared by the hospital pharmacy (University Hospitals Bristol healthcare 
Trust).  
One hour after drug dosing, calibration of the RSVP task was repeated 
(to control for any effect of the drug on performance).  The participants were 
then taken to the MRI suite for the experiment. Before scanning started, 
participants received the high thermal stimulus at the appropriate  
temperature, to ensure that the drug had not altered their perception. 
Participants were then verbally asked for a pain score and if it was 6±1, the 
temperature was kept the same, otherwise it was adjusted accordingly. 
Neither reboxetine nor naltrexone caused a significant change in pain 
perception or task velocity during the calibration, as verified with paired t 
tests (placebo versus reboxetine and placebo versus naltrexone, see 
Supplementary Figure 1). On average, participants were delivered a 
temperature of 43.8± 1.25°C. The median velocity for the task was 48ms, 
range [32-96].  
In the MRI scanner, participants received innocuous (low) or noxious 
(high) thermal stimulus while performing the RSVP task at either difficulty 




level (easy or hard). The 4 experimental conditions (easy|high, hard|high, 
easy|low, hard|low), are repeated 4 times each in a random order. The hard 
version (70% d’ performance) of the task and the high (noxious) thermal 
stimulus were calibrated as described above. In the easy version of the task 
the inter-character presentation speed was always set at 192ms, except 
when a participant’s hard task velocity of was equal or slower than 96ms, 
whereby the easy task was set to 256ms. The low (innocuous) thermal 
stimulus was always set to be a plateau of 36 °C with spikes of 2, 3 and 4˚C 
above this baseline. Participants performed the task (to identify hits) and 
gave a pain score immediately after each experimental block on a visual 
analogue scale (0-100), using a button response (Lumina). 
4.2.5 Acquisition of functional images 
Functional images were obtained with a 3T Siemens Skyra MRI scanner, 
and 64 channel receive-only head and neck coil. After acquisition of localiser 
images, a volumetric T1-weighted structural image of brain, brainstem and 
spinal cord was acquired using the MPRAGE pulse sequence, (Wang et al.,  
2014, TR =2000ms, TE = 3.72ms, flip angle = 9°, inversion time = 1000 ms, 
field of view = 320 mm, GRAPPA acceleration factor = 2). Images a resolution 
of 1.0 x 1.0 x 1.0mm. Blood oxygenation level dependent (BOLD) functional 
data of was acquired axially from the top of the brain to the intervertebral 
disc between C6 and C7, with TR = 3000ms, TE = 39ms, GRAPPA acceleration 
factor = 2, flip angle = 90°, field of view = 170 mm, phase encoding direction  
A >> P. Slices were positioned perpendicular to the long axis of the cord for 
the C5-C6 spinal segments, whilst still maintain whole brain coverage, and 
had a resolution of 1.77 x 1.77 x 4mm and a 40% gap between slices 
(increased to 45-50% in taller participants). To determine the optimal shim 
offset for each slice, reference scans of the entire field of view (FoV) were 
acquired cycling through 15 shim offsets. The first 20 spinal slices had 
manual selection of shim offset to identify the optimal one to use for each 
slice during the experiment. The remaining supraspinal slices were acquired 
with the scanner default shim. During scanning, cardiac, and respiratory 




processes were recorded using a Nonin 7500 pulse oximeter and Lafayette 
MRI compatible respiratory belt, respectively. These physiological signals 
and scanner triggers were recorded using an MP150 data acquisition unit 
(BIOPAC, Goleta, CA), and converted to text files for subsequent use during 
signal modelling. 
4.2.6 Analysis of pain scores 
Pain scores recorded during the experiment were investigated 
collectively for the three visits using a three-way ANOVA in Prism version 8 
for Windows (GraphPad Software, La Jolla California USA, 
www.graphpad.com). Any significant interaction was further investigated 
with two separate three-way ANOVAs (placebo versus naltrexone and 
placebo versus reboxetine). Finally, each drug condition was analysed 
individually with three separate two-way ANOVAs. Post-hoc tests were used 
to further investigate any interaction. 
4.2.7 Pre-processing of functional data and single-subject analysis 
Functional images were divided into spinal cord and brain/brainstem, 
by cropping at the top of the odontoid process (dens) of the 2nd cervical 
vertebra. The resulting two sets of image data underwent different pre-
processing pipelines.  
Spinal cord data was motion corrected with AFNI 2dImreg (Cox, 1996) ,  
registering all time points to the temporal mean. The extracted motion 
parameters were used as additional regressor in the subsequent Feat 
analysis. Data was smoothed with an in-plane Gaussian smoothing kernel of 
2mm x 2mm FWHM, using an in-house generated script. The Spinal Cord 
Toolbox (SCT, v4.1.1) was then used to create a 25mm diameter cylindrical 
mask around the entire cord to crop the functional data. The SCT was also 
used to segment the cord from the Cerebrospinal fluid (CSF) and register 
functional images to the PAM50 template (De Leener et al., 2018). Manual 
intervention was necessary to ensure that the segmentation of the cord was 
accurate. The inverse warping fields generated by the registration of spinal 




cord fMRI data to the PAM50 template were used to warp a PAM50 CSF 
mask to subject space. The mask was then used to create a CSF regressor for 
use during correction for physiological noise during first level FEAT analysis 
(part of FSL, Jenkinson et al., 2012). 
Brain functional data was pre-processed and analysed in FEAT. Pre-
processing included smoothing with a 6mm Gaussian kernel, high-pass 
filtering with a 90s cut-off, and motion correction with MCFLIRT (Jenkinson 
et al., 2002). Functional data was unwarped with a fieldmap using FUGUE 
(Jenkinson, 2003), co-registered to the subject’s structural (T1) scan and to 
the 2mm MNI template using a combination of linear (FLIRT, Jenkinson et 
al., 2001) and non-linear (FNIRT, Andersson et al., 2007) registration with 
5mm warp resolution.  
Physiological noise correction was conducted for the brain and spinal 
cord (Brooks et al., 2008; Harvey et al., 2008). Cardiac and respiratory phases 
were determined using PNM software in FSL, and slice specific regressors 
determined for the entire CNS coverage. Subsequently these regressors 
(which are 4D images) were cropped at the level of the odontoid process to 
be used separately for brain and spinal cord physiological noise correction. 
For the brain data, the PNM consisted of 32 regressors, with the addition of 
a CSF regressor for the spinal cord, giving a total of 33 regressors for this 
region. 
All functional images were analysed using a general linear model (GLM) 
in FEAT. Pre-whitening was performed using FILM (Woolrich et al., 2001) . 
The model included a regressor for each of the experimental conditions 
(easy|high, hard|high, easy|low, hard|low), plus regressors of no interest 
(task instructions, rating period). Motion parameters and physiological 
regressors were also added to the model to correct for motion artefacts and 
physiological noise. The experimental regressors were used to build the 
following planned statistical contrasts: positive and negative main effect of 
temperature (high temperature conditions versus low temperature 




conditions and vice versa), positive and negative main effect of task (hard 
task conditions versus easy task conditions and vice versa), and positive and 
negative interactions. 
4.2.8 Analysis Strategy for group analysis 
We used a conservative approach to investigate the differences in CNS 
activity in main effects and interactions caused by administration of 
reboxetine or naltrexone. An initial analysis examined the brain, brainstem, 
and spinal cord activation in the planned contrasts (main effects of 
temperature, task, and their interaction) across all visits. This allowed the 
generation of functional masks, to use for investigation of differences 
between drug conditions.  
PPI analysis was used to resolve effective connectivity changes 
between brain, brainstem, and spinal cord during the attentional analgesia 
experiment. The regions investigated were a-priori specified on the basis of 
our previous study (Oliva et al., 2020), and included the ACC, PAG, LC and 
RVM. Following, connectivity changes between the previously mentioned 
regions and the spinal cord were examined. A first analysis was carried out 
only on the placebo visit, with the purpose of verifying the reproducibility of 
our previous results, and of building a functional localizer to be explored for 
differences after drug administration. Any significant connectivity change 
identified was thus investigated for a significant effect of the drugs (i.e. 
causing a stronger or weaker connectivity change). 
All first-level analyses and single group averages were performed in 
blind to the study drug. Following, the experimenter was unblinded to the 
placebo visit to perform the paired t tests. The experimenter was finally 
unblinded to all the visits for interpretation of the results.  
4.2.8.1 Main effect analysis – spinal cord 
In each subject, contrasts of activation from the three visits, derived 
from the single-subject analysis, were registered to the PAM50 template 




with SCT. Following, they were averaged using a within-subject mixed effects 
OLS model using FLAME (part of FSL) from command line. The resulting 
average contrasts of activation were merged in time between-subjects. 
These were then investigated with a one-sample t test in RANDOMISE, using 
a left C5-6 vertebral mask, derived from SCT. Results are reported TFCE 
corrected for P < 0.05. The significant functional clusters were binarized for 
use in the paired t tests. 
4.2.8.2 Main effect analysis – brainstem 
Similarly to what was done in in the spinal cord, in brain and brainstem 
contrasts of activation from the three visits were averaged with an OLS 
model in a FEAT analysis. The resulting average was the input of a between-
subjects, mixed effects, one-sample t test in FLAME (FEAT). Group 
activations in each contrast were investigated with permutation testing in 
RANDOMISE, using a whole brainstem mask. Results are reported TFCE 
corrected for P < 0.05. Functional maps of activation were binarized for later 
use. 
4.2.8.3 Main effect analysis – brain 
Brain functional data was averaged and analysed in the same FEAT 
analyses that investigated the brainstem. Group activations were examined 
with a whole-brain analysis, with results reported for Z > 3.1, cluster 
corrected P < 0.05. This produced functional maps of activation (one per 
planned contrast) that were then binarized to produce masks that are used 
later in paired t-tests. 
4.2.8.4 Within subject comparison – paired tests  
Paired t tests were performed to resolve changes in activity in 
reboxetine versus placebo and naltrexone versus placebo, separately. 
Design and contrast files for input in RANDOIMSE were built in FEAT. A group 
file with appropriately defined exchangeability blocks was additionally 
defined. Permutation testing in RANDOMISE was finally used to assess group 
level differences between placebo and the two drugs, separately for brain, 




brainstem, and spinal cord. The investigation was restricted to the functional 
masks derived from the main effect analysis for each contrast.  
4.2.8.5 Effective connectivity analysis  
For the connectivity analysis, functional images of brain and spinal cord 
were pre-processed as previously described. Time-series were extracted 
from the peak responding voxel in the a priori identified regions. In 
particular, data was extracted from the peak voxel responding to the main 
effect of temperature in the RVM and spinal cord, the main effect of task in 
the ACC, PAG and LC, and the task * temperature interaction in the spinal 
cord. The time-series were included in a GLM that also included the same 
regressors present in the first level main effects analysis. Interaction 
regressors were then built by multiplying the time-series by the 
experimental regressors, and the planned contrasts were specified in the 
first level analysis. Models for brain and spinal cord seeds were identical, 
built in separate FEAT analyses. Group responses were obtained with 
permutation testing in RANDOMISE, using as target the same ROI masks 
used for time-series extraction. For example, a gPPI analysis that used the 
RVM as seed, used PAG, LC, ACC, and a left C5-6 vertebral mask to estimate 
connectivity changes between brain/brainstem and spinal cord. 
Paired t tests were used to detect differences between drug visits in the 
significant connections, as described above.  
4.3 Results 
4.3.1 Pain scores 
A three-way mixed effects ANOVA was used to resolve the main effects 
of task, temperature, and drug (and their interactions) on pain ratings 
(Figure 4.1). This revealed the expected main effect of temperature on pain 
scores, with higher ratings associated with high temperature stimuli (P < 
0.001, F (1, 38) = 221.6). A main effect of task also reached significance, with 
lower pain scores in the hard task conditions (P = 0.034, F (1, 38) = 4.87),  
suggestive of a general analgesic effect of the task. However, there was a 




significant interaction between task and temperature (P = 0.0025, F (1, 38)  
= 10.5) implying that the change in pain ratings (due to task) depended on 
applied temperature. Furthermore, we observed an interaction between 
drug and temperature on recorded pain ratings (P = 0.04, F (2, 76) = 3.2),  
suggesting that the effects of drugs on pain perception depended on the 
applied temperature. The main effect of drug, the interaction between drug 
and task,  and the 3-way drug * temperature * task interaction were all 
below significance (P = 0.11, F (2, 76) = 2.3; P = 0.3, F (2, 76) = 1.2; P = 0.2, F 
(2, 76) = 1.6 respectively). 
To further investigate drug * temperature interaction, two separate 
follow-up three-way mixed effects ANOVAs were conducted for placebo 
versus reboxetine and placebo versus naltrexone. For placebo versus 
reboxetine, a drug * temperature interaction was revealed (P = 0.0304, F (1, 
38) = 5.060, Figure 4.1), with lower pain scores in the reboxetine arm, 
indicating an overall analgesic effect of the drug. Post-hoc tests revealed this 
interaction to be driven by a decrease in pain scores in the easy|high (P = 
0.0441) and hard|high (P = 0.0137) conditions. The drug * task and drug * 
task * temperature interactions were below significance (P = 0.68, F (1, 38)  
= 0.1738 and P = 0.5578, F (1, 38) = 0.3496).  




Comparison of placebo and naltrexone conditions revealed no 
significant drug interactions: drug * temperature interaction, drug * task 
interaction and drug * task * temperature interaction were all below 
significance (P = 0.39, F (1, 38) = 0.7509, P = 0.22,  F (1, 38) = 1.529, and P = 
0.21, F (1, 38) = 1.650, respectively). 
Figure 4.1 Pain scores across the four experimental conditions (i.e. easy|low, 
hard|low, easy|high and hard|high), in the three drug visits. A three-way ANOVA 
revealed a significant main effect of temperature, main effect of task and task * 
temperature interaction. In addition, a significant drug * temperature interaction 
was driven by a decrease in pain scores in the reboxetine vs the placebo condition 
during high temperature stimulation. Error bars are standard error means.  
 
Finally, two-way mixed effects ANOVAs were used to investigate each 
drug condition separately to resolve how temperature and task impacted 
pain scores. In the placebo condition, as expected, the pain scores were 
higher during high temperature stimulation than during low temperature 
stimulation, manifesting as a significant main effect of temperature (P < 
0.0001, F (1, 38) = 147.7,  Figure 4.2A). A main effect of task was also noted, 
with lower pain scores during the hard task conditions (P = 0.0078, F (1, 38)  
= 7.884). There was an interaction between task and temperature (P = 




0.0019, F (1, 38) = 11.20) and post-hoc testing showed the interaction to be 
due to a significant lowering in pain scores during the hard|high (37.5±19.4)  
versus easy|high (40.4±19.8, P = 0.0010) condition, indicating an analgesic 
effect induced by high cognitive load. 
 Naltrexone dosing appeared to block the analgesic effect of attention 
as reflected in a loss of the task * temperature interaction (P = 0.5133, F (1, 
38) = 0.4355, Figure 4.2A), and little difference in pain scores between the 
hard|high (37.4±17.1) versus easy|high (38.3±17.1) conditions, similarly to 
what has been shown before (Sprenger et al., 2012).  There was still a main 
effect of temperature (P < 0.0001, F (1, 38) = 173.0), but no main effect of 
task (P = 0.6379, F (1, 38) = 0.2251). 
Similar analysis of the effect of reboxetine dosing showed a similar 
picture to the placebo condition, with a task * temperature interaction (P = 
0.0047, F (1, 38) = 9.023, Figure 4.2A). A post-hoc test revealed again a 
decrease in pain scores in hard|high (31.9 ± 15.84) versus easy|high (35.6 ± 
15.49, P = 0.0034) condition, indicative of reboxetine not having a strong 
impact on attentional analgesia. There was still a main effect of temperature 
(P < 0.0001, F (1, 38) = 170.7), but no main effect of task (P = 0.0615, F (1, 
38) = 3.713). 
4.3.2 Analysis of functional images 
Functional images from the three visits were analysed to investigate the 
biological substrates of attentional analgesia. The analysis of main effects 
and interactions provided functional masks to use for examination of the 
impact of the drugs on brain, brainstem, and spinal cord activation. 
4.3.2.1 Main effect analysis – Spinal cord 
A cluster of activation representing the positive main effect of 
temperature was located in the left dorsal horn (DH), in the C6 spinal 
segment (Figure 4.2B). This represents a population of neurons that 
responded more strongly to noxious stimulation versus innocuous 




stimulation. The location was remarkably similar to the location of clusters 
resolved previously in Sprenger et al., (2012), Sprenger et al., (2015), and 
Eippert et al., (2009). This cluster was anatomically located where expected, 
given that the thermal stimulus was applied to the left C6 dermatome on the 
forearm. Since a left cord mask at the C5/C6 level was used to obtain this 
result, the specificity of the finding was tested with a whole cord mask. This 
revealed the same main effect of temperature cluster in the left C6 spinal 
segment, that expanded toward the right side. In addition, a cluster in the 
bilateral DH in C5 also reached significance (Supplementary Figure 2).  
Parameter estimates were extracted to investigate the activity of this 
cluster across the four experimental and three drug conditions. In the 
placebo condition, parameter estimates from the peak voxel displayed a 
pattern that was strikingly similar to the pain scores: the BOLD response to 
a noxious stimulus in the spinal cord was lower in the  hard|high than 
easy|high condition, suggesting that the spinal cord activity was modulated 
during attentional analgesia (Figure 4.2C). An inter-subject correlation 
between the delta of parameter estimates (main effect of temperature) and 
the delta in pain scores (main effect of temperature) was not significant (R = 
0.28, P = 0.08,  Supplementary Figure 3A). 
A decrease in parameter estimates in the hard|high condition was also 
revealed after reboxetine administration, again suggesting spinal cord 
modulation during attentional analgesia (Figure 4.2C). The same pattern was 
not observed in the naltrexone condition, where the DH showed a similar 
response to the easy|high and hard|high experimental conditions (Figure 
4.2C), in keeping with the similarity of reported pain ratings for these 
conditions, indicative of opioid antagonism blocking attentional analgesia.  
Within the pooled data, the task * temperature interaction contrast 
revealed a second discrete and only partially overlapping cluster (Figure 
4.2B). This was also located on the left side but was slightly caudal and closer 
to the midline with respect to the main effect of temperature. Extraction of 




parameter estimates from this interaction in the placebo condition, revealed 
it to be driven by increased activity in the hard|high condition (Figure 4.2D).  
This suggests an active role of this cluster, possibly composed of spinal 
interneurons, in modulation of nociception during the analgesic effect. The 
same pattern was observed in all three drug conditions (Figure 4.2D). The 
delta in parameter estimates (task * temperature interaction) did not 
significantly correlate with the delta in pain scores across subjects (task * 
temperature interaction, R = 0.08, P = 0.6, Supplementary Figure 3B). No 
cluster reached significance in the main effect of task. 




Figure 4.2 (A) Pain scores across the four experimental conditions (i.e. 
easy|low, hard|low, easy|high and hard|high), in the three drug visits. (B) 




Functional clusters showed significance in the main effect of temperature (red-
yellow) and in the task * temperature interaction (blue-light blue). (C) Extraction of 
parameter estimates from the main effect of temperature cluster revealed a 
decrease in BOLD in the hard|high versus easy|high condition, in placebo and 
reboxetine but not in naltrexone. (D) Extraction of parameter estimates from the 
task * temperature interaction cluster revealed an increase in BOLD in the 
hard|high condition, in all three drug visits. Error bars are standard error means.  
 
4.3.2.2 Main effect analysis - Brainstem 
In the main effect of temperature, activity was detected in the PAG, 
RVM and bilateral LC (Figure 4.3A). Large clusters were found the midbrain 
(PAG) and lower medulla (RVM), with smaller discrete clusters in the dorsal 
pons. In the main effect of task, the activity was more diffuse (Figure 4.3B),  
and also included PAG, RVM and bilateral LC. No clusters reached 
significance in the positive or negative task * temperature interaction, nor 
in the negative main effects of task and temperature.  
  




Figure 4.3 (A)Main effect of temperature activation in the PAG, bilateral LC and RVM, after permutation testing with a whole brainstem mask. (B) Main effect 
of task activation in PAG, bilateral LC and RVM, after permutation testing with a whole brainstem mask.




4.3.2.3 Main effect analysis - Brain 
Significant activity was observed to the main effect of temperature in a 
range of cortical territories including the primary somatosensory cortex, the 
operculum, dorsal posterior insula, and anterior cingulate cortex, with larger 
clusters contralateral to the side of stimulation (i.e. right side of brain)  
(Figure 4.4A, Supplementary Table 5). Only the frontal medial cortex 
showed deactivation during high temperature stimulation (Figure 4.4A,  
Supplementary Table 5). During the main effect of task, activity was 
recorded in the bilateral occipital cortex, the anterior insula, and the anterior 
cingulate cortex among the others (Figure 4.4B, Supplementary Table 5). 
Clusters active during the negative main effect of task were found in the 
cerebellum (Crus I) and precuneus among others (Figure 4.4B,  
Supplementary Table 5). No cluster reached significance in the positive task 
* temperature interaction. On the other hand, a cluster in the frontal pole 
and one in the anterior insula responded to the negative task * temperature 
interaction (Supplementary Figure 4A, Supplementary Table 5). These 
analyses of main effects and interactions provided functional masks which 
were subsequently interrogated to examine drug effects on brain, 
brainstem, and spinal cord activity with paired t-tests.




Figure 4.4 (A) Main effect of temperature after a whole brain analysis. Clusters of activation include the contralateral primary somatosensory cortex, the dorsal 
posterior insula and the PAG (red-yellow). The frontal medial cortex de-activated during high temperature stimulation (blue-light blue). (B) Main effect of task after 
a whole brain analysis. Clusters of activation include the superior parietal cortex, the frontal pole, and the anterior cingulate cortex (red-yellow). The posterior 
cingulate cortex and lateral occipital cortex showed decrease in activation in the hard task conditions (blue-light blue).




4.3.2.4 Drug effects – paired tests 
Differences in functional activity in placebo versus reboxetine and 
placebo versus naltrexone were investigated using paired t tests, comparing 
main effects and interactions between drug conditions. No significant 
differences in spinal cord main effect of temperature or task * temperature 
interaction were detected, in placebo versus naltrexone nor in placebo 
versus reboxetine. Thus, the overall spinal cord response to e xperimental 
conditions did not significantly change after drug administration. This is in 
line with the lack of significant drug * task * temperature interaction in the 
pain scores. However, it does not reflect the significant decrease in pain 
scores in the reboxetine condition (drug * temperature interaction), 
suggesting the analgesic effect of this drug might not to be spinally 
mediated.  
In the brainstem, a stronger response to temperature was detected in 
the lower medulla, in naltrexone versus placebo (Supplementary Figure 5A). 
This is suggestive of a disinhibitory effect of the opioid antagonist on this 
region. No significant differences were detected in the main effect of task. 
No significant differences were present in reboxetine vs placebo in any 
statistical contrast.  No brain region responded differently to the main effect 
of temperature in different drug conditions. On the other hand, in the main 
effect of task the left anterior insula responded more strongly in the 
naltrexone condition than in the placebo condition (Supplementary Figure 
5B).  
4.3.2.5 Effective connectivity analysis 
To define a network of cortical and brainstem regions whose 
connectivity was modulated by the experimental conditions, and for 
previous results of cortico-brainstem interactions in attentional analgesia 
(Oliva et al., 2020), an initial gPPI analysis was performed on the data 
acquired under the placebo condition alone. By exploring the connectivity 
between our a priori identified regions (ACC, PAG, LC and RVM), we created 




a “localiser” of effective connectivity for this sample , that was subsequently 
used to explore changes in the drug conditions in the same subjects.  
The following connections reached statistical significance (Figure 4.5A): 
• RVM seed - increased effective connectivity with PAG and right 
LC in the task * temperature interaction, and again with the 
right LC in the main effect of task. 
• ACC seed - no significant changes in effective connectivity. 
• PAG seed – increased effective connectivity with the ACC in the 
main effect of task and increased effective connectivity with the 
LC in the main effect of temperature. 
• Right LC seed – increased effective connectivity with the ACC 
and RVM in the main effect of temperature. 
Parameter estimates revealed that the ACC-PAG, PAG-RVM and RVM-
LC connections were larger in the hard|high versus the easy|high condition, 
consistent with a role in attentional analgesia (Figure 4.6B). Reassuringly, 
these results (obtained in an independent sample) mostly recapitulated 
those observed in an earlier study (Oliva et al., 2020).  
To examine connectivity to the spinal cord (under placebo condition),  
the same cortical and brainstem seeds were also used to test effective 
connectivity changes, examining the hypothesis that brainstem nuclei 
modulate the DH during attentional analgesia. Additionally, time series 
extracted from the spinal cord was used to investigate functional changes 
with cortical and brainstem regions of interest.  
• RVM seed – increased effective connectivity with the left DH in 
the main effect of temperature and in the task * temperature 
interaction. 




• ACC seed – no significant changes in effective connectivity. 
• PAG seed – no significant changes in effective connectivity.  
• LC seed – no significant changes in effective connectivity.  
• Spinal cord temperature seed – no significant changes in 
effective connectivity. 
• Spinal cord task * temperature interaction seed – no significant 
changes in effective connectivity. 
Parameter estimates extracted from the spinal cord peak voxel 
connecting with the RVM in the task * temperature interaction, revealed a 
strong interaction in the hard|high condition, consistent with a role of this 
path in attentional analgesia (Figure 4.5B). No significant correlation with 
behavioural pain ratings was found. 
  




Figure 4.5 (A) Summary of significant connection changes revealed by the PPI analysis (placebo condition only). The masks used for time-series extraction are 
shown in yellow. Permutation testing revealed a significant change in connectivity in the main effect of task contrast between ACC and PAG, and in the task * 
temperature interaction contrast between PAG and RVM, LC and RVM, and finally RVM and DH. Masks used for time-series extraction are shown in the sagittal slices. 
The spinal cord axial slice shows the voxels significantly connecting to the RVM (threshold at P = 0.1 for visualization purposes). (B) Extraction of parameter estimates 
revealed an increase in pairing in the analgesic condition (i.e. hard|high). Error bars are standard error means.




4.3.2.6 Drug effects on connectivity changes – paired tests 
Having established the network of brain, brainstem and spinal regions 
that show effective connectivity changes in the placebo condition, we used 
paired t tests to explore whether patterns of connectivity altered under 
either reboxetine or naltrexone conditions compared to placebo (Figure 
4.6A). 
The connection between RVM and DH in the task * temperature 
interaction was significantly reduced by the administration of naltre xone 
(Figure 4.6B), consistent with opioidergic involvement in attentional 
analgesia, which behaviourally was also abolished by naltrexone.  The 
strength of the RVM-LC connection in the main effect of temperature was 
significantly diminished by reboxetine (Figure 4.6B). There was also a trend 
toward the RVM-LC connection in the task * temperature interaction, and 
the PAG-LC connection in the main effect of temperature being reduced 
under reboxetine (P = 0.064 and P = 0.052 respectively). This suggests a 
negative impact of high noradrenaline availability on the connections 
between the LC and other brainstem nuclei. The connection between ACC 
and PAG was significantly weakened during both the reboxetine and 
naltrexone visits, suggesting this connection to be modulated by both 
endogenous opioids and noradrenaline (Figure 4.6B). None of the other 
connections altered significantly across drugs.




Figure 4.6 (A) Schematic representation of the connections after in reboxetine or naltrexone. Dashed lines indicate significantly weaker connections after drug 





Using simultaneous whole CNS imaging, we demonstrated that the 
opioid antagonist naltrexone impaired attentional analgesia by acting on 
ACC-PAG and RVM-DH connectivity, thereby preventing spinal cord 
modulation. The alteration in connectivity by naltrexone mirrored its 
behavioural effect of impairing attentional analgesia. We therefore show an 
opioid-dependent mechanism in the descending pain modulatory pathway 
implicated in the attentional modulation of pain. Conversely, the 
noradrenaline re-uptake inhibitor reboxetine did not alter connectivity to 
the spinal cord, and did not have a behavioural impact on attentional 
analgesia.  
We identified a functional cluster that responded to hot painful 
stimulation in the ipsilateral DH of the spinal cord. Investigation of this result 
revealed a decrease in BOLD in the high cognitive load versus the low 
cognitive load condition, which remarkably mirrored the analgesic effect 
seen in the pain scores. This is consistent with what has been found before 
(Sprenger et al., 2012) and indicates modulation of spinal cord activity during 
distraction from pain. Additionally, we identified a cluster encoding the 
interaction between pain and attention, located more caudally and more 
medially in respect to the main effect of temperature cluster. Parameter 
estimates revealed that the interaction was driven by enhanced activity in 
the hard|high condition, suggesting an active role of this neuronal 
population in the analgesic effect. The medial location of this cluster is 
consistent with  inhibitory interneurons located in deep laminae (i.e. 
laminae III-V) receiving inputs from supraspinal regions to inhibit the 
adjacent main effect of temperature cluster (Bardoni et al., 2013; Hochman, 
2007).  
Our previous study implicated the ACC-PAG-RVM pathway in 
attentional analgesia (Oliva et al., 2020), providing further evidence for the 
long-standing hypotheses that attentional pain relief is achieved by 




2012; Tracey et al., 2002; Valet et al., 2004). Here, we re-produced the same 
result and expanded it by demonstrating a functional connection between 
RVM and DH. This for the first time provides evidence for top-down control 
of spinal cord nociception during distraction from pain, via the ACC-PAG-
RVM pathway, known (from non-human animal studies) to be involved in 
spinal cord modulation (De Felice et al., 2016; Millan, 2002; Ossipov et al.,  
2010). We therefore propose a system where the ACC signals high cognitive  
load to the PAG, that recruits spinally-projecting cells in the RVM. It is 
biologically plausible that analgesia is then achieved through disinhibition of 
spinally-projecting OFF-cells (Lau et al., 2014), that can inhibit DH neurons 
directly via GABAergic and opioidergic projections to the primary afferents 
(Morgan et al., 2008; Zhang et al., 2015). 
The RVM is also functionally connected to the LC in the interaction 
between pain and attention, providing an additional route to analgesia. A 
possible mechanism for spinal cord modulation is the engagement of 
spinally-projecting neurons in the LC (Hirschberg et al., 2017) through direct 
projections from the RVM (Astier et al., 1990; Cedarbaum et al., 1978) . 
Alternatively, the LC could act supraspinally by recruiting the RVM through 
direct (Fritschy et al., 1990; Kwiat et al., 1992; Tanaka et al., 1996) or indirect 
projections via the PAG (Kwiat et al., 1992). The latter mechanism was also 
hypothesised in a spinal cord stimulation study in rodents, where analgesia 
mediated by the LC did not seem dependent on spinally-projecting neurons 
but recruited OFF-cells in the RVM (Song et al., 2013). 
We next used the opioid antagonist naltrexone to investigate the 
functional involvement of endogenous opioids in the pain modulatory 
network implicated in attentional analgesia. A previous study demonstrated 
that systemic administration of the opioid antagonist naloxone could reduce 
attentional analgesia behaviourally (Sprenger et al., 2012). We observed a 
similar result and provide evidence for a functional mechanism behind this 
effect. Diminished attentional analgesia after naltrexone administration can 




RVM. In this area, endogenous opioids mediate anti-nociception by 
inhibition of ON-cells, resulting in OFF-cell disinhibition (Fields, 2004; 
Heinricher et al., 1994; Roychowdhury et al., 1996). During endogenous 
analgesia, opioidergic stimulation is likely caused by activity in the  PAG, a 
known opioidergic region that was recently shown to release endogenous 
opioids during deep brain stimulation in humans (Sims-Williams et al., 2017) . 
Indeed, in animal studies opioid antagonists were shown to block PAG -
mediated analgesia by acting on the RVM, in line with our result (Kiefel et 
al., 1993; Roychowdhury et al., 1996). Since the connection between PAG 
and RVM was not significantly impaired by opioid antagonism, it is possible 
that this functional interaction is glutamate and GABA-mediated (Aimone et 
al., 1986; Heinricher et al., 1999; van Praag et al., 1990). According to this 
hypothesis, the opioid antagonist would specifically prevent the 
disinhibition of OFF-cells, thereby blocking spinal cord modulation 
(Heinricher et al., 1994). Naltrexone also had a disruptive effect on the 
connection between ACC and PAG, recruited during the hard version of the 
task. The opioid dependence of this connection during endogenous 
analgesia has already been shown in a placebo study (Eippert et al., 2009) ,  
where naloxone abolished the placebo’s analgesic effect through inhibition 
of the ACC-PAG interaction. This effect may be mediated by mu opioid 
receptors, that were shown to be extensively expressed in the ACC 
(Baumgärtner et al., 2006), with their recruitment linked to endogenous 
analgesia in humans (Zubieta et al., 2001). We therefore propose a model 
where distraction from a painful stimulus triggers release of endogenous 
opioids in the ACC and RVM, promoting interaction with the PAG and spinal 
cord, respectively. Naltrexone therefore blocks these mechanisms, 
preventing modulation of spinal cord, and the consequent decrease in pain 
perception. This was indeed observed as the spinal cord activity after 
naltrexone administration was constant during high temperature 
stimulation, despite the change in cognitive load.  
In the present study, naltrexone completely abolished the analgesic 




antagonist only partially attenuated analgesia  (Sprenger et al., 2012). This 
hinted at the existence of a parallel, redundant mechanism to attentional 
analgesia that does not rely on endogenous opioids. In this context, the 
functional contribution of the noradrenergic LC has been suggested to play 
a role in attentional processes (Sara, 2009) and analgesia (De Felice et al.,  
2016; Hickey et al., 2014; Hirschberg et al., 2017; Millan, 2002). For example, 
BOLD signal in this region was found to significantly correlate with the 
behavioural analgesic effect, and its interaction with the anterior cingulate 
cortex was implicated in attentional analgesia (Brooks et al., 2017; Oliva et 
al., 2020). However, contrary to expectations, the noradrenaline re-uptake 
inhibitor reboxetine did not have any effect on attentional analgesia 
behaviourally. This suggests that either noradrenaline does not play a major 
role in the attentional modulation of pain, or that higher noradrenergic 
availability does not have a significant impact on the analgesic mechanisms. 
On the other hand, reboxetine had an analgesic effect on the pain scores 
independent of task, a finding in line with the increasingly popular use of 
noradrenaline-manipulating drugs in treating chronic pain conditions 
(Bahari et al., 2019; Kremer et al., 2016, 2018). Although reboxetine was 
previously found to induce analgesia by engagement of spinal cord receptors 
in a chronic pain model (Hughes et al., 2015), we did not find a similar effect 
using spinal fMRI. The main effect of temperature cluster in the spinal cord 
did not differ in the placebo versus reboxetine condition, suggesting that the 
spinal cord activity was not inhibited by reboxetine. On the other hand, 
reboxetine diminished the strength of the RVM-LC connection in the main 
effect of temperature, suggesting a possible functional mechanism for 
analgesia induced by this drug. It was recently found that the functional 
connection between RVM and LC during resting state is abnormally strong 
in chronic pain patients, which, according to the authors, might enhance 
nociceptive transmission (Mills et al., 2018). It is possible that the higher 
availability of noradrenaline in the presence of reboxetine acts on inhibitory 
alpha2 receptors in the LC to reduce its activity, thereby attenuating 
noradrenergic connectivity to the RVM (Fritschy et al., 1990; Kwiat et al.,  




effect on the connection between ACC and PAG. This suggests that, in 
addition to endogenous opioids, this interaction is also modulated by 
noradrenaline, perhaps indirectly via the ACC-LC pathway (Oliva et al., 2020) . 
Further investigation is needed to resolve the exact contribution of 
noradrenaline signalling in the cognitive modulation of pain. 
We used a modified version of an innovative approach for whole CNS 
imaging, namely z-shimming, that was proposed for the first time by 
Finsterbusch in 2012 and 2013. By manually choosing the best shim offset 
for each spinal cord slice, we were able to increase the voxel intensity and 
decrease signal distortions in the spinal cord, thereby improving the quality 
of the functional images. Spinal cord-midbrain connections during noxious 
stimulation have been resolved before (Sprenger et al., 2015), however, to 
our knowledge, this is the first time the whole CNS has been imaged in the 
context of the cognitive modulation of pain. Since our goal was of exploring 
functional connections between brain, brainstem, and spinal cord, we 
decided to use a single sequence of acquisition, with identical parameters 
(e.g. orientation of slices, voxel dimensions) for the entire CNS. This differs 
from other approaches (Finsterbusch et al., 2012, 2013; Islam et al., 2019) ,  
and is motivated by the idea that the use of different acquisition parameters 
for brain and spinal cord could be a confounding factor in connectivity 
analyses. By taking advantage the z-shimming approach and of the recently 
developed Spinal Cord Toolbox (De Leener et al., 2017), we have been able 
to detect significant signal changes in response to experimental 
manipulations as well as more subtle drug effects on connectivity. On the 
other hand, we have not been able to reproduce the previous finding of an 
ACC-LC interaction during attentional analgesia (Oliva et al., 2020). This 
disparity could be due to the larger voxel size used here to be able to image 
the entire CNS, which could have penalized LC imaging (Liu et al., 2017). In 
addition, previous studies resolved inter-subject linear correlations between 
pain ratings and BOLD signal in PAG (Tracey et al., 2002), RVM (Brooks et al.,  
2017), LC (Oliva et al., 2020) and DH (Sprenger et al., 2012) during attentional 




correlation between DH BOLD and pain perception was not far from 
significance (P = 0.08). A possible explanation is that we did not use identical 
acquisition parameters across subjects. To be able to image the same 
anatomical regions, in taller participants we had to increase the gap 
between slices from 40 to 45-50%. Thus, the small variability in BOLD across 
individuals could be due to this other confound and not be related to 
perceived pain intensity.  
In summary, we show an opioid-mediated system where, during high 
cognitive load, the ACC recruits the PAG and RVM to modulate the spinal 
cord response to a noxious stimulus. Opioid signalling is especially important 
in the interaction between PAG and ACC and between RVM and DH. LC-
mediated noradrenergic modulation of the system occurs in the connection 





4.5 Supplementary Material 
Supplementary Table 5 Results from main effect analyses in the whole brain, 
across the three drug conditions. Obtained with cluster-forming threshold Z>3.09 
and cluster-corrected p<0.05. The tables were created with Autoaq (part of FSL), 
with atlas labels based on the degree of overlap with probabilistic atlases (Harvard 
Oxford Cortical Structural Atlas, Harvard Oxford Subcortical Structural Atlas, 







(mm) Atlas labels 
Main effect of temperature 
3295 12.4 36 12 -10 74% Insular Cortex 
531 6.56 -32 -14 22 12% Frontal Operculum Cortex, 
436 7.53 -34 14 16 
47% Precentral Gyrus, 26% Central 
Opercular Cortex 
246 6.86 -58 0 8 10% Occipital Fusiform Gyrus 
131 6.49 38 -66 -22 
25% Juxtapositional Lobule Cortex 
(formerly Supplementary Motor 
Cortex) 
65 6.83 4 -38 -46 100% Brain-Stem 
61 6.24 -40 -2 -2 10% Right V 
47 5.81 24 -20 64 72% Frontal Pole 
43 8.07 -20 52 26 
43% Supramarginal Gyrus, anterior 
division, 20% Parietal Operculum 
Cortex, 11% Postcentral Gyrus 
16 6.11 -4 -68 -40 
46% Frontal Operculum Cortex, 15% 
Insular Cortex 
13 5.68 -34 22 6 31% Insular Cortex 
11 5.43 -36 -20 -2 
11% Frontal Operculum Cortex, 5% 
Inferior Frontal Gyrus, pars triangularis 
10 5.43 36 22 14 
29% Middle Frontal Gyrus, 8% Inferior 
Frontal Gyrus, pars triangularis, 7% 
Inferior Frontal Gyrus, pars opercularis 
10 6.94 40 22 26 
10% Supramarginal Gyrus, posterior 
division, 6% Superior Parietal Lobule 
8 5.42 24 -46 -22 
45% Frontal Pole, 12% Inferior Frontal 
Gyrus, pars triangularis, 11% Middle 
Frontal Gyrus 
5 5.87 44 36 14 
43% Frontal Pole, 5% Inferior Frontal 
Gyrus, pars triangularis 
4 5.38 18 -12 28 6% Precuneus Cortex 
4 5.23 -18 -60 36 11% Postcentral Gyrus 
4 5.79 -22 -62 -38 20% Frontal Orbital Cortex 
3 5.11 -32 32 -4 
45% Frontal Operculum Cortex, 19% 
Frontal Orbital Cortex, 12% Insular 
Cortex 
3 12.6 0 -36 -6 71% Brain-Stem 
2 5.57 20 56 20 5% Temporal Occipital Fusiform Cortex 
2 5.03 46 -52 -28 56% Frontal Pole 
2 8.8 -40 42 4 34% Frontal Pole 
2 5.93 22 50 20 
23% Temporal Occipital Fusiform 
Cortex, 23% Temporal Fusiform 
Cortex, posterior division 
2 5.16 -32 -44 -24 
23% Precuneus Cortex, 15% 




Gyrus, 10% Cingulate Gyrus, posterior 
division 
2 8.66 2 -36 52 
61% Frontal Pole, 9% Middle Frontal 
Gyrus, 6% Inferior Frontal Gyrus, pars 
triangularis 
2 5.74 14 -70 -42 83% Frontal Pole 
2 5.7 44 40 14 
48% Lateral Occipital Cortex, inferior 
division 
2 5.47 -28 60 14 
24% Lateral Occipital Cortex, inferior 
division 
2 5.52 52 -70 -16 
52% Cingulate Gyrus, anterior division, 
16% Paracingulate Gyrus 
2 5.03 -34 -80 -2 
48% Occipital Pole, 8% Lateral 
Occipital Cortex, inferior division 
2 5.03 24 -22 24 
32% Parietal Operculum Cortex, 17% 
Supramarginal Gyrus, anterior division, 
6% Planum Temporale 
2 5.09 26 -94 -8 
10% Lingual Gyrus, 5% Occipital 
Fusiform Gyrus 
2 5.06 10 -48 -22 
10% Frontal Pole, 5% Middle Frontal 
Gyrus 
2 5.68 8 -82 -20 
35% Supramarginal Gyrus, anterior 
division 
1 5.02 -22 -4 32 
14% Supramarginal Gyrus, posterior 
division, 7% Planum Temporale, 6% 
Angular Gyrus 
1 5.79 -32 36 18 13% Cingulate Gyrus, anterior division 
1 5.15 68 -22 30 
35% Supramarginal Gyrus, anterior 
division 
1 5.4 -48 -46 20 
14% Supramarginal Gyrus, posterior 
division, 7% Planum Temporale, 6% 
Angular Gyrus 
1 5.26 12 6 34 13% Cingulate Gyrus, anterior division 
1 5.06 22 48 26 ,56% Frontal Pole 
1 7.82 36 -32 16 
37% Planum Temporale, 9% Parietal 
Operculum Cortex 
1 11.5 40 22 44 51% Middle Frontal Gyrus 
1 8.47 28 62 20 66% Frontal Pole 
1 9.91 -68 -38 36 
7% Supramarginal Gyrus, anterior 
division 
1 7.81 -40 -6 36 10% Precentral Gyrus 
1 5.93 6 -26 24 9% Cingulate Gyrus, posterior division 
1 5.02 -30 40 22 
,38% Frontal Pole, 12% Middle Frontal 
Gyrus 
1 5.17 14 -36 -30 20% Brain-Stem 
1 6.04 -14 -34 -18 
13% Parahippocampal Gyrus, posterior 
division 
1 5.36 -2 -42 -16 10% Brain-Stem 
1 5.38 36 12 -14 65% Insular Cortex 
1 5.13 -2 -88 -12 
48% Lingual Gyrus, 7% Occipital Pole, 
4% Intracalcarine Cortex 
1 5.69 48 -78 -12 
70% Lateral Occipital Cortex, inferior 
division 
1 5.19 -28 16 -12 
33% Insular Cortex, 20% Frontal 
Orbital Cortex 
1 5.04 20 -30 64 
34% Postcentral Gyrus, 31% Precentral 
Gyrus 




1 5.13 -4 -76 -10 61% Lingual Gyrus 
1 5.26 -34 -68 -2 
7% Lateral Occipital Cortex, inferior 
division, 5% Occipital Fusiform Gyrus 
1 5.17 -28 -68 2 5% Intracalcarine Cortex 
1 5.01 -34 -28 2 3% Insular Cortex 
1 5.07 -14 -88 4 
22% Intracalcarine Cortex, 8% 
Occipital Pole, 3% Lingual Gyrus 
1 5.15 -44 -18 4 
53% Heschl's Gyrus (includes H1 and 
H2), 6% Planum Polare 
1 5.01 -46 -8 6 
59% Central Opercular Cortex, 8% 
Heschl's Gyrus (includes H1 and H2), 
7% Planum Polare 
1 5.5 -36 50 6 64% Frontal Pole 
1 5.38 -34 -76 8 
12% Lateral Occipital Cortex, inferior 
division 
1 5.25 -54 -40 14 
26% Planum Temporale, 15% 
Supramarginal Gyrus, posterior 
division, 11% Superior Temporal 
Gyrus, posterior division 
1 5.09 -34 18 -12 
48% Frontal Orbital Cortex, 28% 
Insular Cortex 
Negative main effect of temperature 
25 5.25 -4 46 -14 
81% Frontal Medial Cortex, 11% 
Paracingulate Gyrus 
1 6.15 8 30 -12 
27% Subcallosal Cortex, 12% Frontal 
Medial Cortex 
Main effect of task 
2585 7.81 46 -46 -8 
17% Inferior Temporal Gyrus, 
temporooccipital part 
2535 13.7 -46 -74 -14 
59% Lateral Occipital Cortex, inferior 
division, 17% Occipital Fusiform Gyrus 
260 7.23 10 28 36 
39% Paracingulate Gyrus, 13% 
Cingulate Gyrus, anterior division 
248 6.05 34 20 6 
39% Insular Cortex, 24% Frontal 
Operculum Cortex 
154 6.27 -36 20 6 
65% Frontal Operculum Cortex, 10% 
Insular Cortex 
47 5.73 -22 -64 48 
60% Lateral Occipital Cortex, superior 
division, 5% Superior Parietal Lobule 
18 5.51 -30 -54 56 
44% Superior Parietal Lobule, 7% 
Lateral Occipital Cortex, superior 
division 
10 5.7 6 -30 -2 65% Brain-Stem 
9 5.34 48 6 30 
47% Precentral Gyrus, 8% Inferior 
Frontal Gyrus, pars opercularis 
8 5.35 38 -2 58 
37% Precentral Gyrus, 29% Middle 
Frontal Gyrus 
8 5.65 -4 -30 -4 73% Brain-Stem 
8 5.67 -46 -12 -4 
52% Planum Polare, 12% Heschl's 
Gyrus (includes H1 and H2) 
6 5.26 30 48 26 86% Frontal Pole 
5 5.43 22 -60 58 
2% Lateral Occipital Cortex, superior 
division, 8% Superior Parietal Lobule 
3 5.18 38 -6 50 
37% Precentral Gyrus, 10% Middle 
Frontal Gyrus 
3 5.47 -40 16 -8 
56% Insular Cortex, 9% Frontal Orbital 
Cortex 




2 5.13 18 -68 56 
48% Lateral Occipital Cortex, superior 
division 
2 5.07 -26 -60 -12 
42% Temporal Occipital Fusiform 
Cortex, 16% Occipital Fusiform Gyrus, 
9% Lingual Gyrus 
2 5.29 30 44 40 77% Frontal Pole 
2 11.2 26 -40 -12 
42% Lingual Gyrus, 24% Temporal 
Occipital Fusiform Cortex, 15% 
Parahippocampal Gyrus, posterior 
division, 11% Temporal Fusiform 
Cortex, posterior division 
1 5.1 30 -60 62 
51% Lateral Occipital Cortex, superior 
division, 13% Superior Parietal Lobule 
1 5.1 -2 -34 -22 99% Brain-Stem 
1 5.28 -2 -42 -14 6% Brain-Stem, 75% Left I-IV 
1 5.03 40 -2 48 
31% Precentral Gyrus, 24% Middle 
Frontal Gyrus 
1 5.03 40 -2 -14 
46% Insular Cortex, 11% Planum 
Polare 
1 5.15 42 -38 46 
39% Supramarginal Gyrus, posterior 
division, 18% Superior Parietal Lobule, 
7% Postcentral Gyrus 
1 5.07 -18 -78 42 
57% Lateral Occipital Cortex, superior 
division, 9% Precuneus Cortex 
1 5.03 -42 2 34 
38% Precentral Gyrus, 22% Middle 
Frontal Gyrus 
1 5.92 -48 -8 -4 
43% Planum Polare, 18% Heschl's 
Gyrus (includes H1 and H2) 
1 5.11 -4 32 26 
47% Paracingulate Gyrus, 44% 
Cingulate Gyrus, anterior division 
1 10.1 18 -28 0 88% Right Thalamus 
1 6.22 40 22 24 
26% Middle Frontal Gyrus, 10% 
Inferior Frontal Gyrus, pars 
opercularis, 5% Inferior Frontal Gyrus, 
pars triangularis 
1 5.34 2 36 20 
66% Cingulate Gyrus, anterior division, 
16% Paracingulate Gyrus 
1 5.05 26 48 18 62% Frontal Pole 
1 5.11 46 16 12 
29% Inferior Frontal Gyrus, pars 
opercularis 
1 5.01 -48 -24 10 
59% Heschl's Gyrus (includes H1 and 
H2), 7% Planum Temporale, 7% 
Central Opercular Cortex 
1 9.19 42 -2 0 75% Insular Cortex 
1 11.3 -40 -6 34 14% Precentral Gyrus 
Negative main effect of task 
333 6.18 -48 -62 24 
40% Lateral Occipital Cortex, superior 
division, 34% Angular Gyrus 
9 5.21 12 -50 38 
42% Precuneus Cortex, 19% Cingulate 
Gyrus, posterior division 
8 5.53 -24 -52 22 2% Precuneus Cortex 
4 6.56 -10 -34 8 57% Left Thalamus 
3 5.49 48 -74 46 
1% Lateral Occipital Cortex, superior 
division 
2 5.55 34 -52 4 
2% Lingual Gyrus, 1% Precuneus 
Cortex 
1 13 -14 -40 36 





1 6.38 18 -42 30 1% Cingulate Gyrus, posterior division 
1 9.05 34 -52 24 4% Angular Gyrus 
1 6.78 40 -52 22 18% Angular Gyrus 
1 7.07 38 -48 8 
1% Angular Gyrus, 1% Supramarginal 
Gyrus, posterior division 
1 7.41 -68 -52 2 
22% Middle Temporal Gyrus, 
temporooccipital part 
1 5.48 -4 48 -14 
83% Frontal Medial Cortex, 5% 
Paracingulate Gyrus 
1 5.03 22 -80 -36 95% Right Crus II 
Negative task * temperature interaction 
5 6.39 46 44 22 80% Frontal Pole 
1 5.27 42 20 2 
63% Frontal Operculum Cortex, 8% 
Frontal Orbital Cortex, 5% Insular 
Cortex 
1 5.23 50 40 22 
50% Frontal Pole, 13% Middle Frontal 
Gyrus 
1 5.09 56 26 32 19% Middle Frontal Gyrus 
1 5.52 52 34 32 




Supplementary Figure 1 (A) Administration of Reboxetine or Naltrexone did 
not significantly cause a change in temperature delivered as revealed by paired t 
tests (Placebo versus Reboxetine P = 0.74; Placebo versus Naltrexone P = 0.57). (B) 
Task velocity also did not change after Reboxetine nor Naltrexone administration 





Supplementary Figure 2 Main effect of temperature analysis using a whole 
cord mask revealed a cluster in the C6 bilateral DH, with lower significance in the 
right side. A bilateral cluster in the C5 dorsal horn was also found.  
Supplementary Figure 3 (A) The delta of parameter estimates extracted from 
the main effect of temperature spinal cord cluster did not significantly correlate with 
the delta of pain scores (main effect of temperature). (B) Similarly, the delta in 
parameter estimates extracted from the task * temperature interaction cluster in 





Supplementary Figure 4 The anterior insula and the frontal pole responded 
significantly to the negative task * temperature interaction.  Investigation of this 
result through extraction of parameter estimates does not suggest a role for these 
two regions in attentional analgesia. The anterior insula activates during all the 
conditions of high cognitive load (e.g. both pain and attention). The frontal pole also 
seems to activate during the condition of high cognitive load, except than during 









Supplementary Figure 5 (A) A cluster in the lower medulla responded more 
strongly in the naltrexone than in the placebo main effect of temperature. Result 
obtained with permutation testing using a main effect of temperature brainstem 
mask, obtained from the pooled analysis.  (B) The anterior insula responded more 
strongly in the naltrexone than in the placebo in the main effect of task (obtained 






Chapter 5 General Conclusions 
 
5.1 Summary 
The present collection of studies significantly contributed to the 
understanding of the attentional modulation of pain in health and disease. 
An attentional task with two levels of difficulty distracted study participants 
from a hot painful stimulus delivered on their left forearm. Concurrent fMRI 
in the entire CNS resolved the neural interactions behind attentional 
analgesia. Finally, through pharmacological manipulation, the functional 
contribution of endogenous opioids was resolved. The noradrenergic 
influence on attentional analgesia requires further investigation.  
The experimental set-up was successful in inducing attentional 
analgesia behaviourally in healthy volunteers, in the three different studies 
presented. The decrease in pain scores was of approximatively 5% in the 
three studies, consistent with previous work (Bantick et al., 2002; Tracey et 
al., 2002).  
In agreement with what has been showed before (Sprenger et al., 
2012), the opioid receptor antagonist naloxone abolished the analgesic 
effect, suggesting an opioid-dependent mechanism in attentional analgesia. 
On the other hand, the analgesic effect was present after administration of 
the noradrenaline reuptake inhibitor reboxetine, with a similar effect size to 
the control condition. The noradrenergic contribution to attentional 
analgesia is therefore less clear.  
Analyses of main effects resolved the cerebrum, brainstem, and spinal 
cord contribution to different aspects of attentional analgesia. Identical 
analysis techniques and software have been used for the three different 
studies and were able to reach most of the same findings. Main effect of 




showed increased activity with noxious versus innocuous stimulation. This 
network included the primary somatosensory cortex, the dorsal posterior 
insula, and the anterior cingulate cortex, among the others, consistent with 
the most important regions contributing to  the composite neurological pain 
signature (Wager et al., 2013). Importantly, the same cerebral set of regions 
was observed in the three different studies, and also after administration of 
an opioid antagonist or a noradrenaline re-uptake inhibitor. Main effect of 
task analyses revealed significant activity in the hard version of the task 
versus the easy version of the task, in regions consistent with the visual 
attention network (Nieuwenhuis et al., 2011). This included the lateral 
occipital cortex, the anterior cingulate cortex, and the anterior insula, in a 
pattern that was seen across the three studies. The drugs used did not have 
any effect on the attentional network, except for an increase in activity of 
the anterior insula after naltrexone administration. Notably, the ACC 
responded significantly to both main effect of task and of temperature, with 
overlapping clusters. The involvement of this area in both aspects of the 
attentional analgesia experiment suggested a role in attentional analgesia, 
and prompted investigation of the interactions of the ACC with the 
brainstem. 
In the brainstem PAG, LC and RVM were involved in both aspects of the 
experiment, with significant activation in main effect of temperature and 
main effect of task. Despite the challenges with imaging the brainstem with 
functional imaging (see section 1.4.3), these results were also consistent 
across the three different studies. Neither reboxetine nor naltrexone had 
any impact on the overall activity of the three nuclei during noxious 
stimulation or attentional demand. The lack of effect of reboxetine on LC 
activity was especially surprising. Animal data (Szabo et al., 2001) showed 
that reboxetine causes a dose-dependent inhibition of LC firing, by 
increasing the noradrenergic effect on alpha2 receptors. The lack of this 
effect in the study presented could be caused by underdosing of reboxetine. 
Alternatively, it is possible that the physiological noise in the LC did not allow 




On examination of spinal cord activity, a functional cluster responding 
to noxious stimulation was resolved in the dorsal horn of the spinal cord, in 
the C6 spinal segment. BOLD signal extracted from this area was lower in the 
high cognitive load versus the low cognitive load condition during high 
temperature stimulation, indicating spinal cord modulation during 
attentional analgesia. This effect was also observed after reboxetine 
administration, but was abolished by naltrexone, in line with the behavioural 
findings. A cluster in the spinal cord also reached significance in the task * 
temperature interaction contrast, with strong activity in the analgesic 
condition. It is therefore possible that this pool of neurons has an active role 
in modulating the dorsal horn response to noxious stimulation during 
distraction from pain. This cluster was not modulated by noradrenaline or 
endogenous opioids.  
Connectivity analyses were used to resolve functional interaction of 
brainstem nuclei with each other and with the cortex during attentional 
analgesia. It was found that high cognitive load has a top-down influence on 
the ACC-PAG-RVM system, during high temperature stimulation. In parallel,  
the attentional task also modulates the bidirectional interaction between 
ACC and LC. Both pathways are likely to have a causal involvement in the 
analgesic effect, with direct modulatory projections to the spinal cord. This 
was indeed demonstrated for the ACC-PAG-RVM pathway, where evidence 
for spinal cord modulation by the RVM was found. On the other hand, the 
role of the LC in this network is less clear. Study 3 failed to re-produce the 
functional interaction with the ACC, but provided evidence for a LC-RVM 
pathway to analgesia. The disparity in findings might be due to the larger 
voxel size used in study 3 to be able to measure functional activation in the 
whole CNS. A meta-analysis of LC imaging studies indeed found large voxels 
to dramatically decrease the ability of measuring functional signal form this 
very small nucleus (Liu et al., 2017). Further studies, perhaps with LC-specific 
imaging, are needed to finally resolve the functional connections to and 




Contrary to expectations, the same experimental paradigm was also 
successful in inducing attentional analgesia in fibromyalgia patients. 
Appropriate calibration of the thermal stimulus and cognitive task might 
have been crucial for achieving this unexpected result. This suggests that 
therapeutic approaches that target attentional processes have the potential 
of being efficient for this patient population. For example, cognitive  
behavioural therapy strategies that promote attention diversion and mental 
imagery (Elomaa et al., 2009). Importantly, the brainstem mechanisms 
behind attentional analgesia also seem to be identical to the ones in healthy 
volunteers, with engagement of PAG and RVM. This challenges the long-
standing hypothesis that these patients have dysfunctional pain modulatory 
mechanisms (Julien et al., 2005; Kosek et al., 1996; Lannersten et al., 2010; 
Staud et al., 2005; Vierck et al., 2001).  
5.2 Strengths and limitations 
The experiment used in the present thesis had two level of task 
difficulty and two levels of stimulus intensity, giving rise to a 2x2 design. This 
accurate definition of the CNS regions and connections between regions that 
responded specifically to high cognitive demand, to high thermal 
stimulation, and to the interaction between pain and attention. This is more 
sophisticated than the approaches that have been employed previously, 
where the only factor with two levels was the cognitive load (Bantick et al.,  
2002). As a consequence, these early studies could have only resolved 
regions involved in attentional processing. Regions resolved in the present 
thesis are confirmatory to the previous findings and are more directly 
implicated in generating analgesia.  
A recent article demonstrated that different choices in the pre-
processing or analysis pipelines of the same fMRI dataset can lead to 
radically different results (Botvinik-Nezer et al., 2020). The problem of 
between-group reproducibility in human imaging studies is indeed well 
known in the field and has been pointed out at other times (Eklund et al.,  




variability are addressed with mixed statistical models and the problem of 
multiple comparison with stringent statistical thresholds. The work 
presented here uses both strategies and addresses reproducibility issues by 
replicating identical analyses on independent datasets. Results of main 
effect analyses in brain and brainstem were indeed consistent across the 
three studies presented. This is especially important considering that a 
different head and neck coil, acquisition and pre-processing parameters 
were used in study 3 (Chapter 4) to be able to image the bigger field of view. 
In addition, functional imaging results presented here are in good 
agreement with findings from different research groups, adding robustness 
to the findings. Examples include spinal cord modulation during distraction 
from pain (Sprenger et al., 2012), involvement of the PAG in attentional 
analgesia  (Bantick et al., 2002; Tracey et al., 2002; Valet et al., 2004), and 
functional interaction between ACC and LC in conflict resolution (Köhler et 
al., 2016). 
An external, acute stimulus was used to cause pain in the fibromyalgia 
Study (Chapter 3). The reasons for it being consistency with the same studies 
on healthy volunteers, as well as temporal precision and titrability. However, 
this is an ecologically different sensation from the endogenous pain 
perceived by these patients. Experimental pain is also likely to not cause as 
much of the emotional response typically associated with chronic 
(inescapable) pain. Therefore, care should be taken in suggesting that our 
study is a definite demonstration that attention diversion can be a viable 
strategy in treatment of this patient population. Additionally, fibromyalgia 
patients reported regularly taking analgesic medications to manage their 
pathology, including noradrenergic drugs. It is possible that such drugs had 
an impact on the attentional and nociceptive processes. 
An obvious limitation of Study 3, common to most human pharma-fMRI 
experiments, is that the drugs were given systemically. This means that such 
medications could act on all available receptors in the central and peripheral 




simultaneous functional imaging it was possible to resolve the specific 
mechanisms affected, we were unable to target a specific region or neuronal 
population like is common in animal studies.  
5.3 Future directions 
This thesis shed light on the functional mechanisms in brainstem and 
spinal cord in the attentional modulation of pain. However, the issue of  how 
conflict is resolved in the brain during this paradigm remains unresolved. As 
discussed in section 1.2.3, pain is a highly attention demanding process 
(Legrain et al., 2009), thus a concurrent attentional task competes for 
attentional resources. The process that results in one of the two having 
precedence is likely to require high-level computations and weighting of the 
two stimuli. Computational models in conflict resolution experiments have 
been useful in suggesting mechanisms that might underlie this process in the 
ACC, for example a cost-benefit function (Botvinick et al., 2001, 2004) . 
Attentional analgesia studies would highly benefit from this approach, that 
would help to clarify how pain and attention interact in the brain, and how 
one takes precedence over the other. Such a study would also be of interest 
for general neuroscience research by furthering the understanding of 
conflict resolution in the brain.  
The acquisition sequence used in Chapter 4 can also be used to address 
unresolved mechanisms behind chronic pain pathologies, for example 
fibromyalgia. QST demonstrated hyperalgesia to hot and cold stimuli in 
these patients, consistent with results from other groups (Brietzke et al., 
2019; Hurtig et al., 2001). Different mechanisms have been proposed to 
explain this finding, for example altered central processing of the stimuli, or 
hyperexcitability of peripheral nociceptors. Altered spinal cord activity 
during rest has indeed been recently demonstrated in fibromyalgia patients 
(Martucci et al., 2019). It would be interesting to investigate whether the 
spinal cord also shows altered response during noxious stimulation. Full CNS 
imaging would also resolve whether the enhanced perception in these 




cause enhanced pain perception in the cortex), or top down effect (i.e. 
alterations in brain and brainstem cause facilitation of spinal cord response). 
Reboxetine was used in study 3 to investigate the role of noradrenaline 
in attentional analgesia. This drug is a noradrenaline reuptake inhibitor and 
was expected to enhance the analgesic effect of attention. However, no 
differences with the placebo condition were found behaviourally. This might 
mean either that noradrenaline does not play a significant role in attentional 
analgesia, or that higher noradrenaline availability in the system does not 
have a big impact on this process. Noradrenergic antagonists can cause 
severe side effects in healthy volunteers, for example sedation and low 
blood pressure. Thus, an alternative method of investigation needs to be 
used. Positron emission tomography is able to image cerebral blood flow as 
well as the dynamics of specific neurotransmitters/receptors. Using a tracer 
that tracks noradrenaline transporters or receptors (Chen et al., 2020; 
Sander et al., 2017) during attentional analgesia would be useful for 
addressing this issue.  
Additionally, pupil diameter was consistently found to correlate directly 
with the activity of the LC. This technique is less invasive than PET as it does 
not require tracer administration, and can even be used in individuals that 
could not have an MRI (e.g. because of metal implants). An attentional 
analgesia study using this method would significantly contribute to the 
understanding of the contribution of the LC in this process, especially if used 
in combination with fMRI. 
Finally, we have been able to reproduce a similar acquisition protocol 
to Finsterbusch et al., (2012), where the ideal shim value for each spinal cord 
slice was manually defined. While efficient, this method is however time -
consuming and subjected to human error. Spinal cord imaging would greatly 
benefit from an automated system, for example using machine learning, for 





The remarkable similarity of the biological mechanisms to attentional 
analgesia with the ones involved in placebo analgesia suggests that different 
strategies can be used to harvest the brain’s potential to cause pain relief. 
While distraction from pain only induced a small decrease in pain perception 
in the studies presented, it is worth noting that the attentional task used in 
the studies presented is not particularly engaging. Also, participants are in 
no way motivated in performing well as the monetary reward they received 
for taking part to the studies was not variable. This suggests that a more 
complex and engaging task, for example a videogame, could induce stronger 
analgesia. 
Ideally, in the future no “tricks” (e.g. manipulation of expectation or 
attention) will be needed to achieve analgesia. A patient would learn 
strategies to consciously engage specific brain regions and “switch on” the 
analgesic brain. A similar idea has been explored in a pain neurofeedback 
fMRI study (deCharms et al., 2005). This technique presents study 
participants with a live feedback on the activation of a specific region of their 
own brain, which they learn to actively modulate. While this study was 
successful in inducing significant pain relief by modulating ACC activity, the 
lack of extensive application in clinical practice suggests major challenges 
with this protocol. The present thesis resolved a reproducible functional 
network for endogenous analgesia. It is possible that direct targeting of the 
pathways resolved, perhaps through DCM-based neurofeedback (Koush et 
al., 2013) can be even more successful in inducing pain relief without 
medication. 
5.5 Conclusions 
The present collection of studies provided functional and mechanistic 
insights on the attentional modulation of pain, in health and disease.  Pain 
relief can be reliably achieved by engaging in a visual cognitive task, through 
recruitment of endogenous opioids. Noradrenaline seems to be involved, 




During high cognitive demand, the ACC recruits PAG and RVM in a top-
down network that modulates the spinal cord response to a hot painful 
stimulus. This pathway is dependent on endogenous opioids, that are 
especially important in the functional connections between ACC and PAG, 
and between RVM and spinal cord. This provides strong evidence against the 
hypothesis that cognitive modulation of pain is a supratentorial process, 
while emotional/expectation modulation of pain involves spinal cord 
modulation (Bushnell et al., 2013, see section 1.2.6). The results presented 
here indeed show overlapping biological mechanisms across different 
modalities of endogenous analgesia, perhaps recruited by different cortical 
areas (e.g. ACC in attentional analgesia and DLPFC in placebo analgesia).  
Evidence for a role of the LC in attentional analgesia was suggested in 
two out of three studies presented, in consistency with previous work 
(Brooks et al., 2017). However, its involvement in the network is less clear, 
with possible interactions with the ACC and the RVM during attentional 
analgesia. Further investigation is necessary to resolve the involvement of 
this nucleus and of noradrenaline. 
Interestingly, the pain relief induced by a shift in attention was not long-
lasting as would be expected after taking an analgesic tablet. The 
experimental conditions were randomised, meaning that “analgesic” 
conditions were interspersed with “painful” conditions. Thus, the biological 
mechanisms to attentional analgesia were only recruited briefly, as needed 
when attention was diverted. This is consistent with a continuous 
bidirectional modulation of spinal cord activity by the brainstem (Stroman 
et al., 2016), where cortical regions (e.g. the ACC) can shift the downstream 
influence from facilitatory to inhibitory and vice versa. 
The analgesic effect of attention was also shown in fibromyalgia 
patients, with similar biological substrates. Although the therapeutic 
effectiveness of this strategy on endogenous pain still needs to be clarified, 




useful for this pathology. Furthermore, the long-standing idea that 
brainstem nuclei are malfunctioning and are not efficient in achieving 
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